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Summary 
α-Amylases are a family of enzymes which catalyse the hydrolysis of α-D-(1,4) glucosidic linkages 
in starch and related compounds. α-Amylases are some of the most important industrial enzymes 
and they are used in a number of different industries one of these being the detergent industry. 
The commercial α-amylases are produced by fermentations of genetically modified bacteria, 
where the native gene has been manipulated to code for an enzyme with improved performance 
characteristics. Despite the genome only contains copies of the same α-amylase gene, multiple 
different α-amylase forms varying in pI value can be identified when analysing the final enzyme 
product, hereby indicating that the protein is modified.  
The purpose of the present Ph.D. project is to identify differences between the multiple forms 
of α-amylase derived from the same gene and determine if or how these various modifications 
affect the activity and wash performance. The focus of the present project is on α-amylases from 
Bacillus species used in the detergent industry. The thesis begins with an introduction to Bacillus α-
amylases, modifications which could cause the multiple forms varying in pI value and mass 
spectrometry (MS) methods used for the characterisation of these modifications. This is followed 
by a chapter concerning the methods used, followed by a chapter discussing the results obtained 
during the project. 
Studies of the multiple forms of α-amylases revealed that the multiple forms occur during the 
fermentation, where all the forms were observed already early on in the process. Characterisation 
of the wash performance of the multiple forms from three different Bacillus amylases showed 
tendencies of decreasing wash performance with decreasing pI values. A more thorough 
characterisation of pools of Bacillus licheniformis α-amylase (BLA) varying in pI revealed that the 
pools containing the forms with the lowest pI values had slightly lower catalytic efficiency on 
maltoheptaose and amylose.  
 Identification of the modifications responsible for the multiple forms of BLA was performed 
by tandem mass spectrometry (MS/MS). One of the modifications suspected to be responsible 
for the multiple forms, i.e. glycations, can be difficult to identify by the fragmentation methods 
normally used in MS/MS, such as higher-energy C-trap dissociation (HCD) as they tend to cleave 
of the modification. Therefore, HCD was compared with the soft fragmentations method 
electron transfer dissociation (ETD), which should be better at identifying these modifications 
because it leaves the modifications intact. Both methods were able to identify glycation sites on a 
model protein, though ETD identified more sites and provided higher sequence coverage for the 
glycated peptides.  
MS/MS analysis by HCD and ETD of the multiple forms of BLA identified deamidations, 
glycations and carbamylations as the modifications responsible for the forms varying in pI. The 
modified sites were mainly located on the surface of BLA with a few deamidations in the area 
around the active site. The modifications were in some cases observed on amino acids involved 
in stability, activity and substrate binding. Therefore, some of the multiple forms of BLA will 
most likely differ in stability, activity and performance due to these modifications.  
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Finally the influence of these modified sites was evaluated by characterisation of BLA variants 
with single site specific mutations. The BLA variants with mutations mimicking deamidations in 
the active site and in the substrate binding cleft were found to influence the kinetic parameters 
(kcat and KM) in different ways. The wash performance was also influenced by these mutations 
though these effects were mainly positive. Modified Lys and Arg residues suspected to be 
involved in substrate binding of longer substrates or secondary binding sites were evaluated by 
site specific mutations to amino acids with neutral side chains of approximately the same size. 
Hereby, evaluating the effect of removing possible carbohydrate interaction sites. This did not 
have any effect on the kinetic parameters but it generally resulted in increased wash 
performances.  
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Dansk resumé 
α-Amylaser tilhører en familie af enzymer, der katalyserer hydrolysen af α-D-(1,4) 
glykosidbindinger i stivelse og lignende forbindelser. α-Amylaser er et af de vigtigste industrielle 
enzymer i dag og det benyttes i mange forskellige industrier, som for eksempel detergent 
industrien. Industrielle amylaser produceres ved fermentering af genetisk modificerede bakterier, 
hvor det oprindelige amylase-gen er blevet manipuleret til at kode for et enzym med forbedret 
ydeevne. På trods af at den benyttede ekspressions-celle kun indeholder kopier af dette ene 
amylase-gen identificeres mange forskellige α-amylaser med forskellige pI værdier i det endelige 
produkt. Dette indikerer at enzymet bliver modificeret.  
Formålet med dette Ph.D. projekt er at identificere forskellene mellem de mange amylaseformer 
og undersøge om disse observerede modifikationer har en indflydelse på enzymets aktivitet og 
vaskeegenskaber. Fokus i dette projekt er på Bacillus α-amylaser, der benyttes i detergent 
industrien.  
Ph.D.-afhandlingen begynder med en introduktion af Bacillus α-amylaser, de modifikationer der 
kan forårsage de observerede pI ændringer og de massespektrometriske metoder, der benyttes i 
projektet til identifikation af disse modifikationer. Derefter følger et metode afsnit og til sidst 
præsenteres og diskuteres de opnåede resultater. 
Prøver fra fermenteringen viste, at de mange amylaseformer dannes allerede tidligt i løbet af 
denne proces. Karakterisering af de mange amylaseformer fra tre forskellige Bacillus amylaser viste 
at vaske egenskaberne blev forringet for formerne med de lavere pI værdier. Fraktioner 
indeholdende Bacillus licheniformis α-amylase (BLA) former med forskellige pI niveauer blev 
karakteriseret grundigere. Dette viste at fraktionerne indeholdende BLA formerne med de laveste 
pI værdier også havde lavere katalytisk effektivitet. 
Modifikationer, der forårsager de forskellige BLA former, blev identificeret ved brug af tandem-
massespektrometri (MS/MS). Glykeringer er en af de modifikationer der forventes at være med 
til at forårsage de forskellige former. Disse modifikationer kan være svære at identificere ved brug 
af de gængse fragmenteringsmetoder i MS/MS såsom higher-energy C-trap dissociation (HCD), 
da de kan kløve modifikationen af under fragmenteringen. Derfor blev HCD sammenlignet med 
en mindre hård fragmenteringsmetode kaldet electron transfer dissociation (ETD), som vil være 
bedre til at identificere glykeringer, da den ikke skulle kløve labile modifikationer af. Begge 
fragmenteringsmetoder viste sig brugbare til identifikation af glykeringer, men ETD 
identificerede flere glykeringssites og gav generelt en bedre sekvensdækning for de glykerede 
peptider.  
MS/MS analyser af de forskellige BLA former ved brug af både HCD og ETD fragmentering 
identificerede modifikationerne deamideringer, glykeringer og carbamyleringer. Disse 
modifikationer vil alle forårsage de fald i pI-værdier, som blev observeret for amylaserne. 
Modifikationerne blev kun observeret på aminosyrer på BLA’s overflade på nær nogle enkelte 
deamideringer, der var i området lige omkring det aktive site. Nogle af de modificerede 
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aminosyrer er involverede i enzymets stabilitet, aktivitet og substratbinding. Nogle af 
modifikationerne har derfor sandsynligvis en indflydelse på disse faktorer.  
Indflydelsen af disse modifikationer på BLA blev undersøgt for nogle specifikke sites. Dette 
blev gjort ved karakterisering af BLA varianter med site specifikke mutationer. Kinetiske analyser 
af BLA varianter med mutationer, der ligner deamideringer i det aktive site og i substrat 
bindingskløften, viste at disse enkelt mutationer havde betydning for de kinetiske parametre kcat 
og KM, bestemt på amylose og maltoheptaose. Disse BLA varianter viste også generelt forbedrede 
vaskeegenskaber. Modifikationer på Lys- og Arg-sidekæderne, der kunne være involveret i 
binding af længere substrater eller en del af sekundære bindings sites, blev også analyseret ved site 
specifikke mutationer til aminosyrer med neutrale sidekæder af nogenlunde samme størrelse. 
Derved kunne effekten af at fjerne mulige glykerings sites vurderes. Disse mutationer havde 
ingen indflydelse på de kinetiske parametre bestemt på substraterne amylose og maltoheptaose, 
men de havde derimod en generel positiv effekt på BLA’s vaskeegenskaber.    
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1 Introduction 
α-Amylases are among the most important industrial enzymes and within the detergent industry 
they are the second most used class of enzymes. In the detergent industry α-amylases are used to 
remove starch containing stains from clothes. The industrial α-amylases can become modified 
during the production resulting in multiple forms varying in pI values. The effect of these 
modifications on the activity of the α-amylase is unknown. 
It is the purpose of this section to introduce Bacillus α-amylases, the modifications which could 
create the multiple forms varying in pI value and the theory behind the mass spectrometry (MS) 
methods used in the present project for the characterisation of these modifications.  
1.1 α-Amylase 
α-Amylases are a family of enzymes which catalyse the hydrolysis of α-D-(1,4) glucosidic linkages 
in starch and related compounds hereby releasing maltooligosaccharides and glucose in the α-
anomeric configuration, hence their name (Machius et al., 1998; Vihinen et al., 1989). α-Amylases 
are among the most important industrial enzymes with widespread use in various industries. The 
enzymes are used for starch liquefaction and saccharification in the starch and fuel alcohol 
industries, for starch stain removal in the detergent industry as well as in industries such as baking 
and brewing (de Souza et al., 2010; Kirk et al., 2002; Nielsen et al., 2000). 
Starch is made of glucose residues and serves as an important energy reserve in plants. The 
major components of starch are the two polysaccharides amylose and amylopectin, Figure 1. 
Amylose is essentially a linear α-glucan consisting of approximately 99% α-(1→4) and 1% α-
(1→6) bonds. This means that a certain degree of branching does occur with between nine and 
twenty branch points per molecule. The number of glucose residues per molecule, also referred 
to as degree of polymerisation (DP), range between 650-5000. Amylopectin is a bigger 
polysaccharide with more branching than amylose containing around 95% α-(1→4) and 5% α-
(1→6) bonds. The branch chains of amylopectin are relatively short with 20 – 25 glucose units 
(Gaillard et al., 1987; Tester et al., 2005).  
 
 
Figure 1. The structure of segments of amylose and amylopectin (Chaplin 2012). 
 
Amylose Amylopectin
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The 3D-structures of α-amylases are closely related despite even large differences in their 
primary structure (Janecek 1997). In spite of these differences four highly conserved regions have 
been found by comparing amino acid sequences of different Bacillus α-amylases. These four 
regions are all related to the catalytic and substrate binding sites of the enzyme (Kuriki et al., 1999; 
Nakajima et al., 1986; Svensson 1988). The structure of α-amylases is divided into the three main 
domains: A, B and C. Domain A consists of an N-terminal α/β barrel which forms the core of 
the enzyme. This domain also contains the three catalytic site residues, two Asp and a Glu. The 
other two domains, B and C, are located on each side of domain A. Domain B is a loop domain 
and varies most between α-amylase structures (Janecek et al., 1997). It connects β-strand 3 with α-
helix 3 of domain A thus forming a long loop. Domain A and domain B form the substrate 
binding site. Domain C is a greek key motif comprising the C-terminal part of the sequence 
(Janecek 1997; Nielsen et al., 2000; Svensson 1994). The different α-amylases can contain a variety 
of metal ions, but almost all have at least one bound calcium ion. The conserved Ca2+ is 
interfaced between domain A and B, hereby stabilising the structure around the active site 
making the ion important for proper enzyme activity (Nielsen et al., 2000; Valle et al., 1959).  
The substrate binds in the substrate binding cleft located between domain A and domain B. In 
different α-amylases the cleft can bind between four and ten glucose units where each unit is 
bound by the amino acid residues constituting the binding subsite for that glucose unit 
(MacGregor et al., 2001; Nielsen et al., 2000). The subsites are named according to the location of 
the site to the cleavage bond with negative nomenclature on the non-reducing side of the 
cleavage bond and positive on the other, so the glucose units on each side of the bond to be 
cleaved are in subsites -1 and +1, respectively (Davies et al., 1997). There can be two to three 
subsites towards the substrate reducing end from the cleavage bond (+1 to +3) whereas the 
number of subsites towards the non reducing end of the substrate can vary between 2 and 7 
(MacGregor et al., 2001; Nielsen et al., 2000).   
 
 
Figure 2. The catalytic mechanism for α-amylases. Glu protonates the glucosidic oxygen followed by the first Asp 
residue acting as catalytic nucleophile attacking C1 of the glucosidic residue, hereby forming the first transition state 
leading to a covalent intermediate. The protonated glucosidic unit leaves the active site and water molecules enter the 
active site. Activation of the water molecule results in the second transition state where the covalent bond between 
C1 and Asp is cleaved. The second Asp residue in the active site stabilises the reaction intermediates by hydrogen 
bonding (van der Maarel et al., 2002). 
 
The catalytic mechanism for α-amylases, Figure 2, is proposed to first apply the Glu acting as a 
proton donor in the protonation of the glycosidic oxygen. The first Asp residue then acts as a 
catalytic nucleophile attacking C1 of the glucose residue in subsite -1, hereby forming the first 
transition state leading to a covalent intermediate. The protonated glucose unit in subsite +1 
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leaves the active site and a water molecule is proposed to move into this site and be activated by 
the deprotonated Glu. The water molecule then hydrolyses the covalent bond formed between 
the oxygen of the Asp residue and the C1 of the sugar residue, to complete the catalytic 
mechanism. The role of the third conserved residue, the second Asp in the catalytic mechanism is 
presumed to be involved in the stabilisation of the reaction intermediate through hydrogen bonds 
to –OH groups on the substrate which makes it very important for the enzyme activity (Kuriki et 
al., 1999; Nielsen et al., 2000; van der Maarel et al., 2002). 
Structural studies of amylases have revealed that non-catalytic binding of carbohydrates also 
can occur in secondary binding sites (SBS) (Brzozowski et al., 2000; Dauter et al., 1999; Lyhne-
Iversen et al., 2006; Ragunath et al., 2008; Robert et al., 2003). These SBS are generally located on 
the surface in a certain distance from the substrate binding cleft and the catalytic site. The amino 
acid residues involved in SBS are not conserved among different α-amylases. However, they are 
often observed in the same regions on the surface of α-amylases. SBS generally contain amino 
acids with aromatic side chains such as Trp and Tyr which are able to hydrophobically interact 
with carbohydrates. The exact role of these sites is not fully elucidated and since the sites can be 
located in all three domains of the α-amylases it has been proposed that different sites play 
different roles such as cooperation with the active site in degradation of different substrate, as 
initial substrate recognition sites or to retaining reaction product for further processing by other 
proteins or for import to bacterium/cell (Cuyvers et al., 2011; Janecek et al., 1997; Nielsen et al., 
2008; Nielsen et al., 2009). 
1.1.1 Bacillus amylases  
Bacillus α-amylases are widely used in industrial processes as they generally are thermo stable 
and/or stable under alkaline conditions, the latter being an important property in the detergent 
industry. The main focus of this project is on the amylases from Bacillus sp. working with the 
following: Bacillus halmapalus α-amylase (BHA), alkaline Bacillus sp. α-amylase (AA560), Bacillus 
licheniformis α-amylase (BLA) and Bacillus amyloliquefaciens α-amylase (BAN) where the structural 
analysis will be performed on BLA. The amino acid sequence of these Bacillus amylases differs 
but their overall tertiary structures are very similar. 
B. licheniformis produces at least two α-amylases with different amino acid sequences and action 
patterns where BLA is very thermostable despite the bacterium itself is mesophilic (Kim et al., 
1992; Yuuki et al., 1985). BLA consists of 483 amino acids with the molecular weight (Mw) of 
55239 Da, is stable between pH 6 and 11 and has a temperature optimum between 60 and 105ºC 
depending on pH (Fitter et al., 2001; Tomazic et al., 1988b; Vihinen et al., 1989; Yuuki et al., 1985).  
The structure of BLA follows the general features for α-amylases with domain A as the most 
conserved containing the active site and the conserved calcium binding site, Figure 3. Domain B 
is the least conserved domain and it is established as a protrusion from domain A. The main 
characteristics of domain B in BLA are two long β-strands which wind around each other in a 
double helical manner. The B domain also contains a distinct loop which wind around a Ca2+-
Na+- Ca2+ metal triad. This triad is quite unique as the conserved calcium binding site is a part of 
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this metal binding motif. The three metal ions mainly situated in domain B are linearly arranged 
and involved in 20 interactions with the surrounding amino acid residues and some water 
molecules. BLA also contains a third Ca-ion interfaced between domain A and C. This Ca-ion is 
believed to be a stabilising extra anchor point between the two domains. There is also found 
indications of a chloride binding site in BLA, but this has not been confirmed by 3D structure 
analysis (Machius et al., 1995; Machius et al., 1998).  
 
 
Figure 3. The structure of BLA. Red colour shows domain A, green domain B and blue domain C. The grey colour 
is the region of domain B which in Ca depleted structure is disordered. Calcium ions are shown in cyan and sodium 
in yellow (Machius et al., 1998). 
 
The importance of calcium has been investigated by denaturing BLA with and without Ca2+-
ions showing a much higher resistance to denaturation in the presence of calcium (Nazmi et al., 
2006). The importance of the metal triad for stability has also been identified by mutating amino 
acids in this site, which resulted in loss of stability (Declerck et al., 2000; Declerck et al., 2003). 
The role of the third Ca2+-ion in the stability is not elucidated. The triad, however, cannot 
completely account for the high thermostability since other Bacillus α-amylases are believed to 
contain the same triad along with the third Ca2+-ion, without exhibiting the high thermostability. 
Thus, other factors may also contribute to the stability of BLA (Declerck et al., 2000; Machius et 
al., 1998).  
The three catalytic site residues in BLA are Asp231, Glu261 and Asp328 (Machius et al., 1995) 
where Asp231 acts as the catalytic nucleophile while Asp 328 is the stabilising Asp residue. BLA 
contains several substrate binding sites on the surface for interaction with the polymeric 
substrate. One of these binding sites is the active site cleft including the catalytic site; it consists 
of at least eight subsites each binding a glucosyl residue of the substrate (Kandra et al., 2002; 
Machius et al., 1998). 
Chemical modifications of Lys residues on the surface of BLA have in different studies resulted 
in changes in kinetic parameters as well as in the substrate specificity. The importance of specific 
Lys residues were, however, not elucidated (Habibi et al., 2004; Kandra et al., 2002).  
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1.1.2 Production of industrial amylases 
Industrial enzymes are produced by fermentation of genetically modified organisms such as 
bacteria or fungi. Multiple gene copies of the genetically optimised enzyme with improved 
performance are inserted into the organism’s genome to increase expression of the gene and 
hereby the enzyme yield. 
The amylases for detergent are generally produced by fed-batch fermentation of Bacillus strains. 
The organism used for the production of the amylases are first grown in an inoculation tank and 
is then transferred to the fermentation tank where sterilised nutrients are added to the fermentor 
during the growth of the biomass. The nutrients are based on renewable raw materials such as 
partially hydrolysed corn starch, sugars and soy grit. Additionally inorganic salts are added. The 
pH, temperature, oxygen consumption and CO2 formation are carefully controlled during the 
fermentation to optimise the production process (Olsen et al., 2008).  
The recovery of the amylases from the fermentation medium consists of several steps where the 
first include flocculation. The enzymes are then separated from the biomass and other insoluble 
materials by drum filtration followed by a fine centrifugation or filtration step removing the small 
amounts of sludge remaining after the drum filtration. At last the enzyme solution is 
concentrated by ultrafiltration (Olsen et al., 2008). 
1.1.3 α-Amylases in detergent 
In the detergent industry α-amylases are the second most used enzyme after proteases. They are 
used to remove starch containing stains from for instance pasta, fruit, chocolate and gravy. Starch 
is also commonly used in processed foods as a thickening agent. Gelatinised starch adheres to the 
surface of textiles where it can bind other stain components. Detergent amylases are able to 
degrade the gelatinised starch into soluble dextrins and oligosaccharides, hereby removing the 
starch stain and the stain components bound to it (Eriksen 1996; Kirk et al., 2002; Olsen et al., 
2008).  
There are two main criteria for enzymes in detergent which is their stability in the detergent 
with all the different components and their activity at the wash conditions. The chemical 
properties of detergents can vary considerable though detergents can be divided into two main 
groups, liquid and powder. These two detergent types differ in wash pH as the former has a pH 
around pH 8 and the latter a pH around 10. The trend within laundry wash in Europe has moved 
toward lower temperatures to save energy with 30 – 40°C being standard wash temperatures. 
Though, the goal is to lower the temperature even further. Some detergent components have a 
negative effect on the enzymes stability and activity by interacting with the protein structure or 
the active site (Eriksen 1996; Kirk et al., 2002; Olsen et al., 2008). Especially detergents ingredients 
such as chelators and surfactants influence the stability (Lund et al., 2012). Therefore, a good 
detergent amylase is stable and active at neutral to alkaline pH, in the presence of other detergent 
ingredients and in the temperature range 20 – 60°C. 
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1.2 Post-translational modifications 
Post-translational modifications (PTM) on proteins can occur either as enzymatically induced 
reactions or as chemical reactions. During the production of recombinant proteins these can 
undergo non-enzymatic PTM. These reactions can influence the enzyme stability and activity 
when they occur on amino acid residues involved in these factors. Some of the most prevalent 
non-enzymatic PTMs are deamidation, oxidation and glycations and these will be described in the 
following sections (Jenkins et al., 2008; Manning et al., 2010). 
1.2.1 Glycation 
Glycation is a non-enzymatic reaction between primary amines on proteins and the carbonyl 
group of a reducing sugar also known as a Maillard reaction (Maillard 1912). Since the reaction 
occurs at amino groups, the N-terminal ends (α-amino group) of proteins along with lysine (ε-
amino groups) and arginine (guanidino group) side chains are prone to the reaction. The 
glycation forms a ketoamine also known as the Amadori compound which can undergo a series 
of rearrangement reactions to form a group of more reactive carbonyl compounds termed 
advanced glycation end products (AGEs), Figure 4 (Baynes et al., 1989; Brownlee et al., 1988). 
 
 
Figure 4. The reaction pathway for the Maillard reaction. An amino group on a protein reacts with the reducing 
sugar and undergoes Amadori rearrangement forming an Amadori product. This can then undergo several different 
reactions leading to the formation of different advanced glycation end products (AGEs) (Kislinger et al., 2004). 
 
The Maillard reaction can be divided into three stages where the first stage is the formation of a 
covalent bond between the amino group and the aldehyde or keto group of the reducing sugar 
Amadore rearrangmentEarly phase 
Maillard reaction
Late phase 
Maillard reaction oxidation or degradation
oxidation or degradation
glucosone
3-deoxyglucosone
sugar oxidation and degradation products
carboxymethyllysine
carboxyethyllysine
imidazolone A
advanced glycation end products
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resulting in a Schiff base, Figure 4. Rearrangements then form the early glycation Amadori 
product (ketoamine). In the second stage the Amadori product can be degraded into a variety of 
reactive carbonyl compounds most often deoxyglucosones formed through dehydration. In the 
last stage the reactive carbonyl compounds leads to the formation of AGEs. These are formed by 
reaction of the carbonyl compounds with free amino groups and through rearrangements. So far 
several glycation products have been identified, but from model reactions several other structures 
have been proposed (Horvat et al., 2004; Kislinger et al., 2004; Martins et al., 2000). These AGEs 
include 3-deoxyglucosone (144 Da), carboxymethyl (58 Da), carboxyethyl (72 Da), imidazolone A 
(144 Da) and methylglyoxal-derived hydroimidazolone (MG-HI, 54 Da) as some of the most 
described (Ames 2008; Barnaby et al., 2011; Kislinger et al., 2004; Kislinger et al., 2005).  
The Maillard reactions play an important role in food chemistry as it is a source of colour and 
flavour in processed food but the reactions are also suspected to be involved in the development 
of a number of different diseases (Priego-Capote et al., 2009; Horvat et al., 2004; Martins et al., 
2000). AGEs are believed to be involved in the development of diabetic complications (Ahmed 
2005; Thorpe et al., 1996) and they are suspected to play a role in other diseases for instance 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease (Munch et al., 1998; 
Nicolls 2004). However, glycation also occur during the production and storage of recombinant 
proteins. When the proteins are secreted to the cell culture medium during the fermentation they 
are exposed to reducing sugars. The proteins can in some formulations also be exposed to 
reactive sugars. This can result in conformational changes, instability, changes in biological 
properties of proteins and loss of enzyme activity (Bruins et al., 2003; Chobert et al., 2006; Fischer 
et al., 2008; Li et al., 1996; Quan et al., 2008).   
The Maillard reaction is highly dependent on temperature, pH, reactants (type of sugars and 
amine) and the concentration of the reducing sugars. The initial glycation is favoured by alkaline 
conditions and the rate of reaction increases with temperature. The reactions occurring in the 
second and third stages of the Maillard reaction also seem to be influenced by pH. Different 
products will form dependent on whether the conditions are acidic, neutral or alkaline (Martins et 
al., 2000; Quan et al., 2008). There are indications that properties of nearby amino acids influence 
which Lys residues undergo glycation (Baynes et al., 1989; Johansen et al., 2006). 
1.2.2 Deamidation 
Deamidation is one of the most prevalent non-enzymatic reactions and it can have an influence 
on protein stability and activity. The amino acid most prone to deamidation is asparagine 
resulting in the formation of either isoaspartate or aspartate. Deamidation occurs in two steps, 
Figure 5, where the first is a nucleophilic attack by the α-amino group of Asn forming a cyclic 
imide. The imide intermediate then undergoes hydrolysis forming either isoaspartate or aspartate. 
The formation of either of these two causes a change in pI for the protein as the amino acid side 
chain changes from neutral to acidic (Aswad et al., 2000; Manning et al., 1989; Powell et al., 2007). 
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Figure 5. Deamidation of asparagine is caused by the nucleophilic attack by the α-amino group, releasing ammonia. 
A succinimide intermediate is formed which then hydrolyses to either isoaspartate or aspartate, where isoaspartate 
formation dominates (Chelius et al., 2005). 
 
Glutamine residues can also undergo deamidation but this reaction is one hundred times slower 
than for asparagines. Gln is less susceptible since it is incapable of forming the same 5-membered 
cyclic imide intermediate. It can produce a six membered ring structure but this is less stable than 
the five membered counterpart (Joshi et al., 2002; Manning et al., 2010; Patel et al., 1990).  
Deamidation can occur at neutral and alkaline conditions and the reaction is accelerated by 
increasing temperature and pH. Deamidations can also occur at acidic conditions, however here 
the side chains are hydrolysed directly to the corresponding acid not forming the cyclic 
intermediate (Patel et al., 1990; Stratton et al., 2001). Asparagines on the surface of proteins are 
more exposed to deamidations. The amino acid sequence also influences the rate of deamidation 
as amino acids with smaller side chains after Asn residues increase the reaction rate, due to low 
steric hindrance leaving the amino group open for attack (Vieille et al., 2001). Amino acids which 
can perform hydrogen bond-donation also seem to promote the reaction. Therefore, it has been 
observed that Asn-Gly is the most reactive sequence but also Asn followed by Ser or His are very 
reactive sites (Aswad et al., 2000; Manning et al., 2010; Robinson et al., 2001; Robinson 2002). The 
secondary structure of α-helices and β-sheets tend to protect Asn residues against deamidation 
(Xie et al., 1999).  
1.2.3 Carbamylation and other PTMs 
Another PTM occurring with the primary amines on proteins is carbamylation. This spontaneous 
non-enzymatic reaction modifies Lys and Arg residues as well as the N-terminal on proteins. 
Urea can spontaneously form cyanate of which the reactive form isocyanic acid can irreversibly 
modify non-protonated amino groups, Figure 6. This reaction can change the charge and 
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function of amino acids and it has been found to alter enzyme activity and protein stability 
(Albert et al., 2011; Harding et al., 1989; Kraus et al., 2001). 
 
 
Figure 6. The spontaneous formation of cyanate and isocyanate from urea and the following carbamylation of 
proteins by isocyanate. 
 
Acetylation is the addition of acetyl (CH3CO) to amino groups of Lys residues and the N-
terminal of proteins. This reaction is enzymatically controlled within cells and the modification is 
important for controlling the life span of proteins within the cell as non acetylated proteins 
quickly become degraded by intracellular proteases (Lodish et al., 2004). This modification is 
therefore not the most likely modification to occur on Bacillus amylases as these are extracellular 
enzymes.    
The side chains of Met, Cys, His, Trp and Tyr can undergo oxidation at any stage of the protein 
production and purification and this can lead to protein degradation. The oxidation rate is 
determined by the protein structure as a side chain buried in the structure can be partially 
protected, but also pH and temperature are important factors, though Met oxidation appears to 
be pH independent (Jenkins et al., 2008; Manning et al., 2010). 
Protein truncation is the shortening of the protein by proteases resulting in a new N-terminal or 
C-terminal residue. Truncation may also arise from mutations leading to premature termination 
of mRNA translation. In this project protein truncation also includes the removal of 1 – 3 amino 
acids from the C-terminal end by carboxypeptidases. These enzymes are produced during the 
fermentation and released either as extracellular enzymes or due to cell lysis. This modification 
may affect the 3D structure and the activity of the enzyme. The pI value of the protein molecules 
are affected if some of the lost amino acids contribute to the pI of the full-length protein.  
 
  
=
O
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1.3 Mass spectrometry 
MS is a method capable of determining mass per charge (m/z) from which the molecular weight 
of most molecules from small metal ions to proteins can be determined. MS is an invaluable tool 
within biochemistry as this highly sensitive method is able to identify proteins and their amino 
acid sequence in relatively short time. The main focus of this report is on the MS methods used 
to determine PTMs on proteins and the methods used to perform relative quantification. 
1.3.1 Methods for protein characterisation  
Protein identification is possible with tandem mass spectrometry (MS/MS). In this method the 
protein is first digested into peptides by specific proteases such as the endoproteinases trypsin, 
Asp-N and Lys-C. The amino acid sequence of the peptides are then determined with MS/MS 
(Koomen et al., 2005; Mann et al., 2001; Pappin et al., 1993). 
In MS/MS peptides are fragmented into smaller amino acid sequences by collision with an inert 
gas or by reaction with electrons. The fragmentation occurs in the peptide backbone producing 
fragment ions which are designated, according to the Roepstorff-Folhmann-Biermann 
nomenclature, after the peptide bond which is fragmented, Figure 7 (Biemann 1992; Roepstorff et 
al., 1984). For the most common fragmentation techniques the amide bonds are broken 
producing what is called b and y ions depending on which part of the broken peptide retains the 
charge (Barrett et al., 2005; Mikesh et al., 2006).  
 
 
Figure 7. The different kind of ions obtained by MS/MS. The peptide is fragmented in the backbone. When the 
fragmentation occur in a peptide bond either y or b ions are obtained depending on which end is charged. If other 
bonds in the peptide is broken a and x ions or c and z ions are obtained (Hjernø et al., 2005). 
 
The amino acid sequence of the peptides is determined by calculating the differences between 
peaks and finding those correlating to amino acid masses (Roepstorff et al., 1984). However, as 
MS/MS spectra often also contains other than b and y ions (a and x, c and z) and they can be 
very complex and difficult to analyse. Therefore, protein databases are most often used to analyse 
MS/MS spectra.  
The datasets obtained from MS/MS are generally quite large and the individual spectrum can as 
mentioned previously be very complex so protein and peptide identifications are obtained with 
search engines applying search algorithms such as MASCOT or SEQUEST to search protein 
databases. The search engines identify proteins from the MS/MS data by comparing the masses 
of the peptides and the peptide fragments with theoretical masses or spectra of protein sequences 
in the applied database. Various algorithms and statistical tools are used to evaluate the 
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significance of the identifications and provide a probability score for the identification (Cramer et 
al., 2005; Steen et al., 2004). 
1.3.2 Mass spectrometer 
A mass spectrometer consists of an inlet for the sample, an ion source, mass analyser, detector 
and a data processing system. The system works by first converting the sample ions into gas 
phase. This is done by an ion source, from here the ions are accelerated into the analyser where 
they are separated according to m/z. The detector then collects the signals from the ions and a 
data processing system converts these signals into a mass spectrum (Gross 2011; Hoffmann et al., 
2008a). 
In MS of proteins and peptides the ion source used has to be able to perform soft ionisation to 
avoid excessive fragmentation of these molecules during ionisation. Two types of ion sources are 
able to do this, the MALDI (Matrix-Assisted Laser Desorption Ionisation) and the ESI 
(Electrospray Ionisation) (Domon et al., 2006; Koomen et al., 2005). In this project the mass 
spectrometers used are equipped with ESI ion source.  
In the ESI ion source developed by Fenn an co-workers (1989) a liquid sample is passed 
through a metallic capillary tube with a strong electrical field under atmospheric pressure. This 
causes an accumulation of charge on the surface of the liquid which then will disperse into small 
highly ionised droplets. The solvent are removed by exposing the droplets to a counter current of 
heated inert gas most often nitrogen. In this way the molecules become charged and are hereafter 
led into the analyser. In ESI the peptides can be doubly or multiply charged (though they are 
mostly doubly charged) which makes the ESI spectrum complex (Gross 2011; Hoffmann et al., 
2008b). 
ESI can be run in a positive and a negative mode. In positive ESI mode the positively charged 
ions are detected and in negative ESI mode negative ions are detected. In positive mode the 
positive charge on droplets is generated by removing the negative charges through 
electrochemical discharge of negative ions on the metal wall of the capillary tube. In negative ESI 
mode the positive charges are removed by the same principles (Bruins 1998).   
As the ESI method is based on a liquid sample this ion source can be couple to liquid 
chromatography (LC) and many different types of mass analysers. This makes it possible to 
separate complex mixtures in the liquid phase before the ESI-MS analysis (Gross 2011; 
Hoffmann et al., 2008b). The development of the nanoESI has made it possible to analyse much 
smaller volumes and hereby smaller amounts of analyst (Wilm et al., 1996). 
1.3.2.1 Orbitrap and ion trap analysers 
The linear (or quadrupole) ion trap (LIT) analyser is able to perform both MS and MS/MS in the 
same analyser, as it is able to scan, select and fragment peptides. The LIT separates in time as it 
traps the gaseous ions between trapping plates using radiofrequency voltages. Changes in 
amplitude or frequencies make it possible to select specific ions for fragmentation or push ions 
out of the trap for detection. These analysers are sensitive, quick, have a high trapping capacity 
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and operate with low kinetic energy which results in higher MS/MS efficiency but it generally 
runs at lower resolution and mass accuracy (Glish et al., 2008; Gross 2011; Hager 2002). 
Another trap analyser is the orbitrap which incorporates another concept where the ions are 
trapped in an electrostatic field. The gaseous ions are moving in spirals around a central 
electrode. The orbitrap is not able to perform MS/MS, as it needs a proper ion injection and ultra 
high vacuum to perform properly. Therefore a radiofrequency voltage C-trap is used to 
accumulate, store and thermalize ions for injection into the orbitrap by a low pressure of 
nitrogen. The orbitrap operates at high resolution with a high mass accuracy but the kinetic 
energy is high which can result in reduced MS/MS efficiency (Gross 2011; Makarov et al., 2006; 
Makarov et al., 2010).  
The LIT and orbitrap analysers can be combined in hybrid MS instruments such as the LTQ-
Orbitrap instruments hereby combining the advantages of the two analysers such as the mass 
accuracy of the orbitrap with the speed and high MS/MS efficiency of the LIT. In the hybrid 
instrument ions can be moved after accumulation between the two analysers through a C-trap 
which moves packets of ions between the two traps (Glish et al., 2008; Gross 2011; Makarov et 
al., 2006). For this project the two hybrid instruments LTQ Orbitrap XL and LTQ Orbitrap 
Velos (both from Thermo Scientific) were available for sample analysis. The LTQ Orbitrap Velos 
has higher isolation and fragmentation efficiency compared to the XL as well as better resolving 
power and mass accuracy. The LTQ orbitrap XL was, however, upgraded with the fragmentation 
method electron transfer dissociation (see section 1.3.2.2). 
1.3.2.2 Fragmentation 
Numerous different fragmentation methods exist, however as only orbitrap hybrid instruments 
was used in this project the focus of this section is on fragmentation methods used in these 
instruments.  
The most common method used for peptide fragmentation is low-energy collision induced 
dissociation (CID) (Mikesh et al., 2006). In CID the peptides selected for MS/MS are fragmented 
by interaction with a collision gas most often nitrogen or argon. As peptides are most vulnerable 
in their amide bonds these are generally the ones broken in the collision producing b and y ions, 
but other bonds can also be broken. CID is most effective on short low charged peptides (Syka et 
al., 2004; Wysocki et al., 2000). CID is sometimes not hard enough to achieve sufficient 
fragmentation in the LIT of the hybrid instruments so a harsher CID can be obtained in the C-
trap by raising the radiofrequency voltage. This method termed Higher-energy C-trap 
Dissociation (HCD) applies the nitrogen already present in the C-trap as collision gas. The most 
optimal HCD fragmentation with a wide m/z range is obtained by attaching a collision cell at the 
end of the C-trap (Olsen et al., 2007; Scherl et al., 2008). In the fragmentation of peptides with 
labile PTMs CID and HCD often cleave off the modification leaving the peptide backbone 
intact. This can result in a MS/MS spectrum devoid of consecutive peptide backbone cleavage 
product ions and as a consequence in poor peptide sequence assignment (Mann et al., 2003; 
Mirgorodskaya et al., 2001).  
 23 
 
The fragmentation method Electron Capture Dissociation (ECD) (Zubarev et al., 1998) is a soft 
fragmentation method where low energy electrons react with peptide cations in the magnetic field 
of Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometers. This induces 
random breakage of the peptide backbone producing mainly c and z ions, Figure 7, while leaving 
labile modifications intact. However, ECD is only compatible with FT-ICR the most expensive 
MS instrument (Boyne et al., 2006; Kjeldsen et al., 2003; Zubarev 2004). 
Electron transfer dissociation (ETD) is an alternative soft fragmentation method that can be 
used in combination with trap analysers. In ETD an electron from a radical anion, typically 
fluoranthene, is transferred to a multiple charged peptide hereby causing cleavage of the Cα – N 
bond in the peptide backbone producing mainly c- and z-ions but y-ions can also be produced. 
This soft fragmentation method is very suitable for characterisation of peptides containing PTM 
as it leaves labile modifications intact allowing for direct mapping of peptide modifications (Chi et 
al., 2007; Hogan et al., 2005; Kjeldsen et al., 2007; Mikesh et al., 2006; Syka et al., 2004). However, 
ETD has limited application on doubly charged peptides and is most effective on triply or above 
charged ions, it also performs best on ions below 850 m/z (Good et al., 2007; Swaney et al., 2007). 
1.3.3 Identification of post translational modifications by MS 
PTMs on proteins can be identified by determining the intact mass of the protein and compare 
this to the theoretical mass hereby determining the extent and mass of the PTM. The modified 
amino acids can be identified by MS/MS on the digested protein. In theory all PTMs can be 
identified by MS providing they lead to a reduction or increase in mass. However, PTM 
determination is not always as simple since the modified protein can comprise a very small 
fraction of the sample and therefore be difficult to detect, the modifications can be labile and 
easily lost in the fragmentation or the modification might also arise during sample preparation 
(Barnes et al., 2007; Kamath et al., 2011; Larsen et al., 2006). 
1.3.3.1 Glycations 
Glycations can be studied by gel electrophoresis, chromatography and various assays but these 
methods do not provide information about the specific glycation site. MS by either ESI or 
MALDI are also used to study glycated peptides (Kislinger et al., 2005; Lapolla et al., 2005; Priego-
Capote et al., 2009). MS/MS is able to determine the specific glycation site on peptides. However, 
MS/MS of glycated peptides is difficult as the most common fragmentation techniques results in 
extensive patterns of neutral loss and loss of labile modifications such as glycations (Kjeldsen et 
al., 2007; Lapolla et al., 2004; Mikesh et al., 2006; Priego-Capote et al., 2009). A LC-MS/MS 
method has been developed on a quadropole-TOF (time of flight) instrument where the peptides 
are subjected to a weak fragmentation which results in specific neutral losses from glycated 
peptides (162 Da). Peptides experiencing this neutral loss are selected for further stronger 
fragmentation producing b- and y-ions hereby providing peptide sequence information (Gadgil et 
al., 2007). Similar methods have been developed for ion trap instruments where product ions 
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showing neutral loss in MS2 are selected and further fragmented in MS3, hereby providing further 
sequence information (Zhang et al., 2008b).  
The soft fragmentation method ETD leaves labile modifications intact allowing for direct 
mapping of peptide modifications which makes it very suitable for characterisation of glycated 
peptides (Chi et al., 2007; Hogan et al., 2005; Kjeldsen et al., 2007; Mikesh et al., 2006; Syka et al., 
2004). As the fragmentation leaves the glycation intact the backbone fragmentation and peptide 
identification is greatly improved. It has been found that ETD fragmentation produces almost 
complete series of c- and z-ions without any neutral losses and it outcompetes CID in the 
identification of glycated peptides (Zhang et al., 2007a; Zhang et al., 2007b). As mentioned 
previously the method does, however, also have some limitations, as it is less sensitive than CID, 
most effective on triply or above charged ions and on ions below 850 m/z (Good et al., 2007; 
Swaney et al., 2007). 
1.3.3.2 Quantification of glycations 
Quantification has become an important tool in MS based proteomics and this has resulted in 
numerous different techniques for either absolute or relative quantification (Aebersold et al., 
2003; Bantscheff et al., 2007; Ong et al., 2005). However, only a few methods exist for relative 
quantification of glycations by MS and these are generally based on addition of internal standards 
of the corresponding isotopically labelled glycated peptides (Delatour et al., 2009; Priego-Capote 
et al., 2010).  
Isobaric stable isotope tagging is a quantitative method allowing for relative quantifications of 
proteins or peptides between two or more samples (up to 8) by use of MS/MS.  The isobaric tags 
are made from light and heavy isotopes, which mean that all the tags have the same total mass as 
well as the same physiochemical properties. The tags consist of a reporter group, a balance group 
and an amino reactive end which reacts with the amino groups of the N-terminus of peptides as 
well as the epsilon amino groups of lysine. Each sample is digested and labelled whereafter all 
samples are mixed and the differentially labelled peptides are selected for MS/MS as a single 
precursor ion, Figure 8A. Upon fragmentation the specific reporter ions for each sample are 
released and relative quantification is performed by determining the ratios between the reporter 
ion intensities. The MS/MS spectrum of the peptide is not altered by the tags and can therefore 
also be used to identify the peptide sequence. One of the advantages of this method is the low 
level of noise generally obtained in MS/MS (Dayon et al., 2008; Ross et al., 2004; Thompson et al., 
2003; Zhang et al., 2005). This method does also have drawbacks for instance it relies on very 
high labelling efficiency for reliable quantification (Bantscheff et al., 2007). The reporter ions have 
to exceed a certain intensity to perform consistent quantification. For instance the reporter ion 
intensities have to exceed 1000 and 100,000 for ETD and HCD respectively to achieve average 
errors below 10% for the quantifications. The reporter ion intensities can be improved by 
increasing the collision energy, however this results in reduced formation of suitable ions for 
peptide identification (Dayon et al., 2010; Phanstiel et al., 2008). 
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Figure 8. A) Quantification with isobaric stable isotope tags. The samples for quantification are prepared separately 
and labelled with individual tags. The labelled samples are mixed and the quantification is performed in MS/MS 
mode (Domon et al., 2006). B) Chemical structure of the TMT 6-plex tags. The functional groups of the tags are 
illustrated on tag 126. Stars indicate isotope positions, the fragmentation sites are illustrated with dotted lines for 
CID and corrugated lines for ETD (Thermo Scientific 2012). 
 
Two types of commercially available isobaric stable isotope tags exist; tandem mass tags (TMT) 
(Thompson et al., 2003) allowing quantification of up to 6 samples and isotope tags for relative 
and absolute quantification (iTRAQ) (Ross et al., 2004) quantifying up to 8 samples. A study of 
the commercially available tags revealed that they all perform equally in terms of quantitative 
precision and accuracy, but that the iTRAQ 4-plex identifies more proteins and peptides than 
TMT 6-plex and that iTRAQ 8-plex has the lowest identification rate (Pichler et al., 2010). 
It has been shown previously that ETD can be used for relative quantification with isobaric 
tags. However, the reporter ions produced by ETD differ from those produced by CID and 
similar fragmentation techniques due to the different fragmentation mechanism, producing c- 
and z-ions. This has resulted in some of the isobaric tags producing the same reporter ions so for 
instance the TMT 6-plex tags could previously only quantify up to four samples. However, very 
recently the position of some of the heavy isotopes have been changed for the TMT 6-plex tags 
so each tag now generates a unique reporter ion in ETD fragmentation (114, 115, 116, 117, 118 
and 119 from the 126-131 TMT tags, respectively), Figure 8B (Han et al., 2008; Phanstiel et al., 
2009; Phanstiel et al., 2008; Thermo Scientific 2012; Viner et al., 2009). 
1.3.3.3 Deamidations 
Deamidation of Asn and Gln creates a mass increase of 1 Da, which can be site specifically 
determined by MS/MS. Other methods for deamidation detection also exist such as 
enzymatically based detection assays, antibodies or Edman degradation. These methods do, 
however, have limitations such as being site unspecific, requiring highly specific antibodies or 
Reporter 
group
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group
Amino reactive 
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requiring relatively high quantities of protein. Therefore, MS has become the preferred method 
for determination of deamidations as the method is fast, accurate, requires relatively small 
amounts of sample and is site specific (Li et al., 2008; Powell et al., 2007; Yang et al., 2010).  
Characterisation of deamidations by MS does, however, also pose some problems as the slightly 
increased temperatures and alkaline conditions during sample preparation accelerate 
deamidations (Chelius et al., 2005). The rate of deamidations is also increased as deamidation 
rates are much higher on peptides than proteins as secondary and tertiary structure can protect 
against the reaction (Kosky et al., 1999; Li et al., 2008). Optimisation of the digest procedure has 
been proposed to minimize the deamidations occurring during sample preparation (Ren et al., 
2009). It has, however, also been observed that by incubation of protein in H2
18O the 
deamidations occurring resulted in a mass increase of 3 Da (Terashima et al., 2007). So by 
performing the digest in H2
18O it is possible to differentiate between deamidations present prior 
to sample preparation (1 Da mass increase) from the ones occurring during sample preparation as 
these will result in a mass shift of 3 Da. The mass difference of 2 Da between the deamidations is 
due to the incorporation of 18O from H2
18O (Gaza-Bulseco et al., 2008; Li et al., 2008). Trypsin 
digestion in H2
18O also results in the incorporation of one 18O into the C-terminus resulting in a 
mass increase of 2 Da. Though, incorporation of two 18O can also occur as the peptides can act 
as a pseudo substrate for some proteases such as trypsin, hereby incorporating a second 18O in 
the C-terminus (Schnolzer et al., 1996). Incorporation of two 18O does create more complex 
isotopic patterns in the MS spectrum. Though by performing the sample preparation in H2
18O it 
is possible to differentiate between deamidations occurring during sample preparation from those 
occurring prior to sample preparation (Gaza-Bulseco et al., 2008; Li et al., 2008). 
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1.4 Objectives 
α-Amylases are among the most important industrial enzymes as they are used in a number of 
very different industries. The commercial α-amylases are produced by fermentations of 
genetically modified bacteria, where both the native gene has been manipulated to code for an 
enzyme with improved performance characteristics and a number of gene copies have been 
inserted in the genome of the cell to allow expression in high yields. Although the genome only 
contains copies of the same α-amylase gene, multiple different α-amylase forms can be identified 
when analysing the final enzyme product, hereby indicating that the protein is modified.  
It is the aim of this PhD project to identify the differences between the multiple forms of α-
amylase derived from the same gene and determine if or how these various modifications affect 
the stability and performance during application. The main focus will be on α-amylases from 
various Bacillus species used in the detergent industry. 
It is to be determined where in the production (fermentation and recovery) the different α-
amylase forms are generated for a few selected α-amylases. The multiple forms will be isolated 
and the effect on wash performance will be determined for the α-amylases. The characterisation 
will be more thorough for one of the amylases (from B. licheniformis) also determining kinetic 
parameters on different substrates.  
The nature of the modifications on the α-amylase is identified along with the site of 
modification by MS. The conditions during production are favourable for modifications such as 
deamidations and glycations. Glycations, especially in low amounts, can be difficult to detect by 
MS. Therefore, MS methods for determination of these modifications are set up using a glycated 
model protein in this case barley α-amylase/subtilisin inhibitor (BASI).   
The influence of specific modifications at specific sites is evaluated by studying structural 
models of the α-amylases. The hypotheses for the most interesting sites are examined by 
characterisation of prepared enzyme variants to prove the functional roles of the specific amino 
acids in the α-amylases, and thus validate the role of specific modified sites in the function and 
stability of the enzyme.  
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2 Experimental work 
2.1 α-Amylase 
BLA, BHA, BAN and AA560 were provided by Novozymes. BLA, BHA and AA560 are 
expressed in recombinant B. licheniformis while BAN is expressed in B. amyloliquefaciens. The 
fermentation is performed as fed batch with soy protein and various carbohydrates such as 
degraded starch, maltose, or sucrose as substrates. The recovery occurs under alkaline conditions 
with pH above 9. It consists of flocculation, filtration and concentration by ultrafiltration, and 
hereafter the amylases are stabilised in 30% 1,2-propane diol at pH 5.5. The amylases for this 
project were all fermented and recovered in 2009. 
2.2 Barley α-amylase/subtilisin inhibitor 
The BASI used in these experiments was expressed in Pichia pastoris fermented and recovered by 
Novozymes in June 2009 (Micheelsen et al., 2008). 
2.3 Isoelectric focusing (IEF) 
Different IEF gels were studied to find the gels with the best separation and reproducibility. The 
gels CleanGel IEF (GE Healthcare), AmpholineTM PAGplate pH 3.5–9.5 (out of production, GE 
Healthcare), Novex IEF gel (Invitrogen) and FocusGel (Gelcompany) were tested. The different 
gels were run according to the manufacturers’ protocols. The FocusGels gave the best separation 
with clear bands and the results were reproducible, therefore these gels (Focusgel 4–6, 3–7 and 
3–10) were used with Amersham Isoelectric Focusing Calibration Kit (GE Healthcare) broad 
range (pH 3–10) or low range (pH 2.5–6.5) as standards.  
2.4 SDS-PAGE 
NuPAGE 4–12% Bis-Tris gradient gel (Invitrogen) was used for SDS-PAGE. Samples were 
prepared and the gel ran according to the manufacturer’s protocol using the described solutions 
from Invitrogen. For standards Precision Plus Protein Standard Kaleidoscope (BIO-RAD) was 
used.  
2.5 Separation of multiple forms of BLA 
For the separation of the multiple forms of BLA several different chromatography techniques 
were investigated; chromatofocusing, boronate affinity chromatography, cyclodextrin affinity 
chromatography and ion exchange chromatography. The technique which resulted in the best 
separation was anion exchange chromatography eluting with pH gradient followed by NaCl 
elution. All separation was performed on an Äkta-FPLC chromatographic system (Amersham 
Biosciences). 
BLA was loaded on a Resource Q column 6 ml (GE healthcare) through a 2 ml loop with flow 
6 ml/min washing with 1 column volume (CV) wash buffer (20 mM Tris, 1 mM CaCl2, pH 8.6) 
and eluting with 0–100%  buffer B1 (33 times diluted polybyffer 96 (GE Healthcare), 1 mM 
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CaCl2, pH 5.6) for 110 min followed by 0–60% buffer B2 (33 times diluted polybuffer 96, 0.5 M 
NaCl, 1 mM CaCl2, pH 5.6) for 25 min. The BLA sample loaded to the column was 
approximately 27 mg/ml in wash buffer. Buffer change was performed on a NAP-25 column 
Sephadex G-25 DNA grade (GE Healthcare) according to manufacturers’ protocol. Eluted 
fractions were analysed by IEF gel and similar fractions were pooled, concentrated and buffer 
changed to 20 mM HEPES, 1 mM CaCl2, pH 7.0 on Vivaspin 20 10,000 MWCO PES (Sartorius 
Stedim).   
2.6 Separation of multiple forms of AA560 
Separation was performed on an Äkta-FPLC chromatographic system (Amersham Biosciences). 
AA560 was loaded on a Resource Q column 1 ml (GE healthcare) through a 2 ml loop with flow 
1 ml/min washing with 6 CV wash buffer (20 mM ethanolamine pH 9.9) and eluting with 0–80% 
buffer B1 (11 times diluted polybyffer 96 (GE Healthcare), 1 mM CaCl2, pH 7.3) for 90 min 
followed by 100% buffer B2 (11 times diluted polybyffer 96, 0.5 M NaCl, 1 mM CaCl2, pH 7.3) 
for 20 min. Approximately 10 mg AA560 in wash buffer was loaded to the column where the 
buffer change was performed on a NAP-25 column sephadex G-25 DNA grade (GE Healthcare) 
according to the manufacturer’s protocol. Eluted fractions were analysed by IEF and similar 
fractions were pooled, concentrated and buffer changed to 20 mM HEPES 1 mM CaCl2 pH 7.0 
on Vivaspin 20 10,000 MWCO PES (Sartorius Stedim).   
2.7 Separation of multiple forms of BHA 
Separation was performed, on an Äkta-FPLC chromatographic system (Amersham Biosciences). 
BHA was loaded on a Resource Q column 1 ml (GE healthcare) through a 2 ml loop with flow 1 
ml/min washing with 5 CV wash buffer (20 mM Bis-Tris, 1 mM CaCl2, pH 7.0) and eluting with 
0–100% buffer B1 (20 times diluted polybyffer 74 (GE Healthcare), 2 mM CaCl2, pH 5.0) for 125 
min followed by 100% buffer B2 (20 times dilute polybyffer 74, 0.5 M NaCl, 2 mM CaCl2, pH 
5.0) for 15 min. Approximately 14 mg BHA in wash buffer was loaded to the column where the 
buffer change was performed on a NAP-25 column Sephadex G-25 DNA grade (GE Healthcare) 
according to manufactures protocol. Eluted fractions were analysed by IEF and similar fractions 
were pooled, concentrated and buffer changed to 20 mM HEPES, 1 mM CaCl2, pH 7.0 on 
Vivaspin 20 10,000 MWCO PES (Sartorius Stedim).   
2.8 Capillary isoelectric focusing (cIEF) 
CIEF was performed by Samuel Fox (application support specialist) at Beckman Coulter (High 
Wycombe, UK) on a PA800 Plus (Beckman Coulter). Samples were prepared and run following 
the chemical mobilization method according to the application guide. Samples were analysed as 
duplicates. For analysis samples undergo buffer exchange to 20 mM Tris pH 8.0 with 30 kDa 
MWCO filters with a final concentration of approximately 10 mg/ml. cIEF were performed in pI 
range 3–10 with three standards at pI values 4.1, 9.5 and 10. 
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2.9 Amino acid analysis 
Amino acid analysis was performed by Anne Blicher, Enzyme Protein and Chemistry, 
Department of Systems Biology, DTU. Samples were hydrolysed in 6 M HCl, oxidised and 
derivatized with orto-phtalaldehyde and injected for ion exchange chromatography. Each amino 
acid was quantified and identified according to 1 nmol of standard amino acid mixture (Barkholt 
et al., 1989; van Wandelen et al., 1997). Double determination was performed for all samples. 
2.10 Laundry wash  
Wash experiments was performed at pH 7.5 and 10 in 50 mM Na2CO3 buffer at 30 or 50°C in 
duplicates. Each wash was performed in 20 ml buffer under magnetic stir with 3 CS-28 (coloured 
rice starch cotton, Center For Testmaterials BV) patches of 2 cm diameter. The wash ran 20 min 
with enzyme concentration of 0.15 mg/l (determined by A280) and afterwards the patches were 
rinsed 5 min in cold tap water and dried over night. The colour remission was measured at 460 
nm in a Macbeth COLOR-EYE 7000 spectrophotometer (Macbeth) subtracting the blank value.  
2.11 Differential scanning caliometry 
Differential scanning calorimetry (DSC) measurements were carried out using a Microcal VP-
capillary DSC (GE Healthcare). Scan rate of 1.5°C min-1 was used to a final temperature of 
130°C. Samples for analysis were approximately 1 mg/ml in 25 mM HEPES, 1 mM CaCl2, pH 
7.0 and 400 μl sample including a reference with the HEPES buffer was added to a 96 well plate. 
The plate was placed in the thermostated auto sampler compartment kept at 10°C. Tmax was 
determined as the temperature at the peak maximum of the transition from the folded to 
unfolded state. For data analysis the Origin software package (MicroCal, GE Healthcare) was 
used for baseline subtraction and graph presentations. 
2.12 Maltoheptaose p-nitrophenol (G7-pNP) assay 
The amylase kit AMYL α-amylase liquid (Roche) was used for kinetic determinations on 
maltoheptaose (G7) substrate. This kit contains an α-glucosidase solution R1 and a substrate 
solution R2: 22 mM 4,6-ethylidene-(G7)-pNP. The R2 solution was diluted with 52.5 mM 
HEPES pH 7.0 to the following final substrate concentrations in the assay; 3, 2, 1, 0.5, 0.25, 
0.125, 0.08, 0.075, 0.0625, 0.05, 0.025 mM. The substrate solutions were inserted in the 
KONELAB ARENA 30 (Thermo Electron Corporation) as samples. The R1 solution and 
enzyme solution (3–18 nM in 52.5 mM HEPES pH 7) were inserted as Reagent 1 and 2, 
respectively. The experiment was run on the KONELAB with a program set at 30ºC where 147 
µl Reagent 1 was mixed with 83 µl sample and incubated 5 min. Hereafter, 20 µl Reagent 2 was 
added and further incubated 3 min. After this the absorbance was measured 7 times over 120 sec 
at 405 nm. pNP standard (0, 0.030, 0.075, 0.151, 0.226, 0.301, 0.602 mM in HEPES buffer) was 
made from p-nitrophenol standard solution 10 mM (Sigma) and mixed as for the substrate 
solutions and measured. KM and kcat were obtained by fitting to the Michaelis-Menten equation 
with the program CurveExpert 1.3 (http://www.curveexpert.net/). Significant differences 
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solutions were prepared with water-18O, 97atom% 18O (Sigma-Aldrich). To each gel pieces 15 μl 
0.025 μg/μl trypsin (Trypsin Sequencing grade, Roche Diagnostics) or 15 μl 0.0027 μg/μl Asp-N 
(Endoproteinase Asp-N Sequencing grade, Roche Diagnostics) in 50 mM NH4HCO3 is added 
and stored for 45 min at 5°C. The remaining protease solution is removed and 25 μl 50 mM 
NH4HCO3 is added to each gel piece and incubate at 37°C over night. After digesting the gel 
pieces are spun down and 50 μl 70% acetonitrile 0.1% triflouroacetic acid is added. After 15 min 
the supernatants are transferred to a clean tube. This step is repeated twice. The supernatants are 
dried and dissolved in 80 μl 5% formic acid.  
2.16 In solution digestion  
The proteolytic digestions were performed on 100 µg protein. BASI samples were added 350 µl 
12.5 mM DTT in 8 M UREA 50 mM Tris pH 8.0 and incubated 1 h 42°C. Then 50 µl 20 µg/µl 
iodoacetamide was added and incubated 1 hr at room temperature in the dark. Before digestion 
500 µl 50 mM NH4HCO3 pH 7.8 were added. BLA samples either incubated 6 h or over night in 
cold acetone (preincubated at -20°C) at 4°C, centrifuged 10 min at 8000 g and dried pellet 
dissolved in 250 μl 50 mM NH4HCO3 pH 7.8 or incubated 20 min in 25 mM EDTA before 
digestion.  
For digestion 15 µl 0.1 µg/µl trypsin in 50 mM NH4HCO3 pH 7.8 were added to the samples and 
incubated at 37°C for 5 hr or over night. The samples were purified on EMPORE C18 standard 
density, solid phase extraction cartridge (3M) according to manufactures protocol, dried and 
dissolved in 5% formic acid. 
2.17 Intact protein mass spectrometry 
Intact proteins were analysed on a micrOTOF II (Bruker Daltonics) coupled to an Agilent LC 
1000 series (Agilent). LC was performed on a MassPREP On-Line Desalting Cartridge 2.1x10 
mm (Waters Corporation) eluting with an acetonitrile step gradient in 0.05% triflouroacetic acid 
with flow 400 µl/min. For each analysis 100 µg protein was used. Data analysis was performed 
with DataAnalysis vers. 3.4 (Bruker Daltonics). 
2.18 Tandem mass spectrometry 
The LC-MS/MS experiments were performed on either a LTQ Orbitrap Velos (Thermo 
Scientific) for samples fragmented with HCD or on a LTQ Orbitrap XL (Thermo Scientific) 
fragmenting with HCD or ETD. Both instruments have a nano-ESI source (Nanospray Flexion 
Source, Thermo Scientific) couple to an EASY-nLC II (Thermo Scientific). The peptides were 
separated on Thermo Scientific EASY-Column (C18) 2 cm x 100 µm i.d. column followed by a 
Thermo Scientific EASY-Column (C18) 10 cm x 75 µm i.d. column, eluting from 5–50% 
acetonitrile in 0.1% formic acid over 60 min at a flow rate of 250 nl/min.  
Experiments on the Orbitrap Velos were only conducted in the orbitrap with automatic gain 
control (AGC) target of 1,000,000 with 30,000 resolution and a maximum ion injection time of 
10 ms in full MS. For MS/MS AGC target was 50,000 with injection time of 100 ms and 
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resolution of 7500. The HCD normalized collision energy was 40% and the 10 most intense 
precursor ions in the range 350–1750 m/z were selected for MS/MS. 
For analysis on the Orbitrap XL MS1 was performed in the orbitrap mass analyser with a 
resolution of 60,000 (at 400 m/z) for ETD and of 30,000 for HCD. AGC target was 500,000 
with a maximum ion injection time of 300 ms for the orbitrap in full MS. AGC target for MS/MS 
was 40,000 for the ion trap and 100,000 for the orbitrap. Normalized collision energy of 45 were 
used for HCD and fragment ions were detected in the orbitrap with 7500 resolution with a 
maximum injection time of 300 ms using 2 microscans selecting precursor ions in the range 300–
2000 m/z. ETD reactions were performed for 85 ms detecting fragment ions in the ion trap with 
a maximum injection time of 200 ms using 3 microscans selecting precursor ions in the range 
350–1200 m/z. For both HCD and ETD the four most abundant precursor ions were selected, 
rejecting charge state 1 for HCD and charge states 1 and 2 for ETD.   
The data analysis was performed with Mascot Distiller (Matrix Science) and Mascot Deamon 
(Matrix Science) for raw data processing and automation of the searches with the Mascot search 
engine. The searches were conducted against a custom made database containing 14,100 
sequences with decoy option enabled. The searches were conducted with trypsin or Asp-N as 
enzyme allowing 5 missed cleavages with 10 ppm precursor mass tolerance, 0.5 Da fragments 
mass tolerance for ETD and a mass tolerance of 0.02 Da for HCD. Static modification 
carbamidomethyl (C) was set for searches on BASI and no static modifications were selected for 
searches on BLA. The following variable modifications were chosen: Deamidation (NQ), Hex 
(KR), 3-deoxyglucosone (KR), carboxymethyl (KR), Carboxyethyl (KR), MG-H1 (KR), 
Oxidation (M), Carbamyl (KR), Acetyl (K) and Deamidated: 18O(1) (NQ), Label: 18O(1)(C-
term), Label: 18O(2)(C-term) for samples digested with H2
18O. 
2.19 Relative quantification of glycation sites  
The TMTsixplex isobaric mass tagging kit was purchased from Thermo Scientific (Rockford). 
Samples were digested, reduced, alkylated and labelled with TMT tags according to manufacturer 
protocol. Glycated BASI samples (see section 2.14) were mixed 1:1 for BASI incubated 4 and 8 
days. The BLA pools (PA-PD) were mixed 1:1:1:1 after labelling. Labelled samples were purified 
on Solid phase extraction cartridge (C18 octadecyl standard density, 3M) according to 
manufacturer’s protocol. The samples were dried and diluted in 5% formic acid. 
All experiments were performed on a LTQ Orbitrap XL mass spectrometer (Thermo Scientific) 
with nano-ESI source couple to an EASY-nLC II (Thermo Scientific). The peptides were 
separated on Thermo Scientific EASY-Column (C18) 2 cm x 100 µm i.d. column followed by a 
Thermo Scientific EASY-Column (C18) 10 cm x 75 µm i.d. column, eluting from 5–50% 
acetonitrile in 0.1% formic acid over 60 min at a flow rate of 250 nL/min. MS1 was performed in 
the orbitrap mass analyser with a resolution of 60,000 (at 400 m/z), AGC target was 500,000 with 
a maximum ion injection time of 300 ms. AGC target for MS/MS was 40,000 for the ion trap 
and 100,000 for the orbitrap. Normalized collision energy of 45 and 55% were used for HCD 
and fragment ions were detected in the orbitrap with 7500 resolution with a maximum injection 
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time of 300 ms using 2 microscans selecting precursor ions in the range 300 – 2000 m/z. ETD 
reactions were performed for 85 – 100 ms detecting fragment ions in the ion trap with a 
maximum injection time of 100 ms using 1 microscan selecting precursor ions in the range 350 – 
1200 m/z. For both HCD and ETD the four most abundant precursors ions were selected, 
rejecting charge state 1 for HCD and charge state 1 and 2 for ETD.   
The data analysis was performed using Proteome Discoverer 1.3 (Thermo Scientific) for spectra 
processing with SEQUEST or Mascot (Matrix Science) as search engines for protein/peptide 
identification and quantification. Mascot Distiller (Matrix Science) was also used for raw data 
processing and Mascot Daemon (Matrix Science) was used for search automation with Mascot 
server as search engine for protein/peptide identification and quantification. 
For data analysis in Proteome Discoverer 1.3 SEQUEST searches were conducted against a 
custom made against databases containing only BASI or BLA. The searches were conducted 
against tryptic peptides allowing 5 missed cleavages with 10 ppm precursor mass tolerance, 0.5 
Da fragments mass tolerance for ETD and 0.02 Da mass tolerance for HCD. Static modification 
TMT-6plex of N-terminus and carbamidomethyl (C) was set and the following variable 
modifications were chosen: Deamidation (NQ), Hex (KR), 3-deoxyglucosone (KR), 
carboxymethyl (KR), Carboxyethyl (KR), MG-H1 (KR), Oxidation (M). The quantitation was set 
to TMT-6plex. The false discovery rates were set below 0.05. Both Mascot Searches was 
conducted with the same parameters as described for SEQUEST against a custom made database 
containing 14100 sequences (mainly enzyme sequences from different organisms) also searching 
against a decoy database.  
For TMT quantification normalization was not used, auto outlier removal was chosen and 
peptide threshold was set to above homology level. Quantification data was corrected for TMT 
isotope impurities. The peptide ratios and standard deviations were obtained from triple 
determinations of each labelled sample mix. 
2.20 Expression of BLA mutants 
BLA mutants and BLA for comparison were produced by Novozymes in October 2011. The 
constructs were made by site directed mutagenesis according to the principles described by others 
(Deng et al., 1992). BLA and its variants was expressed in recombinant B. subtilis, fermented in 
500 ml shaking flasks at 270 rpm and 37°C for 96 h in a medium consisting of 100 mg/ml 
sucrose, 40 mg/ml soya flour, 10 mg/ml Na2HPO4·12H2O, 0.01% v/v Dowfax 63N10, 5 mg/ml 
CaCO3.  
2.21 Purification of BLA variants 
The fermented samples were centrifuged at 5400 g for 50 min and filtered through 0.2 μm PES 
filters. MOPS, CaCl2 and (NH4)2SO4 were added to concentrations of 20 mM, 1 mM and 1 M 
respectively, and pH adjusted to 7.5. Samples were loaded to a 50 ml phenyl sepharose column 
(Phenyl sepharose 6 fast flow packed in a XK 26/20 column, GE Healthcare) with flow 8 
ml/min and washed with 2 CV washing buffer (20 mM MOPS, 1 mM CaCl2, 1 M (NH4)2SO4, pH 
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7.5) eluting from 100–0% (NH4)2SO4. Selected fractions were tested on SDS-PAGE. Eluted 
amylase fractions were dialysed (MWCO 12–14,000) against 10 mM Tris, 1 mM CaCl2, pH 8.9. 
The dialysed sample (conductivity ≤ 2.0 ms/cm) were loaded to a 50 ml Source 30Q (GE 
healthcare) packed in a XK 26/20 column with flow 8 ml/min washed with 1 CV washing buffer 
(20 mM Tris, 1 mM CaCl2, pH 8.9) eluting with 0–60% elution buffer (1M NaCl, 20 mM Tris, 1 
mM CaCl2, pH 8.9) over 110 min. Eluted fractions were tested on SDS-PAGE. Fractions only 
containing BLA were pooled, concentrated and buffer changed to 20 mM HEPES, 1 mM CaCl2, 
pH 7.0 on Vivaspin 20 10,000 MWCO PES (Sartorius Stedim). 
2.22 Mini wash 
Wash performance for BLA variants were determined on a mini wash robot (Novozymes) on 
coloured rice starch cotton CS-28 (Center For Testmaterials BV). CS-28 strips (5 cm wide) 
mounted on racks which during the wash are moving up and down into the wash beakers (50 
times per min). Washes were performed at 40°C for 30 min at enzyme concentrations 0, 0.015, 
0.05, 0.25, 0.5 and 1.0 mg /L followed by 5 min rinsing in cold water. Each wash beaker contain 
60 ml of either 0.8 g/l liquid detergent pH 8.5 (20% linear alkylbenzene sulfonate (LAS, 
Nacconol 90G), 10% alkyl ether sulfate (STEOL CS-370E), 10% alcohol ethoxylate (AEO, Bio-
soft N25-7, Stepan Company), 4% oleic acid, 0.5% Ethanol, 1.5% SXS (sodium xylene 
sulfonate), 7% 1,2-propanediol, 8% tri-Na-citrat, 0.5% triethanolamine, 1.5% boric acid, pH 8.5) 
or powder detergent pH 10.0 of 1.715 g/L AP powder model detergent X without nonionic 
surfactant (17% LAS, 20% Sodium carbonate, 12% Sodium disilicate, 15% Zeolite A, 1% PCA, 
34% Sodium sulfate) and 0.035 g/L AEO, pH 10.0, both detergents prepared with water 
hardness of 15°dH (Ca/Mg 4:1). Double determinations were performed for each wash. The CS-
28 strips dried O/N and measured twice at 460 nm on TIDAS (Zeiss spectrophotometer). All 
percentages stated are in w/w.  
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3 Results and discussion 
3.1 Multiple forms of Bacillus α-amylases  
The four α-amylases BAN, BHA, BLA and AA560 were examined for the presence of multiple 
forms. Samples from different time points during the fermentation and from the recovery were 
analysed by IEF to determine where in the process the multiple forms arise. The multiple forms 
of some of the amylases were partially separated. The wash performance of the partially separated 
forms was evaluated in a simple laundry wash assay, to determine if the modifications generating 
the different forms influence the wash performance. The distribution of the forms was also 
analysed by capillary IEF (cIEF). Based on these results a more thorough evaluation of the 
influence of the modifications was performed on one of the amylases. 
3.1.1 α-Amylase modifications during production 
The recovered α-amylases all appears to be pure and uniform on SDS-PAGE but on IEF gel 
multiple bands occur for all of them, Figure 9. This reveals that all the amylases become modified 
during the fermentation, recovery or formulation resulting in multiple forms varying in pI values.   
 
 
Figure 9. The α-amylases BAN, BHA, BLA and AA560 on A) SDS-PAGE B) IEF gel. 
 
There appear to be fewer forms of BAN than of the other amylases. AA560 appears to be the 
most complex of the amylases as it merely creates a smear on the IEF gel whereas for the other 
several stronger bonds are observed. The decrease in pI value is most likely due to modification 
of positively charged amino acids or the addition of a charged modification to the amino acids. 
Therefore it is most likely the positively charged Lys and Arg residues which are modified. The 
pKa values of Lys and Arg side chains are approximately 10.8 and 12.5, respectively (Berg et al., 
2007). Neutral modifications on these side chains will remove the charge and hereby lower the pI 
value of the protein. It can also stem from modifications such as deamidation where the 
uncharged Asn and Gln residues are converted into the negatively charged Asp and Glu. This 
conversion results in a decrease in pI value as these neutral amino acids side chains will change to 
charged side chains with pKa values of approximately 4.1 (Berg et al., 2007).  
The observed difference in modification level of the amylases could be caused by variations in 
the number of Asn, Gln, Lys and Arg residues on the amylases. Though, the change can also 
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reflect structural differences as some structural conformations can protect amino acid residues 
from modifications. The number of Lys and Arg residues in the four amylases is more or less the 
same differing only by a few residues as BHA has 44 while AA560, BLA and BAN have 48, 49 
and 50 of these residues, respectively. The number of Gln and Asn residues differ more between 
the amylases as BAN and BLA have 46 and 45 of these residues, respectively, whereas both BHA 
and AA560 have 62 residues. This could explain why BHA and AA560 appear to be more 
heterogeneous and hence more extensively modified than BAN and BLA. BLA, however, also 
appears to be more modified than BAN even though they almost contain the same number of 
Gln and Asn residues. This could indicate that the amino acid composition does not entirely 
account for the differences in the modification level. The structure of the amylases and the 
exposure of reactive amino acid residues most likely also account for some of the differences in 
the modification level.    
To determine where in the production process the multiple forms are created, samples were 
withdrawn at different time points during the fermentation and from different stages of the 
recovery. The samples were withdrawn from the production of BLA, BAN and AA560. They 
were analysed on IEF gel and SDS-PAGE. 
Samples of BLA were withdrawn during the fermentation, after drum filtration and 
ultrafiltration in the recovery and were analysed by IEF gel, Figure 10. This revealed that the 
multiple forms of BLA were present already in the fermentation after 20 hours. It also seems that 
all the forms are present already after 20 hours of fermentation and no new forms appear to be 
generated in the downstream processes. However, the samples are very complex and it is 
therefore not possible to exclude that a few more forms of BLA arise specifically during the 
purification. 
 
 
Figure 10. Samples of BLA withdrawn from the fermentation after 20, 80 and 130 hours and after drum filtration 
(DF) and ultra filtration (UF) on A) IEF gel B) SDS-PAGE. 
 
The samples withdrawn from the production of BAN and AA560 also show that the multiple 
forms arise during the fermentation, Figure 11. No new forms seem to appear during recovery of 
the amylases, as also observed for BLA (data not shown). 
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Figure 11. Samples of AA560 and BAN withdrawn at different time points during fermentation tested on IEF gel 
and SDS-PAGE A) AA560 B) BAN. 
 
The pI characterisations of the four different Bacillus amylases revealed that they all contain 
multiple forms varying in pI values. The number of forms varies between the amylases indicating 
that some of the amylases are more prone to modification than others. This could be due to the 
differences in the number of reactive amino acids, the number of exposed amino acids for 
instance on the surface of the protein or other structural differences. The multiple forms of the 
amylases were found to primarily arise during the fermentation.  
3.1.2 Effect of the multiple forms of amylases 
The multiple forms of amylase were observed in all the four amylases. It was attempted to 
separate the multiple forms of the amylases by different chromatographic methods. However, 
due to the high similarity of the forms it was not possible to separate single forms. The multiple 
forms of the amylases were therefore only partly separated into pools varying in pI range. The 
performance of the pools of partly separated amylases were analysed to determine whether the 
forms differ in wash performance. The focus of this project is on detergent amylases therefore 
only the detergent amylases BLA, BHA and AA560 were explored further. The performance of 
the amylases was analysed in some simple laundry wash assays on rice starch cotton patches. The 
washes were performed in NaHCO3 buffer at 50°C as all the amylases are relatively active and 
stable at this temperature. The washes were carried out at pH 7.5 and 10.3 as this is the 
approximate pH in wash with liquid and powder detergent, respectively.  
The starch on the cotton patches are coloured pink, so the more of starch is remove from the 
patch the lighter the colour of the patch becomes. The same amount of enzyme protein (in mg) 
was added to the laundry wash assays for each of the pools. The wash performance on the 
patches was determined spectrophotometrically by measuring the remission of the patches. 
Remission is the reflection of light by a material. In the spectrophotometer the cotton patches are 
subjected to light from a light source. The light reflecting from the patch is then measured at an 
appropriate wavelength. The wash performance of the amylase is determined in delta remission 
units. The delta remission unit is the difference between the absorbance of the remission of a 
blank (a cotton patch washed without enzyme) and the sample. The higher the delta remission 
the better is the wash performance of the enzyme. 
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Figure 13. Wash performance for the partly separated forms of BLA in NaHCO3 buffer. The wash performances 
were determined by double determinations and the 95% confidence interval is marked for each sample. A) The 
partly separated forms of BLA on an IEF gel B) Wash performance of the pools of BLA at pH 7.5 and 10.3 on rice 
starch cotton patches. 
 
The cIEF for BLA revealed that the main band observed in the IEF gel has a pI value of 6.6 
and that this corresponds to approximately 40% of the sample, Figure 14A. The BLA forms with 
the lowest pI values correspond to 12 – 30% of the sample. This indicates that at least 70% of 
BLA is of the forms which did not seem to lose wash performance in the wash assay.  
 
 
Figure 14. Results from cIEF of BLA and AA560. Numbers in blue are the percentage of the form in the sample 
and numbers in black bold are the determined pI value. A) IEF gel and cIEF results for BLA B) IEF gel and cIEF 
results for AA560. 
 
The cIEF results for AA560 revealed a much more complex sample covering a much broader 
pI range, Figure 14B, as was also expected from the IEF results. Two smaller peaks occur with pI 
values of 9.9 and 9.3 only corresponding to approximately 2% of the sample. The next peak has a 
pI value of 7.7 and it is followed by multiple other peaks with decreasing pI. The highest amount 
of one of the peaks represents approximately 14% of the sample. These results indicate that 
AA560 contains a larger portion of modified forms with relatively low pI values which most 
likely have decreased wash performance. 
The cIEF results for BLA and AA560 revealed that AA560 is much more complex than BLA, 
similar to the observations made from IEF gels. AA560 also appears to contain a larger portion 
of the forms with lower pI values which have lower wash performance at 50°C, especially at pH 
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10.3. The overall wash performance of AA560 could therefore be more affected by the multiple 
forms than BLA, as it appears that a smaller amount of this sample is the forms with very low pI 
values having the decreased wash performance.  
The results indicate that the modifications responsible for the multiple forms can result in loss 
of wash performance. It is highly likely that the more modified the amylases become the higher 
the performance loss, especially under less favourable conditions such as around pH 10. 
3.1.3 Characterisation of multiple forms of BLA 
In the previous section it was described that the modifications on the amylases could have a 
negative effect on the wash performance, especially the forms with the lowest pI values appears 
to be affected. The smaller decreases in pI values did not seem to affect the wash performance 
negatively. BLA was selected for further characterisation of the activity and stability of the 
multiple forms. This amylase was selected as its structure and its structure function relationship is 
well described in the literature. 
The multiple forms of BLA were separated into four pools of forms varying in pI value. As 
mentioned previously (section 2.5) several different chromatography techniques were investigated 
where the best separation was obtained by anion exchange chromatography eluting with pH 
gradient followed by a NaCl gradient. This did not result in a complete separation of the forms 
so pools of forms varying in pI range was characterised. The pool PA contain the forms with the 
highest pI values and the pI values of the following pools PB-PD decreases, so the forms in PD 
have the lowest pI values. IEF gel of the pools and the chromatogram from the separation 
highlighting the selected fractions are illustrated in Figure 15. The concentration of the pools was 
determined by amino acid analysis. 
 
 
Figure 15. The chromatogram from the separation of the multiple forms of BLA with an IEF gel of the four pools 
of BLA. In the chromatogram the fractions collected for each pool is highlighted with colours. In the chromatogram 
the blue line is UV280, the red line is UV260, the green line is the gradient, the gray line is pH and the brown is 
conductivity.  
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The stability of the pools was analysed by DSC in buffer at pH 7. This provided Tmax values 
between 104.2 – 104.4°C (Appendix I Figure 1). The four pools do not differ in stability as they 
all show the same Tmax value. Hereby, revealing that the thermostability of the enzyme is not 
affected by the modification occurring in the different pools. It is, however, possible that some of 
the modifications occurring have a negative effect on the stability. Not all the BLA forms are 
present in the pools so it is possible that forms with lower Tmax is not included in the pools. It is 
also possible that a form with a modification affecting Tmax is such a small part of the pools that it 
does not affect the overall Tmax. Thus, indicating that the effect of a single destabilising 
modification is small. Overall it appears that the modifications in general do not affect the 
thermostability of BLA. Studies show that modifying Lys residues decreased the thermostability 
of BLA (Khajeh et al., 2001a; Khajeh et al., 2001b; Tomazic et al., 1988b). The DSC results for the 
four pools did not indicate that the modifications present in these pools influence the stability 
negatively. The present data therefore suggests that the modifications occurring are not of Lys 
residues, or that the modified Lys residues or other modifications occurring during the 
fermentation does not influence the enzymes stability. 
The kinetic parameters kcat, KM and kcat/KM were determined for the four pools on 
maltoheptaose and on amylose at 30°C. The conditions for these experiments were chosen to 
correspond to the conditions normally used in an European laundry wash, where the temperature 
is around 30 – 40°C and the pH is around pH 8 and 10 dependent on the type of detergent.  
The kinetic parameters with maltoheptaose as substrate, Table 1, were only determined at pH 7 
as the substrate is unstable at alkaline pH. The KM values do not reveal any differences between 
the pools but smaller variations occur for kcat. The smaller variations in the catalytic constant (kcat) 
reveal that PB and PC have slightly higher kcat values than PA and PD. The catalytic efficiencies 
(kcat/KM) of the pools do not reveal any significant changes between the pools. The results show 
tendencies of a decreasing catalytic efficiency with decreasing pI values though the differences are 
not significant. Therefore it cannot be concluded that the modifications resulting in decreasing pI 
values influences the catalytic efficiency of BLA on the G7 substrate at pH 7, 30°C.     
 
Table 1. The kinetic parameters kcat, KM and kcat/KM for the four BLA pools, PA-PD, varying in pI range. The 
kinetic parameters were determined at 30°C pH 7.0 on a maltoheptaose substrate. 
 kcat (s-1) KM (mM) kcat/KM (s-1 mM-1) 
PA 74 ± 7 0.011 ± 0.002 7117 (± 1364) 
PB 92 ± 6 0.013 ± 0.002 6968 (± 1108) 
PC 85 ± 4 0.014 ± 0.002 6336 (± 919) 
PD 68 ± 3 0.013 ± 0.002 5072 (± 621) 
 
The kinetic parameters for the four pools on amylose were determined at pH 7.5 and 10.3, 
Table 2. The parameters for pH 7.5 reveals the same tendencies as observed on the short 
substrate. There are no significant differences in KM for the pools. However, smaller differences 
occur for the kcat values as PD appears to be lower than the other pools. The catalytic efficiency 
reveals the same tendencies as for the short substrate. The decrease in pI values result in 
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decreasing catalytic efficiency though again the results do not differ significantly between the 
pools.  
The kinetic parameters for amylose at pH 10.2 are considerably lower than at pH 7.5 revealing 
that the enzyme is not very active at low temperature and alkaline pH. The tendencies at this pH 
also differ from the previous observations as substrate catalysis is the same for the four pools. 
The KM values, however, differ slightly as KM for PA and PD appears to be a bit better than for 
PB and PC. This also appears to be the case for the catalytic efficiencies where PA has the 
highest efficiency followed by PD and the PB and PC with the lowest efficiencies. It appears that 
the modifications have a negative effect on the catalytic efficiency at pH 10 where the least 
modified sample, PA, is better than the other three. The loss in catalytic efficiency does not seem 
to be dependent on level of modification as the sample which appears to contain the most 
modified BLA forms, PD, has the second best catalytic efficiency. It is therefore likely that part 
of the loss in catalytic efficiency at pH 10 is due to specific modifications in specific sites. 
 
Table 2. The kinetic parameters kcat, KM and kcat/KM for the BLA pools varying in pI range determined at 30°C pH 
7.5 and 10.2 on amylose DP440. 
 pH 7.5 
  kcat (s-1)          KM (mg/ml)         kcat/KM (s-1 mg-1 ml) 
pH 10.2 
  kcat (s-1)        KM (mg/ml)         kcat/KM (s-1 mg-1 ml) 
PA 301 ± 21 0.192 ± 0.050 1625 (± 424) 34 ± 4 0.224 ± 0.015 152 (± 20) 
PB 313 ± 10 0.208 ± 0.020 1515 (± 152) 31 ± 3 0.333 ± 0.044 94 (± 15) 
PC 279 ± 12 0.229 ± 0.060 1283 (± 314) 28 ± 5 0.376 ± 0.068 74 (± 19) 
PD 234 ± 20 0.213 ± 0.004 1101 (± 96) 29 ± 3 0.225 ± 0.028 129 (± 20) 
 
The wash performance of the four pools was also determined in buffer at 30°C, pH 7.5 and 
10.3 on rice starch cotton patches, Figure 16. These results correlate with the determinations on 
amylose and show that BLA generally have lower activity around pH 10 than around pH 7.5 at 
30°C. The wash performance for PA and PB appears to be slightly higher than for PC and PD. 
PC appears to have the lowest wash performance. The wash results obtained at 30°C are 
considerable lower than the ones observed for the forms of BLA at 50°C, Figure 13. This 
difference could be due to the enzyme being more active at higher temperatures or that the 
structure of the substrate differs at the two temperatures so it is more accessible for the enzyme 
at higher temperatures.   
 
 
Figure 16. Wash performance of the partly separated pools of BLA, PA-PD, in NaHCO3 buffer pH 7.5 and 10.3 at 
30°C on rice starch cotton patches.  
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The characterisation of the BLA pools varying in pI range revealed that the modifications can 
have an effect on the activity of the enzyme. The kinetic parameters and the wash performance 
assay indicated that the pools containing the forms suspected to contain the most modifications 
generally showed slightly lower catalytic efficiency and wash performance. The modifications do, 
however, not seem to have much effect on the thermostability of BLA. 
Identifying the specific modifications and the modification sites could provide more insight into 
which sites are prone to modifications. Amino acid substitutions at these sites could offer further 
understanding of the importance of these sites and the influence of the modifications in these 
sites on the overall activity of the amylases. 
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3.2 Study of glycation sites on a model protein 
A MS method for the characterisation of glycation sites was setup with barley α-
amylase/subtilisin inhibitor (BASI) as model protein. As mentioned previously glycations can be 
difficult to identify by the conventional fragmentation methods such as CID and HCD as they 
cleave of the modification which can result in poor peptide sequence assignment (Mann et al., 
2003). The fragmentation method ETD should leave labile modifications such as glycations intact 
allowing for direct mapping of the modified site (Chi et al., 2007; Syka et al., 2004). Glycations is 
expected to be among the modifications responsible for the multiple forms of the amylases. 
Therefore, a MS methods fragmenting with ETD was setup for the characterisation of glycation 
sites. The ETD method was compare to HCD to determine if ETD is better at identifying 
glycation sites. BASI was chosen as model protein as it is a smaller protein (20 kDa) with a 
neutral pI value (theoretical pI 6.5) like BLA and it contains multiple Lys (7) and Arg (12) 
residues (Svendsen et al., 1986; Vallée et al., 1998). As glycations occur on Lys and Arg residues 
BASI is a good model protein for the characterisation of this modification as it contains many of 
these residues and it, therefore is possible to force several glycations on it.  
It could be interesting to compare the amount of glycations in the four pools of partly separated 
BLA varying in pI range (pools PA-PD from section 3.1.3). Therefore, a method for relative 
quantification of glycations and the advanced glycation end products (AGEs) was setup using 
isobaric stable isotope tagging with ETD and HCD comparing the two fragmentation methods 
ability to quantify glycation sites with this quantification method.   
3.2.1 Identification of glycation sites by HCD and ETD 
BASI was glycated by incubating with glucose at 40°C pH 9.5 for four and eight days. The 
occurrence of the forced glycations on BASI was evaluated by full-length MS. Before the 
incubation with glucose the homogeneity of the BASI sample was evaluated by full-length MS 
(Appendix I Figure 2). This revealed a peak at 19875.5 m/z corresponding to unmodified BASI 
(theoretical Mw 19875 Da). The main peak was followed by a few smaller shoulders 
corresponding to smaller modifications. The BASI sample was relatively homogeneous and 
therefore not extensively modified so it could be used for the glucose incubation experiments.  
Full-length MS of BASI incubated four days with glucose (BASIG4), Figure 17A, and eight days 
with glucose (BASIG8), Figure 17B both resulted in a pattern of peaks with a mass difference of 
approximately 162 Da corresponding to glycations. In both spectra BASI molecules with up to 
four glycations were detected. The MS spectrum for BASIG8 is much more complex than for 
BASIG4 and it could contain BASI molecules with 5 – 6 glycations. It is, however, not possible 
to identify peaks corresponding specifically to this.  
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Figure 17. Full-length MS of glycated BASI after incubation with glucose at 40°C pH 9.5. G is glycations on BASI. 
A) BASI incubated 4 days with glucose. B) BASI incubated 8 days with glucose. 
  
The BASI samples were digested by trypsin and analysed by LC-MS/MS fragmenting with 
either ETD or HCD to identify the glycation sites. The MS/MS data was searched using the 
Mascot search engine.  
Mascot determines the theoretical data for each of the sequences in the database and compares 
these to the experimental data. All calculated data correlating with the experimental data within a 
given mass tolerance counts as a match and each match is assigned a statistical weight. Peptide 
matches obtained from the MS/MS data are assigned a score which is based on the calculated 
probability that the match between the experimental data and the database sequence is random 
(Matrix Science 2012; Perkins et al., 1999). This score has to exceed a significance threshold 
which for this project was set to 5%. Thus a match is significant if it is expected to occur at 
random with a frequency of less than 5%. Peptide hits of which the scores exceed this 
significance threshold are then reported to exceed the “identity” threshold. However, some 
MS/MS spectra might be of poor quality, for instance if the signal to noise ratio is low. This may 
lead to a correct sequence match with an insignificant peptide score. Therefore, Mascot 
characterises the distribution of random scores and determines a lower relative threshold, 
referred to as the “homology” threshold. The peptide scores are accompanied by an “expect” 
value which is the number of matches with equal or higher score that are expected to occur by 
chance. Mascot also provides a score for each protein hit which is derived from the peptide 
scores. The protein score is the sum of the highest peptide scores for each distinct sequence 
match where a small correction is performed to reduce contributions from low scoring random 
matches (Matrix Science 2012; Perkins et al., 1999).  
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A MS/MS method was setup with ETD for identification of glycation sites. This method was 
then compared to MS/MS fragmenting with HCD to evaluate the fragmentation methods ability 
to identify glycation sites. In the experiments MS was performed in the orbitrap analyser and so 
was the HCD fragmentation, whereas MS/MS with ETD was analysed in the ion trap. ETD 
should be most effective on peptides with three or more charges (Zhang et al., 2008a) and ions 
below 850 m/z (Good et al., 2007; Swaney et al., 2007). Therefore, the most intense ions in MS 
with charge 3 or above within the range 350 – 1200 m/z were selected for ETD fragmentation. A 
quick comparison also revealed that these settings provided better results than settings selecting 
charge state 2 or above in the MS range 350 – 2000 m/z. The reaction time for ETD 
fragmentation was also optimised on glycated BASI as this setting differs between studies 
performed by others (Good et al., 2007; Zhang et al., 2008a). ETD was tested with reaction times 
in the range 85 – 160 ms. The highest sequence coverage for BASI and the highest number of 
identified glycation sites were obtained with reaction times of 85 and 100 ms. Reaction time of 85 
and 100 ms both resulted in a protein hit for BASI with 92% sequence coverage and 
approximately the same protein score. However, three more glycation sites were identified with 
activation time of 85 ms and the MS/MS search results for the glycated peptides had slightly 
better sequence coverage at this activation time. Therefore, activation time of 85 ms was used for 
the identification of glycation sites with ETD fragmentation. 
The sample was also analysed by MS/MS fragmenting with HCD. This resulted in one hit for 
BASI with sequence coverage of 95%. The overall coverage and score for BASI was slightly 
better for the fragmentation with HCD compared to ETD which was expected as HCD is a very 
efficient fragmentation method.  
Comparison of the results for identified glycation sites by the two fragmentation methods 
reveals the identification of more glycation sites by ETD, Table 3. There were found 7 glycation 
sites with ETD and in total 12 combinations of the 7 modification sites with various glycations. 
For the HCD fragmentation 5 glycation sites and 7 of the sites and glycation combinations were 
observed. The sites identified by HCD were also identified by ETD so for the identification of 
glycation sites ETD outperforms HCD.  
The full-length MS of BASIG4 and BASIG8, Figure 17, identified BASI molecules with up to 
four glycations and for BASIG8 it indicated that five or six glycations might occur. The MS/MS 
result identifies seven glycation sites though this method cannot determine if all the sites are 
modified on some of the BASI molecules.  
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Table 3. Glycations observed by LC-MS/MS fragmenting with ETD or HCD on trypsin digested BASI incubated 4 
days with glucose. The results were obtained by Mascot searches. Hex: Glycation with glucose, Cbe: Carboxyethyl, 
Cbm: Carboxymethyl, MG-HI: methylglyoxal-derived hydroimidazolone, () is hits exceeding the homology threshold 
but not the identity threshold, Covered is whether or not the glycation site is directly mapped by the MS/MS results, 
M: missed cleavages. 
Site  Modification Hits Score Expect Covered Peptide M Sequence 
ETD        
R27 Cbm 1 56 4.8E-5 + 16 – 41  1 R.ADANYYVLSANRAHGGGLTMAPGHGR.H   
K72 Hex 7 (1) 61 1.7E-5 + 62 – 75  1 R.ITPYGVAPSDKIIR.L   
K72 Cbm (3) 23 0.033 + 62 – 75  1 R.ITPYGVAPSDKIIR.L 
K115 Hex (5) 40 0.0025 + 108 – 122 1 R.HVITGPVKDPSPSGR.E 
K130 Hex 1 (2) 54 1.2E-4 + 128 – 140 1 R.IEKYSGAEVHEYK.L 
R155 MG-HI 1 50 1.1E-4 + 141 – 158  1 K.LMSCGDWCQDLGVFRDLK.G   
R155 Cbm 1 (1) 50 0.0024 + 141 – 158  1 K.LMSCGDWCQDLGVFRDLK.G   
R155 Cbe 1 (1) 56 5.9E-5 + 141 – 158  1 K.LMSCGDWCQDLGVFRDLK.G   
K158 Hex 4 (5) 69 5.2E-6 + 156 – 176  1 R.DLKGGAWFLGATEPYHVVVFK.K   
K158 Cbm 5 65 5.1E-6 + 156 – 176  1 R.DLKGGAWFLGATEPYHVVVFK.K   
K176 Hex 8 72 7.0E-6 + 159 - 177 1 K.GGAWFLGATEPYHVVVFKK.A 
K176 Cbm (1) 37 7.3E-4 + 159 - 177 1 K.GGAWFLGATEPYHVVVFKK.A 
HCD        
R27 Cbm 1 65 2.9E-6 + 16 – 41  1 R.ADANYYVLSANRAHGGGLTMAPGHGR.H   
K72 Cbm (5) 38 3.3E-4 + 62 – 75  1 R.ITPYGVAPSDKIIR.L 
K115 Hex (4) 18 0.046 - 108 – 122 1 R.HVITGPVKDPSPSGR.E 
K115 Cbm (2) 24 0.0098 - 108 – 122 1 R.HVITGPVKDPSPSGR.E 
K158 Hex (9) 43 1.6E-4 - 156 – 176  1 R.DLKGGAWFLGATEPYHVVVFK.K   
K158 Cbm 3 62 6.0E-6 + 156 – 176  1 R.DLKGGAWFLGATEPYHVVVFK.K   
K176 Hex (5) 24 0.01 - 159 - 177 1 K.GGAWFLGATEPYHVVVFKK.A 
 
The score and expect value for the observed sites were not necessarily better for ETD. Though 
as expected the sequence coverage for the glycated peptides and the coverage of the glycation 
sites were generally better for ETD than for HCD as illustrated in, Figure 18. MS/MS spectra 
and Mascot peptide ion data for the two fragmentations in Figure 18 are shown in Appendix I 
Figure 3 and 4. MS/MS spectra and Mascot peptide ion data for the two fragmentations of the 
peptide H108 – R122 with glycation on K115 are also illustrated in Appendix I Figure 5 and 6. 
For this peptide the mapping of the glycation site by HCD is not very good and the peptide 
scores are quite low especially for HCD.  
It was unexpected that some of the glycation sites are covered by the HCD fragmentation, 
Figure 18. ETD did generally resulted in better coverage by the glycated ions in the MS/MS 
spectrum. This indicates that HCD not always cleaves off labile modifications such as glycations 
and that it sometime is possible to obtain good sequence coverage for glycated peptide by HCD.  
All the peptides identified to be glycated contain one missed cleavage. This is because trypsin is 
unable to cleave after glycated Lys and Arg residues. In Mascot hits where the glycated site is not 
directly mapped, Mascot assigns the glycation site to the Lys or Arg residue in the C-terminal end 
of the peptide instead of assigning it to the Lys or Arg residue at the missed cleavage site. 
Therefore, one should be aware that for peptide hits with low sequence coverage Mascot tend to 
assign the glycation to the wrong Lys or Arg residue. 
The MS/MS analysis of glycation sites by HCD and ETD revealed that ETD was better at 
identifying glycation sites whereas HCD provided a higher overall protein coverage. Therefore, it 
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would be advantageous to use both methods for the identification of modification sites on 
amylases to achieve the best possible results.  
 
HCD 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
b      ● ● ●              
b++     ● ● ● ● ● ●            
Sequence D L K G G A W F L G A T E P Y H V V V F K 
y++       ● ● ● ● ● ● ● ●  ●      
Y              ●  ● ● ● ● ● ● 
 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 
ETD 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
c ● ● ● ● ● ● ● ● ● ● ● ●  ● ●       
c++            ●    ●  ● ● ●  
Sequence D L K G G A W F L G A T E P Y H V V V F K 
z+1++   ● ● ● ●  ● ●  ●  ●      ●   
z+1             ●   ● ● ● ● ● ● 
Y        ● ● ●   ●    ●   ● ● 
 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 
Figure 18. Sequence coverage obtained by HCD and ETD for the peptide D156 – K176 with the AGE 
carboxymethyl on K158. Red dots show the ions found in the Mascot search of the MS/MS spectrum. The ion score 
and expect value for the HCD results were 62 and 6.0E-6, respectively and for the ETD results they were 65 and 
5.1E-6, respectively. The K with the green background in the sequence is the glycated residue. It is observed that 
even though b ions with the glycation are found in the MS/MS spectra for HCD the data for ETD still provides a 
more complete coverage of the sequence series with the glycation.   
3.2.2 Method setup for relative quantification of glycation sites by HCD and ETD 
A method for relative quantification of glycation sites was set up so the glycations in the four 
partially separated BLA pools (PA – PD) could be quantified between the pools. The method 
was setup on BASIG4 and BASIG8 using isobaric stable isotope tags for relative quantification 
by LC-MS/MS fragmenting with HCD or ETD. Isobaric stable isotope tags were selected for the 
quantification as the method can perform relative quantification between four samples in the 
same run hereby reducing the error rate. The method is also easy to start up and use though on 
the downside it is quite expensive.   
The commercially available isobaric tags the tandem mass tags (TMT) 6-plex was selected as 
they are able to produce 6 unique reporter ions in ETD. The other commercially available tags 
(iTRAQ 4-plex) only produces 3 unique reporter ions by ETD fragmentation from the four 
unique tags due to the different reporter ion formation caused by ETD, described previously 
(Phanstiel et al., 2008).  
The intensities of the reporter ions are important for the quantification as reporter ions with 
low intensity exhibit poor quantifications providing high error rates. As mentioned previously the 
reporter ions have to exceed intensities of 1,000 in ETD and 100,000 in HCD to achieve average 
errors below 10% (Phanstiel et al., 2008). Increasing the collision energy should improve the 
reporter ion intensities so the fragmentation methods were optimised to achieve the best 
quantification results while still obtaining good sequence coverage for the peptides.   
The quantification was optimised on glycated BASI labelled with TMT tags. The quantification 
with HCD was performed with normalizing collision energy of 45% and 55%. This resulted in 
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sequence coverage of 95% for both collision energies. The two methods both identified glycation 
sites though a few more were identified with 55% normalised collision energy and the hits also 
appeared to be slightly better for most of the observed modifications with this method, Table 4. 
The reporter ion intensities are high enough to be used for quantification for all the glycated 
peptides identified. The intensities of the reporter ions are, however, higher with 55% normalised 
collision energy and some of the intensities are close to the lower limit when analysed with 45% 
normalised collision energy. Therefore, 55% collision energy was selected for further 
quantification experiments with HCD fragmentation.   
 
Table 4. Glycations sites observed on TMT labelled glycated BASI by LC-MS/MS fragmenting with HCD 
fragmentation at normalised collision energy of 45% and 55%. All the hits provided TMT reporter ions with 
intensities high enough for quantification. The results were obtained using Mascot. Hex: Glycation with glucose, 
Cbm: Carboxymethyl, () is the number of hits only exceeding the homology threshold in Mascot, Cov: whether or 
not the glycation site is directly mapped by the MS/MS results, M: missed cleavages. 
  45% Normalised collision energy 55% Normalised collision energy 
Site Modification Score Expect Hits Cov. M Score Expect Hits Cov M 
R27 Cbm 65 2.9E-6 1 + 1 - - - - - 
K72 Cbm 38 3.3E-4 (5) + 1 30 0.0027 (1) + 1 
K72  Hex - - - -  31 0.0062 (8) + 1 
K115 Cbm 24 9.8E-3 (2) - 1 43 5.9E-4 1 + 1 
K115 Hex 18 0.046 (4) - 1 31 0.0021 (3) - 1 
K130 Hex - - - -  20 0.017 (2) - 1 
K158 Hex 43 1.6E-4 (9) - 1 59 4.9E-6 4 (7) - 1 
K158 Cbm 62 6E-6 3 + 1 48 3.7E-5 1 (2) + 1 
K176 Hex 24 0.01 (5) + 1 57 9.3E-6 3 (5) - 1 
  
The ETD reaction time can influence the performance of the TMT quantification (Viner et al., 
2009). The reporter ion intensities on ETD fragmentation were evaluated with reaction times of 
85 and 100 ms. These two times were selected as they previously provided the best result for the 
identification of glycation sites and these has by others been reported to provide the best 
quantification results (Phanstiel et al., 2008; Viner et al., 2009). The results for the two ETD 
methods on TMT labelled glycated BASI revealed that the reaction time of 85 ms provided 
slightly better results for the identification of glycation sites, Table 5. The reporter ion intensities 
were high enough to be used for quantification on five of the glycated peptides in both methods. 
The 85 ms reaction time method did, however, provide more hits with reporter ion intensities 
high enough for quantification for each of the quantified glycated peptides. Therefore, 85 ms 
reaction time was selected for further quantification experiments with ETD.  
Some of the ETD spectra for the glycated peptides contained the structural ions necessary for 
peptide identification but did not contain any reporter ions. The lack of reporter ions in 
otherwise good ETD spectra is also observed in other studies as well as a higher percent of the 
scans producing low reporter ion intensities. It is proposed that ETD exhibits lower reporter ion 
intensities due to ETD cleaving randomly along the peptide backbone hereby not preferring the 
chemical modifications (Phanstiel et al., 2008; Viner et al., 2009).   
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Table 5. Glycations sites observed on TMT labelled glycated BASI using LC-MS/MS fragmenting with ETD at 
activation time of 85 and 100 ms. The results were obtained by Mascot. Hex: Glycation with glucose, Cbe: 
Carboxyethyl, Cbm: Carboxymethyl, MG-HI: methylglyoxal-derived hydroimidazolone, () is the number of hits only 
exceeding the homology threshold, Cov: whether or not the glycation site is directly mapped by the MS/MS results, 
M: missed cleavages, Quan: hits with reporter ion intensities high enough for quantification. 
  85 ms activation time  100 ms activation time  
Site Modification Score Expect Hits Cov M Quan Score Expect Hits Cov M Quan 
R27 Cbm 56 4.8E-5 1 + 1 - - - - - - - 
K72 Cbm 19 0.023 (3) + 1 - 26 0.01 (2) + 1 - 
K72  Hex 61 1.7E-5 7  (1) + 1 - 56 3.4E-5 5 (4) + 1 - 
K115 Hex 40 0.0025 (5) + 1 4 48 2.2E-4 1 (2) + 1 1 
K130 Hex 54 1.2E-4 1 (2) + 1 3 54 2.1E-4 1 + 1 1 
K140 Hex - - - - - - 29 0.045 (2) - 1 - 
R155 Cbe 56 5.9E-5 1 (1) + 1 - 36 0.012 (2) + 1 - 
R155 Cbm 50 0.0024 1 (1) + 1 - 42 8.8E-4 (1) + 1 - 
R155 MG-HI 50 1.1E-4 1 + 1 - - - - - - - 
K158 Hex 69 5.2E-6 4 (5) + 1 4 74 1.7E-6 6 (4) + 1 5 
K158 Cbm 65 5.1E-6 5 + 1 3 69 2E-6 3 + 1 3 
K176 Hex 72 7E-6 8 + 1 5 70 1.3E-5 5 (2) + 1 3 
K176 Cbm 37 7.3E-4 (1) + 1 - 28 0.028 (1) + 1 - 
3.2.3 Relative quantification of glycation sites on BASI by HCD and ETD 
Relative quantification of glycation sites was performed on BASIG4 and BASIG8 to evaluate the 
quantification method. BASIG4 and BASIG8 were labelled with TMT126 and TMT128, 
respectively, and analysed by LC-MS/MS fragmenting by HCD and ETD. The data were then 
analysed in three different ways: with Mascot Distiller for data file processing searching with the 
Mascot server and with the program Proteome Discoverer for data file processing using either 
SEQUEST or Mascot as search engines. The three different data analysis/search methods were 
conducted to determine whether one outperformed the others or if the results differed in such a 
way that they should be combined to achieve the best results.   
Proteome Discoverer is a program which extracts the relevant MS/MS spectra from the raw 
data file so it can then be searched in selected search engines. The SEQUEST search engine 
applies an algorithm that correlates the experimental MS/MS spectra to theoretical spectra of 
predicted fragment ions derived from the protein database selected for the search. The peptide 
hits are then scored according to the correlation. The score is generated from a scoring system 
based on correlations to the main ion series as well as water and ammonia loss (Sadygov et al., 
2004). 
The overall search results for the three quantifications of glycation sites on the HCD and ETD 
data reveal that the three methods identify approximately the same number of individual 
glycations, Table 6. The SEQUEST search did, however, overall quantify a higher number of 
glycated peptides though this did not result in quantification of more specific glycated peptides 
than the other two methods for either of the fragmentations. 
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Table 6. Overall comparison of the glycation sites quantified by Mascot with Mascot Distiller for data processing 
(Mascot), by Proteome Discoverer (PD) using Mascot and by Proteome Discoverer using SEQUEST. The 
comparison was on data acquired by HCD and ETD fragmentation. Glycated sites are the number of glycated Arg 
and Lys residues quantified. Unique glycation sites are the number of glycation sites including differences in the 
specific glycations. 
 Quantification of glycations by HCD Quantification of glycations by ETD 
 Glycated 
sites 
Unique 
glycation sites 
Total glycated 
peptides 
Glycated 
sites 
Unique 
glycation sites 
Total glycated 
peptides 
Mascot 11 21 132 6 10 77 
PD Mascot 11 22 132 6 10 79 
PD SEQUEST 12 20 153 7 10 94 
 
The quantification results for the glycations are very similar between the three different 
quantification programs on the ETD generated data, Table 7. The relative standard deviation is in 
general lowest for the quantitative results obtained by Mascot searches with Mascot Distiller. 
The search in SEQUEST also assigned the glycation site to the C-terminal Lys or Arg residue 
for glycated peptides with low sequence coverage as was observed previously for Mascot. 
 
Table 7. Quantification of glycation sites between BASI incubated with glucose four (BASIG4) and eight days 
(BASIG8) obtained by ETD fragmentation where BASIG4 was labelled with TMT126 and BASIG8 with TMT128. 
The results were obtained by three different MS search programs. Hex: Glycation with glucose, Cbm: 
Carboxymethyl, MG-HI: methylglyoxal-derived hydroimidazolone, PD: Proteome Discoverer, SD: Standard 
deviation, RSD: Relative standard deviation, Hits: The number of times the glycated peptides has been quantified, 
128/126: relative quantification results between BASIG8 and BASIG4. 
 ETD Mascot   ETD PD Mascot  ETD PD SEQUEST  
Site modified 128/126 SD RSD Hits  128/126 SD RSD Hits  128/126 SD RSD Hits  
R27 MG-HI 1.59 0.34 0.21 4 1.58 - - 1 1.44 0.19 0.13 2 
R61 MG-HI - - - - - - - - 1.43 - - 1 
K72 Cbm - - - - - - - - 1.33 - - 1 
K115 Hex 2.17 0.29 0.13 8 1.95 0.43 0.22 17 1.92 0.42 0.22 34 
K115 Cbm 1.73 0.15 0.09 2 1.72 - - 1 1.45 0.39 0.27 2 
K130 Hex 1.23 0.13 0.10 8 1.20 0.22 0.19 8 1.20 0.22 0.19 8 
K140 Hex 1.43 - - 1 1.03 0.01 0.01 2 - - - - 
K158 Cbm 1.73 0.34 0.20 14 1.66 0.32 0.19 12 1.66 0.32 0.19 12 
K158 Hex 1.36 0.21 0.15 18 1.49 0.30 0.20 18 1.47 0.29 0.20 19 
K158 + K176 Hex 2.83 0.50 0.18 2 2.87 0.51 0.18 3 - - - - 
K176  Hex 1.88 0.29 0.16 16 1.84 0.42 0.23 13 1.86 0.46 0.25 11 
K176 Cbm 1.82 0.15 0.08 4 1.62 0.29 0.18 4 1.62 0.29 0.18 4 
 
The quantification results generated by HCD fragmentation are also very similar between the 
three different quantification methods, Table 8. There are smaller differences between the results 
generated by the programs but none of the quantification methods appear to be considerably 
better than the others. The relative standard deviations for the quantifications obtained by the 
HCD fragmentation are generally lower than the ones obtained by ETD fragmentation.  
The quantification with the three different programs revealed that for the MS/MS data derived 
by HCD fragmentation the quantitative results for glycation sites were very similar. The 
quantification results for the data obtained by ETD fragmentation also revealed similar results for 
the various methods though the relative standard deviations were lower for the quantification 
results generated by Mascot Daemon. This could indicate that the peak picking is slightly more 
precise on the low intensity ions in Mascot Distiller than it is in Proteome Discoverer. Therefore, 
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Mascot Distiller searching in the Mascot server was used for the following quantification 
experiments. 
 
Table 8. Quantification of glycation sites between BASI incubated with glucose four (BASIG4) and eight days 
(BASIG8) obtained by HCD fragmentation where BASIG4 was labelled with TMT126 and BASIG8 with TMT128. 
The results were obtained by three different search programs. Hex: Glycation with glucose, Cbe: Carboxyethyl, Cbm: 
Carboxymethyl, MG-HI: methylglyoxal-derived hydroimidazolone, PD: Proteome Discoverer, SD: Standard 
deviation, RSD: Relative standard deviation, Hits: The number of times the glycated peptides has been quantified, 
128/126: relative quantification results between BASIG8 and BASIG4. 
 HCD Mascot  HCD PD Mascot  HCD PD Sequest  
Site modified 128/126 SD RSD Hits 128/126 SD RSD Hits 128/126 SD RSD Hits 
R27 MG-HI 1.92 0.28 0.14 7 1.85 0.25 0.13 9 2.12 0.11 0.05 3 
R27 Cbe 2.03 0.01 0.05 2 1.89 0.15 0.08 5 1.94 0.01 0.01 2 
R27 Cbm 1.69 - - 1 1.66 - - 1 - - - - 
K72 Cbm 1.82 0.10 0.06 6 1.92 0.17 0.09 10 1.98 0.15 0.07 19 
K72 Hex 1.91 0.07 0.04 16 1.98 0.05 0.02 4 1.95 0.08 0.04 41 
R81 MG-HI 2.74 0.08 0.03 2 2.69 0.06 0.02 3 2.69 0.06 0.02 3 
R81 Cbm 3.63 0.08 0.02 3 3.50 0.15 0.04 5 3.44 0.18 0.05 3 
R81 Cbe 2.67 - - 1 2.69 0.05 0.02 4 2.69 0.05 0.02 4 
R106 Cbe 1.61 - - 1 1.59 - - 1 1.50 - - 1 
R107 Cbm - - - - 2.46 0.25 0.10 2 2.38 0.22 0.09 3 
K115 Hex 2.17 0.14 0.06 18 2.19 0.12 0.06 17 2.17 0.13 0.06 20 
K115 Cbm 1.88 0.03 0.02 3 1.95 0.24 0.12 4 1.95 0.24 0.12 4 
R127 MG-HI 2.09 - - 1 - - - - 2.08 0.03 0.01 2 
K130 Hex 1.44 0.03 0.02 3 1.43 0.04 0.03 5 1.43 0.04 0.03 5 
K130 Cbm 1.26 - - 1 1.25 0.00 0.00 2 1.25 0.00 0.00 2 
K140 Hex 1.81 0.09 0.05 20 1.80 0.07 0.04 9 1.79 0.07 0.04 7 
R155 MG-HI 1.61 0.01 0.01 3 1.58 0.04 0.02 4 1.58 0.04 0.02 4 
R155 Cbe 1.56 0.01 0.01 2 1.58 0.00 0.00 3 - - - - 
R155 Cbm - - - - 1.85 0.04 0.02 3 1.83 0.03 0.02 2 
K158 Cbm 1.82 0.06 0.03 17 1.78 0.06 0.03 16 1.78 0.06 0.03 16 
K158 Hex 1.47 0.05 0.03 10 1.45 0.04 0.03 11 - - - - 
K176 Hex 1.95 0.08 0.04 4 1.97 0.06 0.03 6 1.94 0.04 0.02 4 
K176 Cbm 2.28 0.06 0.02 6 2.24 0.07 0.03 8 2.24 0.07 0.03 8 
 
The quantification ratios between glycations in BASIG4 and BASIG8 reveal that for all the 
quantified glycation sites the BASIG8 sample contains larger amounts of the glycations than the 
BASIG4 sample as would be expected as the sample incubated longer time with glucose.  
To evaluate the relative quantification of glycation sites with HCD and ETD using TMT a 
second sample of TMT labelled BASIG4 and BASIG8 was made with the 127 and 130 tags, 
respectively. 
The comparison of ETD and HCD for relative quantification of glycation sites was performed 
on glycated peptides which were quantified by both HCD and ETD in both of the labelled 
samples. Seven glycated peptides were quantified by both fragmentation methods in the two 
labelled samples, Figure 19. From these results it appears that the relative quantification obtained 
by HCD fragmentation generally is slightly higher than the ETD results of the same sample. For 
some of the glycated peptides it appeared that ETD and HCD provided comparable 
quantification results whereas the peptide with K176 glycated with carboxymethyl and the one 
containing glycated K130 the quantifications appeared to differ significantly between the two 
fragmentation methods. The quantification results also indicated that for some of the glycated 
peptides the different labels can influence the quantification results. 
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Figure 19. Relative quantification of glycated peptides between BASIG4:BASIG8 labelled with both 
TMT126:TMT128 and TMT127:TMT130, respectively. The quantifications were determined by ETD and HCD 
fragmentation. The glycated amino acid is stated with the identified glycation. Hex: Glycation with glucose, Cbm: 
Carboxymethyl. The error bars indicate standard deviation. Columns without error bars are based on single 
quantification determinations. 
 
Comparison of the quantifications by ETD and HCD for the seven peptides, Figure 20, 
indicates that for most of the peptides the quantifications obtained by ETD and HCD are similar. 
Though, for the glycation of K176 with carboxymethyl the quantification obtained by HCD and 
ETD seems to differ. The comparison also indicates that the same is the case for the peptide 
with glycated K130. 
 
 
Figure 20. Relative quantification of TMT labelled glycated peptides using ETD and HCD. BASIG4 and BASIG8 
were mixed 1:1. The data is based on two samples labelled with 127/130 and 126/128 for bASIG4/BASIG8, 
respectively. The glycated amino acid is stated with the observed glycation. Hex: Glycation with glucose, Cbm: 
Carboxymethyl. The error bars indicate standard deviation.  
 
A more thorough statistical analysis was performed on quantification results for the peptides 
containing the following glycated residues: K115, K158, K176 glycated with glucose as well as 
K158 and K176 modified with carboxymethyl. These glycated peptides were chosen for the 
statistical analysis as there for all were quantification data on more than one quantification 
determination for each of the label combinations (130/127 and 128/126) with both 
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fragmentation methods. This analysis was performed to determine if and how much the three 
factors the peptide, the label selection or the fragmentation method influence the quantifications. 
The significance of these factors was assessed using a 3-factor full factorial ANOVA model 
where outlier detection was used to remove six determinations from the entire dataset.  
The statistical analysis revealed that the performance of the fragmentation methods depends on 
the analysed glycated peptide. HCD and ETD perform similarly on the peptides containing K115 
and K176 glycated with glucose but the methods are giving significantly different results on the 
peptides containing K158 glycated with glucose, K158 glycated with carboxymethyl and K176 
glycated with carboxymethyl. The analysis also agreed with the observations from Figure 19 and 
Figure 20 previously stating that the ratios obtained by HCD are higher than the ones obtained 
by ETD. The fragmentation methods dependence on the glycated peptides for their performance 
could at least partly be caused by the extensive pattern of neutral loss which HCD fragmentation 
of glycated can result in. This neutral loss pattern could interfere with the reporter ions providing 
variations in the ratio calculations.   
The statistical analysis also revealed that the performance of the labels can depend on the 
glycated peptides. This was observed for the peptide with glycated K115 and the peptide 
containing K176 glycated with carboxymethyl where the 128/126 and the 130/127 ratios differed 
significantly. The glycated peptides influence on the performance of the labels could be caused by 
the neutral losses occurring in HCD described previously. It is also possible that the 
fragmentation of some peptides forms peptide ions close to or with the same mass as the 
reporter ions. 
In conclusion both ETD and HCD fragmentation can be used for the identification of 
glycation sites by MS/MS, however ETD identifies more glycation sites than HCD. So ETD is a 
very efficient fragmentation method for the identification of glycation site. If one also have to 
identify other non labile modifications or want the highest sequence coverage ETD should be 
combined with HCD. Therefore, for the characterisation of modifications on BLA both 
fragmentation methods will be used to achieve high sequence coverage and to identify as many 
glycations as possible. 
Relative quantification by TMT labelling was easy to use. Relative quantification of glycation 
sites was performed with both ETD and HCD. Even though ETD identified more glycation sites 
HCD was better at acquiring high reporter ion intensities and it was thus able to quantify more 
glycation sites than ETD. Different software was evaluated for the quantification and they 
performed very similar though the relative standard deviation was slightly lower when Mascot 
Distiller was used to transform the raw MS/MS data for the further search and quantification 
compared to Proteome Discoverer. 
It is, however, important to note that the glycated peptides can influence the performance of 
the fragmentation methods and the TMT labels in the quantification experiments. It is therefore 
important in the relative quantification of specifically glycated peptides to use different labels and 
or label combinations and if possible different fragmentation techniques to evaluate the 
significance of the quantifications. The method will later on be used for quantification of 
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glycations between the four partly separated pools of BLA. Here different label combinations will 
be used as well as the both ETD and HCD for the quantification. 
It could be interesting to perform a larger study with more TMT labels and more glycation sites 
and specific glycations (AGEs) for the evaluation of the influence of the peptide, the specific 
glycations, the tags and the fragmentation techniques on the relative quantification. This would 
also provide better understanding of factors to consider in the experimental design. This was, 
however, not possible in the present project due to time limitations.  
 
  
 57 
 
3.3 Analysis of BLA modifications  
The modifications on BLA were investigated using different strategies to determine the extent of 
the modifications and whether specific modification sites are likely to influence the stability or 
activity of the enzyme. Intact mass analysis by LC-MS of the partially separated pools of BLA 
forms varying in pI range was used to determine micro heterogeneity within the pools as well as 
the differences between the pools. The aim was to determine which modifications are responsible 
for the multiple forms. For further identification of the specific modifications and the modified 
sites, in-gel digest followed by LC-MS/MS with both HCD and ETD fragmentation were 
performed. The method set up in the previous section for relative quantification of glycation sites 
was used to perform relative quantification of glycation sites between the four pools of partly 
separated forms of BLA varying in pI range. The glycation patterns produced on BLA were 
investigated using different carbohydrates in order to assess the susceptibility of BLA to glycation 
caused by glucose and maltodextrins.  
3.3.1 Identification of BLA modifications 
The four BLA pools PA – PD (from section 3.1.3) were subjected to intact protein mass analysis 
to determine the overall extent of modifications for the four pools.  
 
 
Figure 21. Full-length MS by LC-ESI on two of the BLA pools varying in pI range. A) Full-length MS of partly 
separated BLA pool PA with the main peak corresponding to unmodified BLA. B) Full-length MS of the BLA pool 
PB is more complex with multiple peaks being BLA species with various modifications. 
 
The intact mass determination for pool PA resulted in a broad peak in the mass spectrum 
corresponding to the mass of BLA, Figure 21A. These results indicate that the PA sample 
contain unmodified BLA (theoretical Mw 55239 Da). Though, the resolution of this method is 
not high enough to separate mass differences of a few Da, so the main peak could also be 
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deamidated BLA. The peak is broad with smaller shoulders which indicate the sample contains 
different forms of BLA modified by smaller PTMs. It is not possible to determine exactly which 
modifications are present but it could be deamidations, oxidations, carbamylations and AGEs.  
The results for PB were more complex consisting of multiple peaks, Figure 21B. The first small 
peak could be unmodified BLA or deamidated BLA. The second large peak corresponds to a 
mass increase of approximately 31 Da which could be a combination of oxidations and 
deamidations. So the sample contains multiple forms of modified BLA and maybe a small 
amount of unmodified BLA. 
The signal to noise ratio for the PC and PD samples were quite low and the spectra contained 
multiple peaks, Figure 22. Both spectra contain the peak of approximately 55272 m/z (also 
observed in the spectra for PB) followed by multiple other peaks. It is not possible to assign 
specific modifications to each peak as they can be results of multiple modifications of the BLA. 
The signal to noise ratio for the PA sample was high but it decreases for the PB, PC and PD 
samples. As the complexity of the samples increases the signal to noise ratio decreases. 
 
 
Figure 22. Full-length MS by LC-ESI on the two of the BLA pools, PC and PD, varying in pI range.  The spectra 
for both PC (A) and PD (B) are very complex containing multiple peaks. Both samples appear to only contain 
various species of modified BLA. 
 
In general the observations from the full-length MS analysis support the observations from the 
IEF gel, Figure 15 (section 3.1.3). The full-length analysis of the samples did not indicate that any 
of the multiple forms were caused by truncations as no decrease in mass was observed. The PA 
sample could contain unmodified BLA as well as deamidated forms though other modified forms 
of BLA also seemed to be present. The PB, PC and PD samples all appeared to only contain 
modified BLA though the specific modifications could not be identified from the spectra. The 
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analysis revealed that the PA sample was the least complex of the samples with PB, PC and PD 
increasing in sample complexity. 
To identify the modifications responsible for the multiple forms of BLA in-gel digest was 
performed from IEF gel followed by LC-MS/MS fragmenting with HCD and ETD. Bands 
selected for digestion with trypsin and Asp-N are illustrated in Figure 23.  
 
 
Figure 23. IEF of BLA and the four pools of partly separated forms of BLA. The bands selected for in-gel digest 
with trypsin and Asp-N followed by LC-MS/MS is marked on the gel. 
 
The Mascot searches on the MS/MS data for the samples all gave BLA as the primary 
significant hit. The total sequence coverage for the selected bands ranged from 48 – 100%, where 
the coverage for band 1 – 7 and 12 were 90% or above, Table 9. As also observed in the previous 
section (section 3.2.1) the HCD results provide higher overall sequence coverage compared to 
ETD fragmentation. For some of the Asp-N samples data was not obtained with HCD due to 
instrumental problems.  
 
Table 9. The sequence coverage obtained for the 12 BLA bands digested by trypsin and Asp-N and analysed with 
LC-MS/MS fragmenting with HCD and ETD. 
Band Trypsin (HCD/ETD) 
Sequence coverage (%)     Mascot score 
Asp-N (HCD/ETD) 
Sequence coverage (%)    Mascot score 
Sequence 
Coverage (%) 
1 92/60 49666/4783 -/52 -/6433 94% 
2 60/52 9069/1663 80/30 2129/3241 94% 
3 52/32 5171/1047 80/38 2746/1124 92% 
4 77/60 18837/4148 86/44 2810/3144 94% 
5 83/43 23862/1940 75/41 1700/4195 90% 
6 78/43 20372/2125 73/30 2388/2917 91% 
7 54/35 6875/856 79/35 1438/663 92% 
8 30/26 1033/471 70/12 672/272 80% 
9 55/29 7242/756 -/33 -/1824 68% 
10 36/12 1167/204 -/18 -/728 48% 
11 73/36 8108/1683 -/38 -/1694 77% 
12 98/57 20332/4762 78/33 1605/3951 100% 
 
The modifications oxidations (Met), deamidations, carbamylations and glycations as well as the 
advanced glycation end products (AGEs) 3-deoxyglucosone, carboxyethyl, carboxymethyl and 
MG-HI were identified by Mascot searches for the 12 samples. The modified residues were 
PA PA PB PB PB PB PC PC PC PC PD PD PD PD BLA BLA
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mainly located on the surface of BLA, though the modifications were not found in all the 
possible modification sites on the surface. This indicates that some of the residues on the surface 
can be favoured for the modifications or that some are protected against modifications possibly 
by interactions with other amino acid residues or by amino acids in the close vicinity creating an 
environment unfavourable for the observed modifications. It is also possible that the 
modifications at these sites were not detected in these experiments or modifications of these sites 
are present in some of the BLA forms which were not analysed. 
Met oxidations and deamidations were observed in all the analysed bands. Especially band nr 1 
contained many identified deamidations. There were only observed few Lys and Arg 
modifications in bands nr 1 and 2. Modifications of Lys and Arg residues were mainly observed 
in the samples from bands with lower pI values. The data suggest that what appears to be one 
band on the IEF gel can contain forms modified in different sites. For instance in band 1, which 
is the band with the highest pI value, multiple deamidation sites were observed. If all these 
deamidations are present on the same BLA molecule the pI value would be expected to be lower. 
It is likely that the band contains multiple BLA forms with one or a few modification at different 
sites. One could thus speculate that one band can contains different BLA forms with 
approximately the same degree of modifications but at different sites, and that the lower the pI 
value the higher the degree of modification. 
3.3.1.1 Oxidations 
There were identified Met oxidations in all the digested samples, Table 10. Oxidations of M304 
and M366 were observed in all the bands except nr 10 and 6, respectively. Oxidations of M8, 
M15, M256 and M438 were also observed. All the oxidised Met residues are located in domain A 
except M438 which is located in domain C.  
Table 10. The Met residues found to be oxidised in the 12 digested BLA samples analysed by LC-MS/MS 
fragmenting with HCD and ETD. The results were obtained using Mascot. T: trypsin digested, A: Asp-N digested, () 
is hits exceeding the homology threshold, Covered is whether or not the glycation site is directly mapped by the 
MS/MS results. 
Site  Hits Score Expect Covered Identity in band Homology in band ID 
M8 17 (1) 78 1.7e-8 + 1, 5, 6, 12  HCDAT 
M15 18 (3) 87 2e-9 + 1, 3, 5, 6, 12  HCDAT 
M256 14 (3) 97 2e-10 + 1, 4, 12 2, 4, 6 HCDAT 
M304 65 (18) 97 5.8e-9 + 1 – 7,  9, 11, 12 8 ETDAT/HCDAT 
M366 242 70 9.7e-8 + 1 – 5, 7 – 12   ETDT/ HCDT 
M438 7 (18) 60 6.2e-6 + 5, 11 2, 3, 6 – 10  ETDA/HCDAT 
 
Studies show that oxidation of Met can decrease the stability and activity of amylases (Hagihara 
et al., 2003; Lin et al., 2003). Therefore, some of the oxidations might influence the activity and 
stability of BLA. Oxidation of M197 and the equivalent position in other Bacillus α-amylases is 
reported to be involved in oxidative inactivation (Hagihara et al., 2003; Hatada et al., 2006; Lin et 
al., 2003). This position was not found to be oxidised but the sequence coverage for this area was 
not very good. It is therefore possible that it occurs. Mutations of M15 provide increased stability 
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and activity (Shaw et al., 1999). Therefore, the oxidation observed at M15 could have an effect on 
activity and/or stability of these BLA forms.  
The main focus of the present project was on the modifications responsible for the pI changes 
and since Met oxidation does not provide changes in the charge of the residue, these 
modifications will not be discussed further. 
3.3.1.2 Deamidations 
As mentioned previously deamidations can occur during the protein digestion. Therefore, the 
protein digest was performed in H2
18O to differentiate between deamidations present prior to 
sample preparation (1 Da mass increase) and the ones occurring during sample preparation (3 Da 
mass increase). 
There were identified 15 deamidation sites and additionally 6 sites were indicated by Mascot 
with scores between the homology and the identity thresholds, Table 11. The deamidations were 
mainly observed in samples 1 – 4 and 12. The observed deamidations were located in all three 
BLA domains, though mainly on the surface of BLA, Figure 24. The deamidations at Q9, N326 
and Q360 are located in the area around the active site in domain A.  
 
Table 11. The observed deamidation site in the 12 digested bands analysed by LC-MS/MS fragmenting with HCD 
and ETD. The results were obtained using Mascot. T: trypsin digested, A: Asp-N digested, () is hits only exceeding 
the homology threshold, Covered is whether or not the glycation site is directly mapped by the MS/MS results. 
Site  Hits Score Expect Covered Identity in band Homology in band ID 
Q9 8 61 7.8E-7 + 1  HCDT 
N27 2 (8) 36 0.0016 + 6 1, 2, 3, 5, 12 ETDA 
Q51 1 46 2.3E-5 - 2  HCDA 
N172 1 39 0.021 + 9  ETDA 
N246 (1) 37 0.07 +  5 ETDT 
Q264 2 (1) 52 5.8E-6 + 12 1 HCDT 
N265 (8) 39 0.00038 -  2, 4, 5, 6, 12 HCDAT 
N272 1 26 0.0026 -  2 HCDA 
N278 1 78 7.8E-5 + 1  ETDT 
N280 (1) 43 0.028 +  1 ETDT 
Q291 3 (1) 72 0.00034 + 1, 4  ETDT 
Q298 4 (2) 78 6.8E-7 + 1  ETDT 
N309 7 (1) 42 6.5E-5 + 3, 4, 11  ETDT/HCDT 
N326 7 (4) 92 7.8E-8 + 1, 2, 9, 12 7 ETDA 
Q360 2 41 8.4E-5 + 2  HCDT 
Q393 1 79 8.7E-5 + 4  ETDT 
Q399 4 (3) 77 7.3E-5 + 12 1 ETDT/HCDT 
N421 1 (2) 67 0.0006 + 4  ETDA 
Q443 (5) 39 0.00014 -  2, 3, 7, 9 HCDT 
N444  (6) 39 0.00014 +  2, 6, 7, 9 ETDA/HCDT 
N463 1 (4) 49 1.2E-5 - 6 3, 5, 7 HCDA 
 
Deamidations are suspected to have a negative effect on the thermostability of BLA (Tomazic et 
al., 1988a; Tomazic et al., 1988b). However, as some of the observed deamidation sites are located 
in the area around the active site, these modifications might also influence the enzyme activity.  
The residue Q9 is located close to the active site and is proposed to play a role in the substrate 
binding (Machius et al., 1995). A deamidation in this site could influence substrate binding and 
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possibly the enzyme’s activity. This deamidation was observed in sample 1 with good search 
results as the score was 61 and expect value of 7.8E-7.  
Q360 is located close to the active site and a deamidation in this site might influence the activity 
and possibly the substrate binding. The search results for this deamidation observed in sample 2 
gave a score 41 which is above the identity threshold and expect value of 8.4E-5.  
The last deamidation site in the active site area was at N326. This site is located very close to 
the active site as H327 is proposed to be involved in substrate binding in subsite -1 (Machius et 
al., 1998). The search results for this site were very good with a score of 92 and expect value of 
7.8E-8. The deamidation in this site is likely to influence substrate binding and catalytic activity.  
 
 
Figure 24. Surface of BLA (PDB 1BLI) with deamidation sites shown in red, modified Lys and Arg residues shown 
in blue (modified by glycations and/or carbamylations) and secondary binding sites shown in yellow. The residue 
R437 are shown as a modification site but it is also a residue in a secondary surface binding site. (The PyMOL 
molecular Graphics System, Version 1.3, Schrödinger, LCC) 
 
Deamidation at Q264 was observed in digest samples 12 and 1 with a max score of 52 and 
expect value of 5.8E-6 exceeding the identity threshold. The site is located at the enzyme surface 
in the substrate binding site and is proposed to be involved in substrate binding in subsite +3 
(Machius et al., 1998). The deamidation in Q264 will therefore very likely affect the substrate 
binding. The results also indicated that N265 could be deamidated. The search results for this 
modification only exceeded the homology threshold with a max score of 39 and expect value of 
3.8E-4. The sequence coverage of this peptide was quite low and the deamidation site was not 
covered, though it was observed in several of the digested samples. As the site is located on the 
surface next to the identified deamidation site Q264 it is, however, possible that N265 also 
become deamidated. As N265 furthermore is located right beside Q264 in the substrate binding 
cleft, a deamidation in this site could also influence the substrate binding. The double mutation 
Q264S-N265Y is shown to significantly increase the activity towards maltoheptosidic substrate 
and starch (Declerck et al., 2003). Thus, indicating that changes, such as deamidations, in these 
sites can influence the activity of BLA. 
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The deamidation at N172 is the only one of the observed deamidation sites located in domain 
B. This site is relatively close to the active site and situated in the area between domains A and B 
containing the Ca-Na-Ca triade, which is proposed to play a vital role in the activity and 
thermostabillity of BLA. Studies show that N172 influences the thermostability of BLA 
(Declerck et al., 2000; Declerck et al., 2003; Machius et al., 1998). Domain B is also speculated to 
contain part of an extended substrate binding site from the active site, however, the sites 
involved are not fully elucidated. The area in which N172 is located is suspected to be involved in 
this extended substrate binding site (Machius et al., 1998). The deamidation on N172 was 
observed in sample 9 with expect value 0.021 and score 39 just exceeding the identity threshold. 
The site N272 is located in domain A in the area between domains A and B containing the Ca-
Na-Ca triade, where it is expected to be involved in the residues stabilising the structure for the 
metal binding sites (Machius et al., 1998). This deamidation was only found in sample 2 and the 
results was not very strong exceeding the homology threshold with score 26 and expects 0.026 
not mapping the deamidation site in the sequence coverage. Though, a deamidation in this site 
could affect stability and possibly activity. 
The four observed deamidation sites in domain C (Q399, Q443, N444 and N463) are not 
suspected to influence the Ca binding site in this region, Figure 3, which involves the residues 
G300, Y302, H406, D407 and D430. Domain C also contains secondary binding sites and N463 
is located in the vicinity of one of these sites, so it might influence the function of this site. The 
deamidation at N463 exceeded the identity threshold with a score of 49 and expect value 1.2E-5. 
3.3.1.3 Modification of Lys and Arg residues 
Several Lys and Arg residues were found to be modified by glycations (including AGEs) and/or 
carbamylations, Table 12. The modified Lys and Arg residues were all located at the surface of 
BLA, Figure 24. The role of Lys residues on the surface of BLA has been studied by introducing 
carboxylic groups on these residues by chemical modifications with reagents such as citraconic 
anhydride (Habibi et al., 2004; Khajeh et al., 2001a; Khajeh et al., 2001b). These studies identify 
approximately 10 modified Lys residues on BLA, though the exact Lys residues involved are not 
identified. These modifications affect the thermostability, kinetic activity and substrate specificity 
(Habibi et al., 2004; Khajeh et al., 2001a; Khajeh et al., 2001b). It is therefore possible that some of 
the modified Lys residues identified by LC-MS/MS in the present study influence the activity and 
stability.  
One of the studies by Khajeh and co-workers (2001a) identifies 10±1 modified Lys residues on 
BLA. This corresponds to the number of modified Lys residues identified on the surface of BLA 
in the present study where 11 out of the 27 Lys residues were found to be modified to some 
extent. Additionally 8 modified Arg residues were found from a total of 22. As some of the 
modified Lys and Arg residues observed are located close to the active site, in areas involved in 
stability as well as close to suspected secondary binding sites, some of the modifications are likely 
to influence activity, substrate binding and stability of BLA.    
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Sucrose was used as substrate during the fermentation of BLA. This carbohydrate is not a 
reducing sugar so it cannot form glycations. However, sucrose can be hydrolysed during 
sterilisation into fructose and glucose (Petersen et al., 1999). So the glycations could be formed by 
these sucrose hydrolysis products formed during sterilisation of the substrate.  
Urea was not used for the fermentation of the BLA characterised in the present project so 
exactly how the carbamylations is formed is unknown. It could be that some of the substrates are 
degraded during the sterilisation forming urea or isocyanate as a by product. Studies at 
Novozymes have shown that there is a correlation between the amount of ammonium in the 
fermentation broth and the level of carbamylation (Andersen 2012a).  
 
Table 12. Identified and indicated modifications on Lys and Arg residues in the 12 digested bands analysed by LC-
MS/MS fragmenting with HCD and ETD. The results were obtained using Mascot. Hex: Glycation with hexose, 
3DG: 3-Deoxyglucosone, Cbm: Carboxymethyl, Cbe: Carboxyethyl, Car: Carbamylation, MG-HI: methylglyoxal-
derived hydroimidazolone, T: trypsin digested, A: Asp-N digested, () is hits exceeding the homology threshold but 
not the identity threshold, Covered is whether or not the glycation site is directly mapped by the MS/MS results. 
Light green shadings for glycations and AGEs. 
Site  Modification Hits Score Expect Covered Identity in 
band 
Homology in 
band 
ID 
R23 Cbm/Cbe (4) 32 0.0031 +  1, 6 ETDA 
R24 MGHI (1) 15 0.041 +  5 HCDA 
K80  Car 3 (1) 45 0.0009 + 4, 6 12 ETDT 
K88 Cbe (1) 28 0.0091 +  6 ETDT 
R127 MGHI 1 (4) 38 0.00015 + 5 9, 12 ETDT/HCDT 
K136 Cbm  (1) 23 0.025 +  6 ETDT 
K154 Cbe 1 (2) 43 0.0012 + 5  ETDA 
K154 Car (2) 24 0.0067 -  5, 6 HCDA 
R173 Car 1 39 0.021 + 9  ETDA 
R173 3DG 7 (7) 34 0.017 + 4, 5, 6, 12  ETDT 
K234 Cbm 4 53 0.00023 + 12  ETDA 
K234 Car 10 (2) 48 0.00023 + 4, 6, 7, 9, 11  ETDA/HCDA 
K237 Car 47 (4) 83 6.8e-6 + 4 – 9, 11, 12  ETDAT/HCDA 
K237 Cbm/Cbe 9 (3) 39 0.0011 + 6, 7 5, 8, 9 ETDAT/ETDT 
R242 Cbe/MGHI 11 (3) 71 2.5e-6 + 4, 5, 6, 7, 9 8 ETDA/HCDA 
R242 Car (1) 29 0.015 +  11 ETDT 
K306 Car 52 (7) 80 3.9e-7 + 4 – 9, 11, 12  ETDAT/HCDAT 
K306 Cbm  5 (7) 57 0.00033 + 5, 12 6  ETDT/HCDT 
K315 Car 34 (3) 86 1.1e-7 + 4 – 7, 9, 11, 12  ETDAT/HCDT 
K315 Hex/Cbm 4 (2) 50 0.0009 + 4 – 6, 12  ETDT 
K319 Car 1 35 0.037 + 4  HCDA 
K381 Cbm (1) 29 0.0011 +  12 HCDT 
K383 Car 7 (2) 39 0.0035 + 6, 11 9 HCDT 
K383 Cbe (1) 20 0.011 +  12 HCDT 
K389 Cbm/Cbe 5 (2) 49 0.00057 + 4, 9 5, 11 ETDT 
K389 Car 1 34 0.0061 + 5  HCDT 
K392 Cbe 1 79 8.7e-5 + 4  ETDT 
R413 Cbe 4 (1) 79 0.00012 + 5, 6, 12  ETDT 
R437 MGHI 1 (6) 30 0.001 + 11 4 – 6, 9, 12 ETDT/HCDT 
R442 MGHI/Cbe/Hex 1 (8) 54 0.00014 + 7 2, 6, 9 ETDA/HCDT 
R442 Car 2 (3) 37 0.0085 + 11, 12 2, 9, 10 ETDA 
 
Structural studies of BHA reveal three secondary binding sites; a maltose binding site and two 
glucose binding sites. The maltose binding in BHA involves P434, D432 and W347. The first 
glucose binding site consist of W439 and W469 and the second glucose binding site is at Y363 
(Lyhne-Iversen et al., 2006). The equivalence to these sites can be found on BLA. From the 
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findings in BHA it can be deduced that the residues W342, P432 and D430 in BLA may compose 
a maltose binding site, Figure 24. The site K383 is located very close to W342 and this site was 
found as a likely modification site for both carbamylation and glycation with scores just 
exceeding the identity threshold for carbamylations. Modification of K383 could influence the 
secondary binding site. 
The two residues R437 and W467 in BLA correspond to the first of the glucose binding sites, 
Figure 24, observed in BHA. Therefore, the possible glycation observed on R437 is located right 
in a possible secondary binding site. The score and value expect for this identification is not very 
high with score 30 and expect value 0.001, just exceeding the identity threshold. The modification 
is observed in half of the analysed samples. A glycation in this site will most likely interfere with 
this secondary binding site. 
The site K234 was found to be both glycated and carbamylated though carbamylation were 
most prevalent with score exceeding the identity hreshold. This site is located right in the active 
site and is proposed to form part of subsite +2 in the substrate binding site (Machius et al., 1995; 
Machius et al., 1998; Nielsen et al., 2000).  Modifications in this site are therefore very likely to 
influence substrate binding and activity.  
K237 is also found to be both glycated and carbamylated again with the carbamylation as the 
most prevalent. The scores for the carbamylations were very good with score of 83 and expect 
value of 6.8E-6. The site is proposed to form a salt bridge with D204 connecting domains A and 
B in the metal ion triade structure. The site is therefore proposed to play an important role in the 
stability of BLA (Machius et al., 1995; Machius et al., 2003). Mutations in this site support this 
theory as they result in considerable destabilisation of BLA (Declerck et al., 2000; Declerck et al., 
2003). So the modifications in this site could interrupt the salt bridge hereby destabilising BLA. 
Both carbamylations and glycations were found on K306 with very good scores for the 
carbamylations. The site is located in what could be the elongation of the substrate binding which 
may be involved in binding of longer substrates. Modifications in this site could therefore 
possibly affect the binding of longer substrates. 
Four regions in BLA have been proposed to be of particular importance for BLAs 
thermostability, one of these regions consists of residues T112 – H142 in domain B, more 
precisely the part of the area involved in the domains A and B contact and the metal ion triad 
(Nielsen et al., 2000). In this region the two sites R127 and K136 appear to be glycated. The 
glycation of K136 was only indicated as the score only exceeded the homology threshold whereas 
the glycation in R127 was identified with score 38 and expect value 0.00015. R127 forms a salt 
bridge with D121 which contributes to the thermostability of BLA (Declerck et al., 2000). A 
modification of R127 is therefore anticipated to influence the thermostability of BLA. The 
specific influence of a modification on K136 is more uncertain as it merely is located in an area 
which is important for the stability. The specific site might not in itself be important.  
Glycation and carbamylation were determined in the site R173. The scores were not particularly 
high for these identifications though for both modifications the scores are above the indicated 
identity threshold. R173 is located right next to N172 on the surface of domain B and as 
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mentioned previously N172 influences the thermostability of BLA (Declerck et al., 2000; 
Declerck et al., 2003; Machius et al., 1998) and this area in domain B could be involved in 
substrate binding (Machius et al., 1998). It is therefore possible that the modifications on R173 
affect the stability and/or the substrate binding. 
In conclusion multiple modification sites were identified on BLA. A few Met oxidations 
occurred. Multiple deamidations of Asn and Gln residues as well as glycations and 
carbamylations of Lys and Arg residues were identified which all can be responsible for the 
creation of the multiple forms of varying pI values. The majority of modifications were observed 
on the surface of BLA though a few deamidations were present inside the structure in the area 
around the active site. Both deamidations and modifications of Lys residues have in other studies 
shown to have a negative effect on the stability of BLA. Several residues related to the stability of 
BLA were also found to be modified especially the modification sites R127, N172, K237 and 
N272 are likely to be important for the enzymes thermostability. However, there were also 
observed multiple modification sites in the active site area likely to influence activity and 
substrate binding. The modifications in the sites Q9, Q360 and N326 located close to the active 
site are likely to result in changes in the enzyme activity. The modifications on K234 and Q264 
which are part of subsites in the substrate binding likely influences the substrate binding and 
possible hereby also the activity. The sites N265 and N172 are also located in close proximity to 
the substrate binding sites and K306 possibly in the elongation of the substrate binding. So the 
modifications in these sites are likely to affect substrate binding. BLA also contains secondary 
binding sites and the modification sites K383 and R437 are located so close to such sites that 
they could influence these secondary binding sites most likely modifications such as glycations 
would decrease the efficiency of the site or completely inactivate the binding site. As the exact 
role of these site are not fully understood the effect of the modifications in these sites are not 
known. Though if the sites function as initial substrate recognition sites or substrate binding for 
longer substrates glycations at the secondary binding sites could decrease the efficiency of the 
amylase.  
Overall several modifications and multiple modification sites were identified or indicated. Many 
of the modifications were found in sites which are important for BLAs stability, activity and 
substrate interaction. These modifications can therefore have a large effect on the function of 
BLA, especially for the BLA molecules with multiple modifications. Further investigations of 
these sites can provide important knowledge concerning the importance of these sites and the 
effect of the modifications. Site specific mutations of the modification sites can provide this 
information and this will be done in section 3.4, where the effect of the modifications in some of 
the modification sites are analysed. 
3.3.2 Relative quantification of glycation sites in BLA pools PA – PD   
Relative quantification of glycation sites were performed on the four BLA pools. Two samples 
were prepared where the BLA pools were digested with trypsin, each pool was labelled with a 
TMT (isobaric stable isotope tag) and the samples were mixed. The pools were labelled with 
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different tags in the two samples. The two TMT labelled samples were analysed by LC-MS/MS 
fragmenting with ETD and HCD.   
The data for the HCD fragmentations resulted in sequence coverage on BLA up to 90% with 
Mascot score of 11031. The Mascot search of the HCD data did, however, not reveal any 
glycation sites.  
The results from the ETD fragmentation also resulted in BLA as primary significant hit with 
sequence coverage of 97% and Mascot score of 8682. Four glycation sites were observed by the 
ETD fragmentation, Table 13, all the glycations were the AGE MG-HI. The reporter ions for the 
glycated peptides were, however, far too low to perform relative quantification between the four 
pools.     
Of the four observed glycation sites only R242 was found in the previous investigations. The 
four sites were all located on the surface of BLA. The site K436 is located right next to the 
secondary binding site containing of R437 and W467. Glycation on K436 could influence the 
function of this carbohydrate binding site. 
 
Table 13. The four BLA pools PA – PD were digested by trypsin labelled with TMT, mixed and analysed by LC-
MS/MS fragmenting with ETD. The following glycations were observed by Mascot searches of the MS/MS data. 
Quan: the quantification results obtained for the glycated peptides, MG-HI: methylglyoxal-derived 
hydroimidazolone, () is hits exceeding the homology threshold, Cov: is whether or not the glycation site is directly 
mapped by the MS/MS results. 
Site  Modification Hits Score Expect Cov Quan Peptide Sequence 
K76 MG-HI 1 (3) 56 3.4E-5 + – 75 – 88  R.TKYGTKGELQSAIK.S 
R242 MG-HI (1) 29 0.013 + – 238 – 249  K.FSFLRDWVNHVR.E 
R375 MG-HI 1 (8) 39 0.0023 + – 371 – 381  K.GDSQREIPALK.H 
K436 MG-HI (1) 25 0.047 – – 414 – 437  R.EGDSSVANSGLAALITDGPGGAKR.M 
 
Overall the ETD fragmentation of the samples provided poor reporter ion intensities with only 
a few exceeding the ion intensity threshold of 1,000, which is required to get an error below 10%. 
The HCD fragmentation provided better results though several of the reporter ions were below 
the threshold and the intensities in general were lower than in the previous experiments on BASI. 
In the quantification experiments on BASI (section 3.2.3) only a few reporter ions were below 
the intensity threshold for each sample. This indicates that increasing the number of tags in a 
sample decreases the reporter ion intensities. It is possible that further optimisation of the 
MS/MS method could improve the reporter ion intensities. The quantification could possibly 
also be improved by quantifying two pools at a time as this would increase the amount of each 
reporter ion in the sample. As described previously ETD fragments randomly along the peptide 
backbone without preference for chemical modifications, therefore only applying two TMT in a 
sample is likely to increase the intensities of the ions as they are in higher concentrations. This 
would most likely also result in identification of more glycation sites as they most likely are such a 
small part of the sample that they are not detected in the LC-MS/MS analysis when all the four 
pools are mixed. It has also been proposed that the charge state influences the formation of 
reporter ions by ETD so selecting precursors of charge state four or above could improve the 
ETD quantification of TMT labelled peptides (Viner et al., 2009). Of the four glycated peptides 
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identified by ETD only the peptide glycated in R242 had charge state four. The other three 
glycated peptides had charge state 3, though the quantification results were not better for the 
peptide with charge state four. 
In conclusion, the glycation sites in the four BLA pools varying in pI range were not quantified. 
The quantification method needs to be further optimised to perform the relative quantification. 
This might be done by only quantifying two samples at a time as this most likely will increase the 
amount of glycated peptides and the amount of each reporter ion in the quantification sample. 
The relative quantification by ETD might also be optimised by selecting peptides with charge 
state four or above as this has been proposed to increase the reporter ion intensities.  
3.3.3 Forced glycations of BLA 
The partly purified pool of BLA with the fewest forms in it (PA) was incubated with glucose, 
maltose, maltotriose, maltoheptaose, soluble starch and in a blank without hexoses, Figure 25.  
 
 
Figure 25. IEF gels of PA incubated at 40°C pH 9.5 up to eight days in buffer (blank) and in different carbohydrate 
solutions. 
 
In the absence of reducing sugars (i.e. in the blank) a few extra forms of BLA with lower pI 
values appeared over time. These extra forms are most likely created by deamidations. Incubation 
with glucose, maltose, maltotriose and maltoheptaose resulted in multiple bands appearing over 
time and the forms with the highest pI values disappearing. Maltose, maltotriose and 
maltoheptaose appeared to be more reactive than glucose as incubation with these rapidly 
resulted in multiple forms with very low pI values and the initial forms completely disappearing. 
Incubation with starch resulted in the same pattern as the incubation with buffer, so glycation 
does not seem to occur in this incubation.   
The forced glycations revealed that glycation also occur with longer reducing sugars such as 
maltoheptaose but at some point the longer chains become less reactive as starch does not seem 
to perform glycation or very slow if it does. This is unexpected as it would be expected that the 
amylase degraded some of the starch to smaller and more reactive carbohydrates and therefore 
some glycations could be observed on the IEF gel.  
It also appeared that glucose was less reactive than maltose and the longer maltosaccharides. A 
study of the reactivity of 15 monosaccharides with amino groups shows that glucose is the least 
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reactive. This decreased reactivity is dependent on the extent to which the carbohydrate exists in 
the open conformation (Bunn et al., 1981). The incubation experiment indicated that glucose also 
is the least reactive of the shorter carbohydrates (up to 7 glucose units). Thus, indicating that the 
reactive glucose units in maltose to maltoheptaose tend to be more in the open conformation 
than glucose itself. Therefore, it is probably advantageous to use glucose rather than the larger 
carbohydrates and dextrins as carbon source in the fermentation to reduce the glycation rate. 
The glucose and maltose incubated PA samples were analysed by LC-MS to determine the 
extent of glycation at different time points. For MS analysis of glucose incubated samples, Figure 
26, the sample incubated three days showed a peak corresponding to unmodified BLA at 55236 
m/z followed by three larger peaks. The larger peaks correspond to the addition of glucose 
(+162 Da). In between the peaks corresponding to glycated BLA smaller peaks appear which 
could be AGEs or other smaller modifications. The presence of 4 – 5 glycations can be observed 
in the spectrum for the sample. The accuracy of the MS analysis on the instrument used can vary 
up to 5 Da depending on protein size and sample complexity. This explains the inaccuracies 
observed in the m/z determinations.  
 
 
Figure 26. Full-length MS of PA incubated with glucose at 40°C pH 9.5. A) Three days incubation. B) five days 
incubation. 
 
For the sample incubated five days in glucose, no or very small amounts of unmodified BLA 
appeared to be present, Figure 26B. The spectrum was more complex with multiple peaks and no 
specific pattern occurred. This indicates that multiple different modifications occur on BLA, 
most likely combinations of glycations, AGEs, oxidations and deamidations. The peak at 56428 
m/z could, however, indicate that some of the BLA molecules are glycated up to seven times. 
Due to the complexity of the spectrum it is difficult to obtain more information from the 
spectrum. 
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Three days incubation with maltose resulted in a much more complex MS spectrum, Figure 27, 
than three days incubation with glucose. The spectrum revealed that the sample only contain low 
amounts of the unmodified BLA which also correspond to the observation on the IEF gel. The 
peak at 56573 m/z could be BLA with four glycations by maltose. So the glycation level does not 
seem to be much different from the glucose incubation which also indicated up to four 
glycations. It just appears that more BLA becomes modified by maltose. These observations 
again correspond with the observations from the IEF gel that maltose is more reactive than 
glucose. MS on samples incubated five and eight days in maltose did not provide interpretable 
spectra possibly due to the complexity of these samples. 
 
 
Figure 27. Full-length MS of PA incubated three days with maltose at 40°C pH 9.5. 
 
The samples incubated in glucose three and eight days along with the sample incubated 3 days 
with maltose were selected for trypsin digest and LC-MS/MS fragmenting with ETD to 
determine the glycation sites, Table 14. The Mascot search results for all three samples resulted in 
significant hits for BLA with sequence coverage of 66% (score 1852), 60% (score 5642) and 62% 
(score 3065) for PA incubated in glucose three and eight days and in maltose three days, 
respectively. 
In the sample incubated three days with glucose three glycation sites were identified. There were 
identified six glycation sites in the sample incubated eight days with glucose and additionally 5 
sites were observed with scores only exceeding the homology threshold. These observations 
support the previous observations that the sample becomes more modified with eight days 
incubation in glucose. In the sample incubated eight days with glucose the AGE carboxyethyl 
was also found. LC-MS/MS of the sample incubated three days with maltose only revealed one 
glycation site. This site was also identified in the glucose incubated samples. 
The trypsin digests found 11 glycation sites where two of these had not been observed in the 
MS/MS analysis of the multiple forms of BLA. The sites R93 and K370 were only identified with 
scores above the homology threshold in the searches. The sites are located on the surface of BLA 
in domain A away from the active site, the metal ion triad and substrate binding site.   
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Table 14. Glycations found by LC-MS/MS on trypsin digested PA sample incubated three and eight days with 
glucose and three days with maltose. The results were obtained by Mascot searches. Hex: Glycation with glucose, 
Hex(2): Glycation with maltose, Cbe: Carboxyethyl, () is hits only exceeding the homology threshold, Covered is 
whether or not the glycation site is directly mapped by the MS/MS results. 
Site  Modification Hits Score Expect Covered Peptide Sequence 
PA glucose 3 days       
K88 Hex 3 61 1.7E-5 + 81 – 93  K.GELQSAIKSLHSR.D   
K381 Hex 1 21 0.033 + 376 – 389  R.EIPALKHKIEPILK.A   
K392 Hex 2 68 1E-6 + 392 – 413  R.KQYAYGAQHDYFDHHDIVGWTR.E 
PA glucose 8 days       
K80  Hex (2) 40 0.0036 + 77 – 88  K.YGTKGELQSAIK.S 
K88 Hex 2 88 3.4E-8 + 77 – 93  K.YGTKGELQSAIKSLHSR.D 
K88 Hex 6 (1) 69 1.5E-5 + 81 – 93  K.GELQSAIKSLHSR.D   
R93 Cbe (2) 34 0.0026 + 89 – 106  K.SLHSRDINVYGDVVINHK.G 
K306 Hex (2) 31 0.0057 + 306 – 319  R.KLLNGTVVSKHPLK.S   
K315 Hex (1) 24 0.018 + 306 – 319  R.KLLNGTVVSKHPLK.S   
K370 Hex (1) 24 0.042 + 355 – 375  R.ESGYPQVFYGDMYGTKGDSQR.E 
K381 Hex 2 42 0.0025 + 376 – 389  R.EIPALKHKIEPILK.A   
K383 Hex 1 30 0.054 + 382 – 389  K.HKIEPILK.A   
K389 Hex 1 33 0.036 + 384 – 391  K.IEPILKAR.K 
K392 Hex 7 102 3.9E-9 + 392 – 413  R.KQYAYGAQHDYFDHHDIVGWTR.E 
PA maltose 3 days       
K88 Hex(2) 3 (1) 54 0.00021 + 81 – 93  K.GELQSAIKSLHSR.D   
 
Overall the forced glycations revealed that maltose, maltotriose and maltoheptaose are more 
reactive than glucose in the formation of glycations. Therefore, glucose is to prefer as carbon 
source during fermentation compared to longer reducing sugars or dextrins, since it reduces the 
overall glycation rate. Two more glycation sites were identified by peptide mapping and MS/MS 
of glycated BLA. The two sites R93 and K370 are as the other identified glycation sites located 
on the surface of the enzyme but they are not suspected to influence the amylase activity or 
stability.  
  
 72 
 
3.4 Characterisation of BLA variants 
On the basis of the modifications and modification sites identified in the previous section new 
BLA variants were produced to determine the possible impact of some of the modifications on 
BLA. A lot of the studies performed on the BLA structure attempted to elucidate the structural 
features related to the thermostability (Declerck et al., 1997; Declerck et al., 2000; Declerck et al., 
2003). The focus of the present project is on BLA as a detergent enzyme. The temperatures used 
in wash today are relatively low with 30 – 40°C as common wash temperatures in Europe. 
Therefore, the focus is on the activity and wash performance rather than thermostability. Time 
did not allow for characterisation of variants by site specific mutation at all of the identified 
modification sites. The modification sites chosen for mutagenesis were therefore selected based 
on their possible impact on the active site or on secondary binding sites. The effect of the 
mutations was characterised by determining the kinetic parameters kcat, KM, kcat/KM and the wash 
performance. The pI values of the variants were analysed by IEF and the stability was tested by 
DSC.  
The variants produced and the possible significance of the selected sites are listed below: 
 
Q9E  – is located behind the active site and may affect activity, pH profile and 
substrate binding.  
N172D   – is located close to the metal ion triad in domain B and may affect substrate 
binding as well as thermostability. 
Q264E – is located in the substrate binding site and is involved in substrate binding in 
subsite +3, thus possibly affecting substrate binding and thus activity. 
N265D  – is located in the substrate binding cleft and may therefore affect substrate 
binding. 
Q360E – is located behind the active site and may affect activity, substrate binding and 
pH profile. 
K306M  – may be located in an elongation of the substrate binding cleft and perhaps 
affecting binding of longer substrates. 
K383M – is located close to a secondary binding site and may affect substrate binding. 
 R437L – is located right in a secondary binding site and may affect substrate binding. 
   
The possible deamidation sites selected were changed to the corresponding acid to mimic the 
deamidation (Q→E, N→D), hereby mimicking the influence of the specific deamidation. For the 
selected glycation sites Lys was substituted with Met and Arg with Leu to evaluate the effect of 
removing the glucose reactive site. Met and Leu were chosen because of their neutral side chain 
and as being close in side chain size to Lys. The variant R437M was also produced, but the 
expression of this variant was very low and it could therefore not be characterised.  
The pI values of the BLA variants were determined on an EIF gel, Figure 28. All the mutations 
result in substitutions to an amino acid with a lower pI value, therefore one should expect a 
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decrease in pI value for all the variants. This is, however, not the case. It appears that the same 
amino acid substitutions at different parts of the molecule can result in different changes in pI 
value or no change at all. The Q264E, N265D and Q360E all result in the same decrease in pI 
value. The pI decrease for Q9E is slightly lower than for the other three, whereas the substitution 
N172D does not give a change in pI value. The decrease in pI value for K383M and R437L 
appears to be the same as for Q9E; for K306M the pI value is unaffected. The changes observed 
for some of the single mutations seem to correspond to bands observed in the BLA sample. 
Several microenvironmental factors can influence the pKa values of the amino acid residues in 
proteins such as electrostatic and hydrophobic effects, hydrogen bond formation and helix dipole 
interactions (Li et al., 2005; Nielsen et al., 2001). This can explain why the same amino acid residue 
substitution or chemical modification at different positions of the amylase results in different 
shifts in pI.  
  
 
Figure 28. IEF gel of the 8 BLA variants. 
 
The observed changes in pI values correlate with the hypothesis made in the previous section 
that one band can contain multiple BLA forms with one or a few modification at different sites, 
as well as with the hypothesis that a band at lower pI value has more modifications on the forms 
present in that band.  
The stability of the variants was determined by DSC, Table 15, (DSC results Appendix I Figure 
7). BLA is a very stable enzyme as the DSC results also show with a Tmax value of 103.2°C. The 
same is evident for the variants as only Tmax values of Q9E, N172D and Q264E are slightly lower 
by 2.6, 4.3 and 4°C, respectively. A drop of ≥3 – 4°C is generally considered as being significant 
(Lund 2011). 
 
Table 15. Tmax values for the BLA variants determined by DSC. 
 BLA Q9E N172D Q264E N265D Q360E K306M K383M R437L 
Tmax (°C) 103.2 100.6 98.9 99.2 102.9 102.7 103.4 103.2 103.1 
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As previously mentioned N172 is suspected to be involved in the thermostability of the enzyme 
since it is located in domain B in the area interacting with the Ca-Na-Ca triade. The introduction 
of a deamidation in this site seems to have a small negative effect on the stability of the enzyme. 
Q9 and Q264 are located in the active site area and changes in these sites were mainly expected 
to influence the substrate binding and activity of the enzyme. The influence of a deamidation in 
Q9 on the stability is almost insignificant. Declerck and co-workers (2003) showed that the 
double mutation Q264S-N265Y increases the stability and has increased activity. This agrees with 
the DSC results which revealed that Q264 can influence stability. By contrast the N265D 
mutation did not seem to affect the stability. The effect of the Q264N mutation was however the 
opposite of the observations made by Declerck and co-workers (2003) for the Q264S-N265Y 
mutant. This may indicate that deamidation at Q264 (i.e. Q264E) has a negative effect on the 
stability. The mutation Q264S, substituting the possible deamidation site with another polar 
uncharged amino acid, increases the stability.  
The kinetic parameters kcat, KM and kcat/KM were determined for the BLA variants on a short G7 
substrate, Table 16, and on a long amylose DP440 substrate, Table 17. Alterations in the kinetic 
parameters on G7 substrates occur for the Q264E, Q360E and Q9E variants. Q264E markedly 
decreased in KM which resulted in an increase in kcat/KM. Both kcat and KM increased for Q360 
which meant that kcat/KM overall was unaffected by the mutation. The Q9E mutation had a 
negative effect on KM as this value almost doubled which decreased kcat/KM. The kcat value was 
slightly higher for both N265D and R437L but the variation was quite high for R437L so this 
difference was not a significant.  
 
Table 16. The kinetic parameters kcat, KM and kcat/KM for the BLA variants and BLA determined at 30°C pH 7.0 on 
maltoheptaose substrate. 
Sample kcat (s-1) KM (mM) kcat/KM (s-1 mM-1) 
BLA 65 ± 12 0.011 ± 0.003 5922 (± 1779) 
Q9E 63 ± 14 0.027 ± 0.008 2394 (± 847) 
N172D 70 ± 9 0.013 ± 0.005 5462 (± 1926) 
Q264E 60 ± 5 0.005 ± 0.001 13013 (± 2887) 
N265D 83 ± 5 0.011 ± 0.002 7277 (± 1584) 
Q360E 155 ± 24 0.026 ± 0.005 5996 (± 1388) 
K306M 70 ± 4 0.010 ± 0.001 7335 (± 1059) 
K383M 69 ± 10 0.010 ± 0.002 7133 (± 2044) 
R437L 81 ± 18 0.010 ± 0.003 8153 (± 3051) 
 
The kinetic parameters obtained on amylose revealed some of the same tendencies as the 
determinations on the G7 substrate. The changes were primarily observed for Q264E, Q360E 
and Q9E. For Q264E and Q360E the changes were more or less the same as for the G7 
substrate though the decrease in KM for Q264E was not as pronounced on amylose as on the G7 
substrate. The changes in kinetic parameters were, however, different for Q9E. On amylose kcat 
decreased, whereas on the G7 substrate KM increased. The different changes observed on the 
different substrates for Q9E did, however result in a decrease in the catalytic efficiency for both 
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substrates. R437L had a higher kcat value on amylose, but the variation for this determination was 
quite high. It is therefore difficult to determine if the difference is significant.  
 
Table 17. The kinetic parameters kcat, KM and kcat/KM for the BLA variants and BLA determined at 30°C pH 7.0 on 
amylose DP440. 
Sample kcat (s-1)  KM (mg/ml) kcat/KM (s-1 mg-1 ml) 
BLA 200 ± 8 0.140 ± 0.03 1455 (± 286) 
Q9E 117 ± 12 0.112 ± 0.04 1099 (± 363) 
N172D 201 ± 6 0.129 ± 0.01 1555 (± 132) 
Q264E 228 ± 15 0.089 ± 0.02 2632 (± 584) 
N265D 232 ± 28 0.128 ± 0.03 1852 (± 483) 
Q360E 416 ± 17 0.261 ± 0.06 1630 (± 363) 
K306M 213 ± 38 0.125 ± 0.04 1740 (± 602) 
K383M 241 ± 33 0.139 ± 0.02 1743 (± 349) 
R437L 307 ± 67 0.137 ± 0.02 2249 (± 707) 
 
Overall the kinetic studies revealed that the mutation Q264E located in subsite +3 in the 
substrate binding site resulted in higher affinity for both substrates so deamidation in this site 
could improve the substrate binding and herby the catalytic efficiency at 30°C pH 7. These data 
correlates with other studies stating that position 264 is involved in substrate binding (Declerck et 
al., 2003; Machius et al., 1998). 
The Q360E modification appeared to increase both kcat and KM so a deamidation at Q360 may 
result in lower substrate binding, but higher rate of substrate catalysis, though the modification 
did not appear to influence the overall catalytic efficiency at these conditions.   
The mutation Q9E decreased the catalytic efficiency strongly indicating that a deamidation in 
this site has a negative effect on the efficiency of the enzyme. The modification appeared to give 
lower substrate affinity towards the smaller substrate and lower substrate turnover number on 
long substrate.  
Removing the reducing sugar reactive sites did not have much influence on the kinetic 
parameters. Although removing the glucose reactive site at R437 showed a small positive effect 
on kcat and the catalytic efficiency but the variations on these results were quite large.   
The wash performance of the variants were analysed on rice starch cotton patches at 40°C in a 
liquid and a powder detergent. European wash conditions were chosen for the variants which 
include running the wash at 40°C. The powder detergent results in pH 10 in the wash and the 
liquid detergent in pH 8. The difference between the wash results has to be more than 1-1.5 delta 
remission units to determine a difference in wash performance. 
The wash performance for the BLA variants in liquid detergent revealed that all the variants had 
improved wash performance, Figure 29. The wash performance of Q360E was approximately 1 
delta remission higher than BLA, therefore it could not be concluded that this form had an 
increased wash performance. The N265D variant stood out from the rest with the best wash 
performance. The remaining variants had a better wash performance than BLA and Q360E but 
not as good a performance as N265D. The fact that more or less all the variants except Q360E 
increased in wash performance at these conditions was unexpected. Though the wash results for 
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the partly separated forms of amylases (section 3.1.2) did indicate that few modifications could 
increase the wash performance. 
 
 
Figure 29. The wash performance of the BLA variants on rice starch cotton patches in a liquid detergent. Standard 
deviation for the determinations is shown. 
 
The wash performances in the powder detergent, Figure 30, were in general higher than the 
performances observed in liquid detergent. Again N265D had the highest wash performance. 
The wash performance of K306M, Q360E, Q264E and K383M was better than of BLA, but not 
as good as N265D. The variants N172D and R437L had the same wash performance as BLA 
under these conditions, whereas Q9E had a lower wash performance.  
 
 
Figure 30. The wash performance of the BLA variants on rice starch cotton patches in a powder detergent. 
Standard deviation for the determinations is shown. 
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In general there was no strong correlation between the kinetic parameters obtained on G7 and 
amylose with the wash performance data. This shows that the structural factors influencing the 
kinetic parameters in the assay are not necessarily the same as the ones affecting the wash 
performance. 
The increased wash performance observed for most of the single mutations can be caused by a 
number of different factors. It has been proposed that decreasing the thermostability of BLA 
might increase the activity at lower temperatures. This is suspected to be due to the rigidity of 
thermostable enzyme as they generally have the highest activity at elevated temperatures but the 
activity decreases with temperature as the structure becomes more rigid (Radestock et al., 2011). 
There was, however, not observed a loss in stability by DSC corresponding to increased activity 
for the BLA variants. It could also be that the mutations on the surface somehow influence the 
enzyme interaction with the substrate structure on the textile hereby increasing the wash 
performance. For the mutation of Lys and Arg residues it is possible the increased wash 
performance is due to the removal of the reducing sugar reactive site. Changing the pKa values 
of amino acid residues around the active site has also been proposed by others to be able to 
influence the pH activity profile of enzymes (Nielsen et al., 2001). Thus the changes around the 
active site could influence the pH activity profile. 
The Q264E mutation resulted in a great improvement on the catalytic efficiency compared to 
BLA and the other variants but in the wash performance the Q264E variant was quite average. 
The increased catalytic efficiency was caused by improved substrate binding. The crystal structure 
of a BLA variant (not from this project) with acarbose has been solved by Novozymes. This 
structure is not published (Andersen 2012b). In the crystal structure of the active site of BLA in 
complex with acarbose Q264 is oriented away from the substrate, Figure 31. In theory the 
carbonyl or amide groups on Gln should be able to make hydrogen bonds with hydroxyl groups 
on the substrate. The Gln side chain is very flexible in this structure so it is possible that 
hydrogen bonding does occur. The Q264E mutation increases the substrate binding. This 
strongly suggests that Glu is hydrogen bonding with hydroxyl groups on the substrate, whereas 
Gln does not. If Gln does form a hydrogen bond to the substrate, the bonds formed by Glu 
appear to be considerably stronger resulting in increased substrate binding. The improved 
substrate binding also is accompanied by a positive effect on the wash performance at pH 8 and 
10.      
The kinetic parameters for the N265D variant did not show an effect of this mutation on the 
enzyme but it outperformed all the other variants in wash performance in both liquid and 
powder detergent. N265 is located right next to residue 264 in which Q264E has shown to 
interact with the substrate. The crystal structure of BLA in complex with acarbose, Figure 31, 
reveals that N265 is located close to the substrate and it should be able to form hydrogen bonds 
with this. Since Q264E increased substrate binding it would be expected that the N265D 
mutation had a similar effect especially on a longer substrate as it looks like a longer substrate 
could bind with that side chain. This is, however, not confirmed by the KM values for the G7 
substrate and amylose. The substantial increase in wash performance for N265D does show that 
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the mutation has a positive effect on the performance. This indicates that the mutation has 
improved substrate binding to the rice starch or the starch structure on the textile.  
 
 
Figure 31. The active site of BLA in complex with acarbose showing the possible substrate binding residues of 
Q264 and N265 (Unpublished structure of BLA with acarbose from Novozymes). Acarbose shown in yellow with 
the bond cleaved in the corresponding substrate, in the active site shown in blue. The subsites +1, +2, +3 and -1 in 
the substrate binding site are shown as S+1, S+2, S+3 and S–1, respectively. Oxygen atoms are shown in red and 
nitrogen in blue. Pymol was used for molecular rendering (The PyMOL molecular Graphics System, Version 1.3, 
Schrödinger, LCC). 
 
The kinetic parameters for Q9E revealed a lower catalytic efficiency on both substrates. Q9 is 
located right behind H327 which can interact with the substrate in subsite -1, Figure 32. This 
region is therefore very important for both substrate binding and catalytic activity. Q9 is most 
likely able to hydrogen bond with H327, though when the substrate binds in the active site H327 
also hydrogen bond to one of the hydroxyl groups in the substrate. The Q9E mutation most 
likely results in salt bridge formation between the carboxy group on Q9E with the imidazole 
group in H327. This bond is stronger than the hydrogen bond so the interaction between H327 
and the substrate will be weakened or even non-existing. This can explain the decreased substrate 
binding for the G7 substrate resulting in lower catalytic efficiency. The mutation does not have a 
negative effect on the substrate affinity for the longer substrate probably because this binding is 
stabilised by more binding sites on BLA than the short substrate. The mutation does, however, 
result in a decreased substrate turnover. The possible loss of hydrogen bonding between H327 
and amylose could result in a different conformation of the substrate in the active site, hereby 
lowering the catalytic efficiency.   
Despite the decrease in catalytic efficiency the wash performance of Q9E increased in liquid 
detergent. The wash performance in powder detergent was, however, considerably lower than of 
BLA and all the other variants. This indicates that the site influences the pH profile of the 
amylase as the performance is good at pH 8 but decreases significantly at pH 10. This also 
correlates with other studies showing that pKa values of amino acid residues around the catalytic 
site can influence the pH activity profile of an enzyme (Nielsen et al., 2001). The differences in 
wash performance could, however, also be due to some in-wash stability problems with the 
powder detergent possibly caused by one or several of the detergent components. Overall the 
N265
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S+3
S+2
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different assays reveal that the Q9 site has an influence on the substrate catalysis influencing 
substrate affinity and substrate turnover as well as possibly the pH activity profile.  
 
 
Figure 32. Close-up of acarbose in the active site showing the three active site residues D231, E261 and D328 along 
with the residues Q9, Q360 and H327. Acarbose is shown in grey with the bond to be cleaved in a corresponding 
substrate in the active site shown in blue. Oxygen atoms are red and nitrogen blue. (The PyMOL molecular Graphics 
System, Version 1.3, Schrödinger, LCC) 
 
Q360 is located very close to Q9 in the area around the active site, Figure 32. Q360 is 
surrounded by several hydrophilic amino acid residues. It is therefore possible that this site is 
involved in the overall packing of the surrounding area as it could be loosening up the packing of 
this area. The Q360E mutation which is more polar at neutral pH could further loosen up the 
packing, thus affecting the area around the active site. The position of Q360 is approximately 5.9 
Å from the active site residue E261. The Q360E mutation is therefore likely to influence the pKa 
of E261. The kinetic parameters revealed that the Q360E mutation improved the substrate 
turnover but lowered kcat thus not influencing the overall catalytic efficiency. This could indicate 
that the Q360E mutation gives rise to some slightly larger conformational changes in the area 
that changes the general substrate binding and catalytic turnover. The Q360E mutation does not 
influence the wash performance in liquid detergent but the performance is slightly improved in 
powder detergent. This could indicate that the site influences the pH activity profile of the 
amylase as no change in performance occurs at pH 8 but performance increases at pH 10.  
The N172D mutation did not have any effect on the kinetic parameters. The crystal structure of 
the active site in complex with acarbose, Figure 33, reveals that N172 is relatively close to the 
substrate binding, but approximately 5 Å from the substrate which is too far to form hydrogen 
bonds. Therefore, it has no effect on the substrate binding. The wash performance in powder 
detergent was the same as for BLA though the performance improved in the liquid detergent. 
The Tmax determinations showed that the mutation resulted in a small decrease in the stability of 
BLA. As previously mentioned it has been hypothesised that for thermostabile enzymes 
decreasing the stability might increase activity at lower temperatures. It is also possible that the 
mutation improves interaction with substrate on the fabric at pH 8 hereby improving wash 
performance. Though, it could also be other parameters responsible for the change such as the 
different components in the detergents. 
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Figure 33. BLA in complex with acarbose in the active site showing the residue N172 in green. Extended acarbose 
is shown in yellow with the bond to be cleaved in a corresponding substrate in the active site shown in blue. The 
subsites in the binding site are indicated by S and the site number. Oxygen atoms are red and nitrogen blue. (The 
PyMOL molecular Graphics System, Version 1.3, Schrödinger, LCC) 
 
The position of K306 in relation to the substrate binding site is illustrated in Figure 34A. It 
appears that this site could be located in an area in which longer substrates bind. Though, the 
K306M mutation did not have any effect on the kinetic parameters thus indicating that K306 is 
not important for interaction with amylose. The mutation does, however, increase wash 
performance. The K → M mutation on the enzyme surface would be expected to have a lower 
binding affinity toward the substrate on the textile as the positively charged Lys can be involved 
in these interactions. The amylose used in the kinetic assay was gelatinised and the substrate 
might have a different structure on the textile which could explain the different results. The 
improved wash performance could be caused by improved interaction with the substrate on the 
fabric or by lover unproductive binding of the enzyme to other surface such as the textile. 
 
 
Figure 34. Different views of the crystal structure of BLA. Oxygen atoms are red and nitrogen blue. A) The 
structure of acarbose in the active site showing K306 in what could be an elongation of the substrate binding. 
Acarbose is shown in yellow with the bond to be cleaved in a corresponding substrate in the active site shown in 
blue. The subsites in the binding site are indicated by S and the site number. B) K383 and the secondary binding site 
W342. C) R437 as part of a secondary binding site with W467 with glucose bound. The position of R437 is estimated 
by modelling after the position of W439 in BHA solved with glucose in the binding site. (The PyMOL molecular 
Graphics System, Version 1.3, Schrödinger, LCC) 
 
N172
S+2
S+1
S-1  
S-2  
S-3 
S-4
S-5
S-6
A) B) C)
K383
W342
R437 W467
S+3
S+2
S+1
S-1 
K306
 81 
 
K383 is located very close to the secondary binding site at W342, Figure 34B, so K383 could be 
involved in carbohydrate binding in this site. The mutation K383M did not result in any changes 
in the kinetic parameters for BLA. It did, however, result in improved wash performance. As 
described above the increased wash performance could be because the K383M mutation 
improves interaction of the enzyme with the substrate on the fabric. It is also possible that the 
mutation hinder the glycation in this site which could block the secondary binding site.  
R437 is a part of a secondary binding site in domain C along with W467, Figure 34C. The 
interaction with glucose shown in the figure is an estimated modelling of the position of R437 
after the position of W439 in BHA of which the structure was solved with glucose in this binding 
site (Lyhne-Iversen et al., 2006). From this structure it could appear that R437 is able to form 
hydrogen bonds to the carbohydrate. The R437L mutation may have a small positive effect on 
the kcat and hereby a slight improvement of the catalytic efficiency, but the variation of this result 
is very high. These results indicate that the site may be involved in substrate binding possibly as 
an initial substrate recognition site. The R437L mutation also has a positive effect on the wash 
performance in liquid detergent. The fact that the improvement only occurs in one of the 
detergents could indicate that the improvement is due to some interaction or lack of interaction 
with a detergent ingredient which is present in one of the detergents. 
The analysis of the variants shows that deamidations in the area close to the active site influence 
the kinetic parameters on different substrates and hereby the activity and substrate binding. 
Deamidations a bit further from the active site do not seem to have much effect on the kinetic 
parameters but they can influence other factors such as stability. The Q→E and N→D variants 
also indicated that deamidations could affect wash performance generally positively though in the 
area close to the active site the modifications are also likely to influence the pH activity profile 
which can have a negative effect on wash performance. 
The removal of possible reducing sugar reactive sites on the surface of BLA (K→M and R→L) 
did not seem to have any effect on the kinetic parameters though all the substitutions seemed to 
have a positive effect on the wash performance in liquid detergent as well as in powder detergent 
for the K→M mutations. This may be the result of changes in the interaction of the amylase 
surface with the substrate on the textile.  
In general the single mutations had a positive effect on the wash performance thus indicating 
that some of the modifications on the surface of BLA improve wash performance. The 
introduction of multiple mutations in one molecule most likely has other effects on the 
performance. This section only focused on single modifications in selected sites likely to affect 
activity and substrate interaction whereas sites relevant to enzyme stability were not evaluated. 
Modifications on these sites might show a more complex picture of the influence of modification 
sites on the wash performance. 
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4 Conclusion 
During fermentation, multiple forms of the α-amylases varying in pI values were formed. Studies 
of partially separated pools of these forms in such different alpha-amylases as BHA, AA560 and 
BLA revealed that the wash performance of the amylases tends to decrease with the decrease in 
pI value. This was especially evident at pH 10.  
A more in-depth characterisation of the BLA pools varying in pI range indicated that the 
multiple modifications affected the enzyme negatively as the pools containing the forms with the 
most modifications showed slightly lower catalytic efficiency and wash performance compared to 
the forms with fewer modifications (i.e. forms in the higher end of the pI range). 
 LC-MS/MS methods with the fragmentation methods HCD and ETD were evaluated for their 
ability to identify glycation sites using BASI, a small protein as a model. Both methods were able 
to identify glycation sites though ETD performed better as it identified more glycation sites and 
the sequence coverage of the glycated peptides was generally higher with ETD fragmentation.  
Methods for relative quantification of glycation sites using tandem mass tags (TMT) were also 
set up using LC-MS/MS fragmenting with HCD and ETD with BASI as model protein. Here 
HCD outperformed ETD as it was much better at acquiring reporter ion intensities high enough 
for quantification. Statistical analysis of the quantification results revealed that the glycated 
peptides could influence the performance of the fragmentation methods and the TMT labels. It 
is, therefore, important in the relative quantification of glycated peptides to perform the 
quantifications with different label combinations and if possible also using different 
fragmentation techniques to evaluate the significance of the quantifications.  
The modifications responsible for the multiple forms of BLA varying in pI values were 
determined by LC-MS/MS by HCD and ETD. Here multiple deamidation, glycation and 
carbamylation sites were identified on the surface of BLA as well as a few deamidations in and 
around the active site. Several of the modified amino acid residues are suspected to be involved 
in the enzyme activity, stability and substrate binding. 
Modifications were observed at the amino acid residues R127, N172, K237 and N272 which are 
suspected to be involved in the thermostability of BLA and it is very likely that the modifications 
in these sites decrease the enzyme stability.  
Modifications were observed at the three residues Q9, Q360 and N326 located in the active site 
and on K234, Q264 and N265 which are located near the substrate binding cleft. These 
modifications would most likely influence the enzymes activity and substrate binding.  
Modifications were also observed at sites which could be involved in binding of longer substrates 
and in residues close to or part of BLAs secondary binding sites.    
On the basis of the identified modification sites BLA variants were produced with focus on the 
impact of modifications in the active site area, substrate binding and on secondary carbohydrate 
binding sites. 
Analysis of BLA variants with mutations mimicking deamidations (Q→E and N→D) revealed 
that deamidations in the area close to the active site influence the activity and substrate binding. 
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These variants generally revealed increased wash performance indicating that single deamidations 
in this area could have a positive influence on the wash performance. 
BLA variants were also made with mutations of Arg and Lys residues on the surface of BLA 
suspected to be involved in binding of longer substrates and secondary binding sites (K→M and 
R→L). These changes did not have an effect on the kinetic parameters though the substitutions 
generally improved the wash performance. The improved wash performance may be due to 
changes in the interaction between the surface of BLA with the starch, the fabric or a 
combination of the two.  
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5 Perspectives 
The influence of the observed modifications was determined by characterisation of BLA variants 
with site specific mutations in identified modification sites. These variants generally showed 
increased wash performance. The mechanism causing this improved effect is not fully 
understood wherefore these results are very interesting. Looking at the mutations in sites 
suspected to be involved in substrate binding or secondary binding sites one explanation for the 
increased performance would be that these sites are involved. This should be explored further 
and it could especially be interesting for the sites located on the surface of BLA away from the 
active site. In a wash performance assay the performance is affected by the interaction between 
the amylase and its substrate, the substrates structure on the textile and unproductive binding of 
the enzyme to other surfaces e.g. textiles. This could be investigated by studies of the BLA 
variants binding affinity to the substrate. This may provide further knowledge of the mechanisms 
involved in the wash performance of amylases which could be used for optimisation of amylases 
in the detergent industry.  
Extending the investigation of the BLA variants exploring more variants with single 
modifications in identified modifications sites could also be very interesting, possibly in sites not 
expected to be involved in the stability, substrate binding and activity. Investigations of the wash 
performance of these variants might reveal more sites involved which can influence the wash 
performance, possibly some where the modifications occurring have a negative effect. Study of 
variants with multiple mutations in modification sites could provide knowledge about whether 
some combinations further increase the performance or have the opposite effect.  
LC-MS/MS methods fragmenting with ETD and HCD were set up for relative quantification 
of glycated peptides with isobaric stable isotope labelling. Statistical analysis of the quantification 
results revealed that the glycated peptides, the tags and the fragmentation method could influence 
the quantification results. As mentioned previously it could therefore be interesting to perform a 
larger study of the quantification of glycated peptides where the influence of factors such as the 
glycated peptides, the specific glycations, the tags and the fragmentation methods are studied 
more thoroughly. 
The relative quantification of glycation sites between the four pools of BLA varying in pI values 
did not provide any quantification results. As mentioned previously the method could be 
optimised by only quantifying two samples at a time. The quantification with ETD could possibly 
also be further optimised by only selecting precursor ions of charge state four as this might 
improve reporter ion intensities.  
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Figure 1. Unfolding of the four partly separated pools of BLA (PA – PD) determined by DSC. 
 
 
 
 
 
 
Figure 2. Full-length MS of BASI. 
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Figure 3. MS/MS results obtained by HCD for the peptide D156 – K176 glycated with the AGE carboxymethyl on 
K158. A) The MS/MS spectra for the peptide. B) The MS/MS spectra from Mascot showing the peptide ions 
matched by Mascot. C) The theoretical peptide ions calculated for the peptide by Mascot. The Peptide ions matched 
by Mascot in the MS/MS data are shown in red. 
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A) 
   
B) 
 
C) 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 362.2237 181.6155 D             21 
2 475.3078 238.1575 L 2506.3696 1253.6884 2490.3509 1245.6791 2491.3587 1246.1830 20 
3 661.4082 331.2077 K 2393.2855 1197.1464 2377.2668 1189.1370 2378.2746 1189.6409 19 
4 718.4297 359.7185 G 2207.1851 1104.0962 2191.1664 1096.0868 2192.1742 1096.5907 18 
5 775.4511 388.2292 G 2150.1636 1075.5854 2134.1449 1067.5761 2135.1527 1068.0800 17 
6 846.4882 423.7478 A 2093.1422 1047.0747 2077.1234 1039.0654 2078.1313 1039.5693 16 
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10 1349.7415 675.3744 G 1575.8732 788.4403 1559.8545 780.4309 1560.8623 780.9348 12 
11 1420.7786 710.8929 A 1518.8518 759.9295 1502.8331 751.9202 1503.8409 752.4241 11 
12 1521.8263 761.4168 T 1447.8147 724.4110 1431.7959 716.4016 1432.8038 716.9055 10 
13 1650.8689 825.9381 E 1346.7670 673.8871 1330.7483 665.8778 1331.7561 666.3817 9 
14 1747.9217 874.4645 P 1217.7244 609.3658 1201.7057 601.3565 1202.7135 601.8604 8 
15 1910.9850 955.9961 Y 1120.6716 560.8395 1104.6529 552.8301 1105.6607 553.3340 7 
16 2048.0439 1024.5256 H 957.6083 479.3078 941.5896 471.2984 942.5974 471.8023 6 
17 2147.1123 1074.0598 V 820.5494 410.7783 804.5307 402.7690 805.5385 403.2729 5 
18 2246.1807 1123.5940 V 721.4810 361.2441 705.4623 353.2348 706.4701 353.7387 4 
19 2345.2491 1173.1282 V 622.4126 311.7099 606.3938 303.7006 607.4017 304.2045 3 
20 2492.3175 1246.6624 F 523.3442 262.1757 507.3254 254.1664 508.3333 254.6703 2 
21     K 376.2757 188.6415 360.2570 180.6321 361.2648 181.1361 1 
Figure 4. MS/MS results obtained by ETD for the peptide D156 – K176 glycated with the AGE carboxymethyl on 
K158. A) The MS/MS spectra for the peptide. B) The MS/MS spectra from Mascot showing the peptide ions 
matched by Mascot. C) The theoretical peptide ions calculated for the peptide by Mascot. The Peptide ions matched 
by Mascot in the MS/MS data are shown in red. 
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A) 
 
B) 
 
 
C) 
# b b++ b* b*++ b0 b0++ Seq. y y++ y* y*++ y0 y0++ # 
1 367.2291 184.1182         H             15 
2 466.2975 233.6524         V 1800.9905 900.9989 1783.9639 892.4856 1782.9799 891.9936 14 
3 579.3816 290.1944         I 1701.9220 851.4647 1684.8955 842.9514 1683.9115 842.4594 13 
4 680.4293 340.7183     662.4187 331.7130 T 1588.8380 794.9226 1571.8114 786.4094 1570.8274 785.9173 12 
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9 1405.8568 703.4320 1388.8302 694.9187 1387.8462 694.4267 D 877.3898 439.1985 860.3632 430.6852 859.3792 430.1932 7 
10 1502.9095 751.9584 1485.8830 743.4451 1484.8990 742.9531 P 762.3628 381.6850 745.3363 373.1718 744.3523 372.6798 6 
11 1589.9415 795.4744 1572.9150 786.9611 1571.9310 786.4691 S 665.3101 333.1587 648.2835 324.6454 647.2995 324.1534 5 
12 1686.9943 844.0008 1669.9678 835.4875 1668.9837 834.9955 P 578.2780 289.6427 561.2515 281.1294 560.2675 280.6374 4 
13 1774.0263 887.5168 1756.9998 879.0035 1756.0158 878.5115 S 481.2253 241.1163 464.1987 232.6030 463.2147 232.1110 3 
14 1831.0478 916.0275 1814.0213 907.5143 1813.0372 907.0223 G 394.1932 197.6003 377.1667 189.0870     2 
15             R 337.1718 169.0895 320.1452 160.5763     1 
Figure 5. MS/MS results obtained by HCD for the peptide H108 – R122 glycated with glycation on K115. A) The 
MS/MS spectra for the peptide. B) The MS/MS spectra from Mascot showing the peptide ions matched by Mascot. 
C) The theoretical peptide ions calculated for the peptide by Mascot. The Peptide ions matched by Mascot in the 
MS/MS data are shown in red. 
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A) 
 
B) 
 
 
C) 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 384.2557 192.6315 H             15 
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4 697.4558 349.2316 T 1359.6751 680.3412 1343.6563 672.3318 1344.6642 672.8357 12 
5 754.4773 377.7423 G 1258.6274 629.8173 1242.6086 621.8080 1243.6165 622.3119 11 
6 851.5301 426.2687 P 1201.6059 601.3066 1185.5872 593.2972 1186.5950 593.8011 10 
7 950.5985 475.8029 V 1104.5531 552.7802 1088.5344 544.7708 1089.5422 545.2748 9 
8 1240.7463 620.8768 K 1005.4847 503.2460 989.4660 495.2366 990.4738 495.7406 8 
9 1355.7732 678.3902 D 715.3369 358.1721 699.3182 350.1627 700.3260 350.6667 7 
10 1452.8260 726.9166 P 600.3100 300.6586 584.2913 292.6493 585.2991 293.1532 6 
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12 1636.9108 818.9590 P 416.2252 208.6162 400.2065 200.6069 401.2143 201.1108 4 
13 1723.9428 862.4750 S 319.1724 160.0899 303.1537 152.0805 304.1615 152.5844 3 
14 1780.9642 890.9858 G 232.1404 116.5738 216.1217 108.5645 217.1295 109.0684 2 
15     R 175.1190 88.0631 159.1002 80.0538 160.1081 80.5577 1 
Figure 6. MS/MS results obtained by HCD for the peptide H108 – R122 glycated with glycation on K115. A) The 
MS/MS spectra for the peptide. B) The MS/MS spectra from Mascot showing the peptide ions matched by Mascot. 
C) The theoretical peptide ions calculated for the peptide by Mascot. The Peptide ions matched by Mascot in the 
MS/MS data are shown in red. 
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Figure 7. Unfolding of BLA and the BLA variants determined by DSC. 
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Abstract  
 
Bacillus licheniformis α-amylase (BLA) is an important industrial enzyme used in the detergent 
industry. The enzyme becomes modified during the fermentation resulting in multiple forms varying 
in pI value. Deamidation of asparagine and glutamine residues and glycations on lysine and argenines 
are partly responsible for these multiple forms. Tandem mass spectrometry (MS/MS) was used to 
identify deamidation and glycation sites on the BLA forms. The modifications were mainly found on 
the surface of the enzyme and some of the modifications are located in sites involved in stability, 
activity and substrate binding. The influence of some of the specific modifications were determined by 
producing BLA mutants with site specific mutations in selected modification sites in the area around 
the active site and in sites suspected to be involved in binding of longer substrates and secondary 
binding sites. KM and kcat values were determined on maltoheptaose substrate and and on amylose for 
the mutants along with the wash performance in a liquid and a powder detergent to determine the 
influence of the single modifications. The mutations mimicking deamidations (N→D and Q→E) 
influenced the KM and kcat values in the sites around the active site differently, though they generally 
improved the wash performance especially the BLA mutant N265D showed great improvement. 
Removing the glucose reactive sites (K→M and R→L) in sites related to binding of longer substrates 
and secondary binding sites did not influence the kinetic values KM and kcat but it improved the wash 
performance especially in liquid detergent. 
 
Introduction 
 
α-Amylases are a family of enzymes which catalyse the hydrolysis of α-D-(1,4) glucosidic linkages in 
starch and related compounds hereby releasing maltooligosaccharides and glucose in the α-anomeric 
configuration [1, 2]. α-Amylases are among the most important industrial enzymes with widespread 
use in various industries. The enzyme is used for starch liquefaction and saccharification in the starch 
and fuel alcohol industries, for starch stain removal in the detergent industry as well as in industries 
such as baking and brewing [3–5]. 
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Bacillus licheniformis α-amylase (BLA) is widely used in industrial processes as it is thermostable and 
stable at alkaline conditions, the latter being an important feature in the detergent industry where α-
amylases are the second most used enzyme after proteases [4–6]. 
The structure of BLA is divided into the 3 main domains; A, B and C where domain A make up the 
core of the enzyme with domain B and C located on each side. Domain A contains the active site with 
the three active site residues Asp231, Glu261 and Asp328 [7]. BLA contains several substrate binding 
sites on the surface for interaction with the polymeric substrate. The binding site in the active site cleft 
consists of at least eight subsites each binding a glucosyl residue of the substrate. This site is formed 
by domain A and B [1, 8]. The interface between domain A and B also contains a quite unique Ca-Na-
Ca metal triad. The three metal ions mainly situated in domain B are linearly arranged and involved in 
interactions with surrounding amino acid residues [1, 7]. The metal triad stabilises the structure around 
the active site and is important for the thermostability of BLA [9, 10].  
Structural studies of amylases have revealed that non-catalytic binding of carbohydrates also can occur 
in secondary binding sites (SBS). These SBS are generally located on the surface more distant from 
the substrate binding cleft and the active site. SBS generally contain amino acids with aromatic side 
chains such as Trp and Tyr which are able to hydrophobically interact with carbohydrates. The exact 
role of these sites is not fully elucidated though they have been proposed to cooperate with the active 
site in degradation of different substrate, to be initial substrate recognition sites and to retaining 
reaction product for further processing by other proteins [11, 12]. 
Industrial α-amylases are produced by fermentation of genetically modified organisms such as bacteria 
or fungi. However, during the fermentation of recombinant proteins these can become chemically 
modified and the modifications can influence the enzyme stability and activity. Some of the most 
prevalent chemical modifications are deamidation, oxidation and glycations [13, 14].  
Glycation is a non-enzymatic reaction between primary amines on proteins and the carbonyl group of 
a reducing sugar so that lysine and arginine side chains are prone to the reaction. The glycations form 
a ketoamine which further can undergo a series of rearrangement reactions to form a group of more 
reactive carbonyl compounds termed advanced glycation end products (AGEs) [15, 16]. These AGEs 
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include 3-deoxyglucosone, carboxymethyl, carboxyethyl, and methylglyoxal-derived 
hydroimidazolone (MG-HI) as some of the most described [17–20].  
It has been observed that BLA becomes chemically modified during the fermentation resulting in 
multiple forms of BLA varying in pI value. The purpose of the present study is to unravel the 
modifications on BLA responsible for the multiple forms varying in pI with focus on glycations and 
deamidations. The influence of specific modifications at specific sites is evaluated for some of the 
most interesting modification sites. BLA variants are prepared and characterised to prove the 
functional roles of the specific amino acids and thus validate the role of specific modified sites in the 
function and stability of the enzyme at the conditions use in laundry detergent wash.  
 
Materials and Methods 
 
Bacillus lichenisformis α-Amylase 
 
BLA expressed in recombinant B. licheniformis were provided by Novozymes.  
 
Isoelectric focusing (IEF) 
 
FocusGel 4–6 (Gelcompany) were used with Amersham Isoelectric Focusing Calibration Kit (GE 
Healthcare) low range (pH 2.5–6.5) as standards and gels stained in Coomasie blue. 
 
In-gel digestion with H2
18
O  
 
Bands of BLA were cut out of the IEF gel (twice) and destained twice in 50% ethanol. The gel pieces 
were dehydrated in 100% acetonitrile for 15 min. The following solutions were prepared with water-
18
O, 97atom% 
18
O (Sigma-Aldrich) to differentiate between deamidations present prior to sample 
preparation and those occurring during the digestion [21, 22]. The digest was performed with trypsin 
and Asp-N, adding 0.4 μg trypsin Sequencing grade (Roche Diagnostics) or 0.04 μg Endoproteinase 
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Asp-N Sequencing grade (Roche Diagnostics) in 50 mM NH4HCO3 and stored for 45 min at 5°C. 
Remaining protease solution was removed and 50 mM NH4HCO3 was added covering the gel piece 
and incubated at 37°C over night. Peptides were extracted from the gel pieces with 70% acetonitrile 
0.1% triflouroacetic acid three times. The peptide samples were dried and dissolved in 5% formic acid.  
 
Tandem mass spectrometry 
 
The LC-MS/MS experiments were performed fragmenting with Higher energy C-trap dissociation 
(HCD) and electron transfer dissociation (ETD) as the latter method leaves labile modifications intact 
during the fragmentation hereby being better at identifying glycations. The experiments were run on a 
LTQ Orbitrap Velos (Thermo Scientific) for HCD fragmentation and on a LTQ Orbitrap XL (Thermo 
Scientific) for ETD fragmentation. Both instruments have a nano-ESI source (Nanospray Flexion 
Source, Thermo Scientific) coupled to an EASY-nLC II (Thermo Scientific). The peptides were 
separated on Thermo Scientific EASY-Column (C18) 2 cm x 100 µm i.d. column followed by a 
Thermo Scientific EASY-Column (C18) 10 cm x 75 µm i.d. column, eluting from 5–50% acetonitrile 
in 0.1% formic acid over 60 min at a flow rate of 250 nl/min.  
Experiments on the Orbitrap Velos were conducted in the orbitrap with automatic gain control (AGC) 
target of 1,000,000 with 30,000 resolution and a maximum ion injection time of 10 ms in full MS and 
for MS/MS AGC target was 50,000 with injection time of 100 ms and resolution of 7500. The HCD 
normalized collision energy was 40% and the 10 most intense precursor ions in the range 350–1750 
m/z were selected for MS/MS. 
For analysis on the Orbitrap XL MS
1
 was performed in the orbitrap mass analyser with a resolution of 
60,000 (at 400 m/z). AGC target was 500,000 with a maximum ion injection time of 300 ms for the 
orbitrap in full MS. MS/MS was performed in the ion trap with AGC target of 40,000. ETD reactions 
were performed for 85 ms detecting fragment ions in the ion trap with a maximum injection time of 
200 ms using 3 microscans selecting precursor ions in the range 350–1200 m/z, selecting the four most 
abundant precursor ions, rejecting charge state 1 and 2.   
 116 
 
The data analysis was performed with Mascot (Matrix Science). The searches were conducted against 
a custom made database containing 14,100 sequences with decoy option enabled. The searches were 
conducted with trypsin or Asp-N as enzyme allowing 5 missed cleavages with 10 ppm precursor mass 
tolerance, 0.5 Da fragments mass tolerance for ETD and 0.02 Da mass tolerance for HCD. The 
following variable modifications were chosen: Deamidated (NQ), Deamidated: 18O(1) (NQ), Label: 
18O(1)(C-term), Label: 18O(2)(C-term), Hex (KR), 3-deoxyglucosone (KR), Carboxymethyl (KR), 
Carboxyethyl (KR), MG-HI (KR), Oxidation (M), Carbamyl (KR), Acetyl (K). 
 
Expression of BLA mutants 
 
BLA mutants and BLA for comparison were produced by Novozymes. The constructs were made by 
site directed mutagenesis according to the principles described by others [23]. BLA and its variants 
was expressed in recombinant B. subtilis, fermented at 37°C for 96 h in a medium consisting of 100 
mg/ml sucrose, 40 mg/ml soya flour, 10 mg/ml Na2HPO4·12H2O, 0.01 % v/v Dowfax 63N10, 5 mg/ml 
CaCO3.  
 
Purification of BLA mutants 
 
The fermented samples were centrifuged at 5400 g for 50 min and filtered through 0.2 μm PES filters. 
MOPS, CaCl2 and (NH4)2SO4 were added to concentrations of 20 mM, 1 mM and 1 M respectively, 
and pH adjusted to 7.5. Samples were loaded to a phenyl sepharose column (Phenyl sepharose 6 fast 
flow, GE Healthcare) pre-equilibrated in 20 mM MOPS, 1 mM CaCl2, 1 M (NH4)2SO4, pH 7.5. 
Elution was done with (NH4)2SO4 gradient (1M–0M). Amylase containing fractions were determined 
on NuPAGE 4–12% Bis-Tris gradient gel (Invitrogen). These fractions were pooled and dialysed over 
night in 10 mM Tris, 1 mM CaCl2, pH 8.9. 
The dialysed sample were loaded on to a Source 30Q column (GE healthcare) pre-equllibrated with 20 
mM Tris, 1 mM CaCl2, pH 8.9. Elution was done with NaCl gradient (0–600 mM) in 20 mM Tris, 1 
mM CaCl2, pH 8.9. Eluted fractions only containing BLA were pooled, concentrated and buffer 
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changed to 20 mM HEPES, 1 mM CaCl2, pH 7.0 on Vivaspin 20 10,000 MWCO PES (Sartorius 
Stedim) spin columns. Protein concentration was determined by amino acid analysis [24, 25]. 
Homogeneity was checked on NuPAGE 4–12% Bis-Tris gel.  
 
Differential scanning caliometry 
 
Differential scanning calorimetry (DSC) measurements were carried out using a Microcal VP-
capillary DSC (GE Healthcare). Scan rate of 1.5°C min
-1
 was used to a final temperature of 130°C. 
Samples for analysis were approx. 1 mg/ml in 25 mM HEPES, 1 mM CaCl2, pH 7.0. Tmax was 
determined as the temperature at the peak maximum of the transition from the folded to unfolded state. 
For data analysis the Origin software package (MicroCal, GE Healthcare) was used.  
 
Maltoheptaose p-nitrophenol (G7pNP) assay 
 
The amylase kit AMYL α-amylase liquid (Roche) contains an α-glucosidase solution and a substrate 
solution (4,6-ethylidene-(G7)-pNP) was used in the assay. The initial rate of hydrolysis was 
determined at eleven substrate concentrations (0.025–3 mM) in 52.5 mM HEPES pH 7.0. 
The assay were run on a KONELAB ARENA 30 (Thermo Electron Corporation) at 30 ºC mixing 147 
µl α-glucosidase solution with 83 µl substrate, adding 20 µl enzyme solution (in 52.5 mM HEPES pH 
7.0). After 3 min the colour formation was measured 7 times over 2 min at 405 nm. pNP standard (0–
0.6 mM in 52.5 mM HEPES) was made from p-Nitrophenol (pNP) standard solution 10 mM (Sigma). 
KM and kcat were obtained by fitting to the Michaelis-Menten equation with the program CurveExpert 
1.3 (http://www.curveexpert.net/).  
 
Amylose assay 
 
The initial rate of formation of reducing power was determined at 30 ºC at ten different amylose 
DP440 (Amylose type III: from potato, Sigma) solutions 0.1–2.5 mg/ml in 20 mM HEPES pH 7.0, 5 
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mM CaCl2, 4.44% v/v dimethyl sulfoxide, 0.005% w/v bovine serum albumin (BSA) by amylase (in 
20 mM HEPES pH 7.0, 5 mM CaCl2, 0.005% w/v BSA) were determined using copper-bicinchoninate 
with maltose as standard [26, 27]. The colour formation was measured in spectrophotometer at A540. 
KM and kcat were obtained as above.  
 
Wash performance assay 
 
Wash performance was determined on a mini wash robot (Novozymes) on coloured rice starch cotton 
CS-28 (Center For Testmaterials BV). CS-28 strips were mounted on racks which during the wash are 
moving up and down into the wash beakers (50 times per min). Washes were performed at 40°C for 30 
min at six enzyme concentrations (0–1.0 mg /L) followed by 5 min rinsing in cold water. Washes were 
performed in 0.8 g/l liquid detergent pH 8.5 (20% linear alkylbenzene sulfonate (LAS, Nacconol 
90G), 10% alkyl ether sulfate (STEOL CS-370E), 10% alcohol ethoxylate (AEO, Bio-soft N25-7, 
Stepan Company), 4% oleic acid, 0.5% Ethanol, 1.5% sodium xylene sulfonate, 7% 1,2-propanediol, 
8% tri-Na-citrat, 0.5% triethanolamine, 1.5% boric acid, pH 8.5) and a powder detergent pH 10.0 of 
1.715 g/L with  0.035 g/L AEO. The powder detergent had the following composition 17% LAS, 20% 
Sodium carbonate, 12% Sodium disilicate, 15% Zeolite A, 1% PCA, 34% Sodium sulphate. Both 
detergents were prepared with water hardness of 15°dH (Ca/Mg 4:1). All percentages stated are in 
w/w. After wash, rinse and drying the colour remission of the CS-28 strips was measured at 460 nm on 
TIDAS (Zeiss spectrophotometer).  
 
Results 
 
The multiple forms of BLA are shown on an IEF gel in Figure 1, where several bands occur over 1–
1.5 pH units. The multiple forms were characterised by LC-MS/MS on twelve of the bands digested 
with trypsin and Asp-N to determine the modifications responsible for the forms varying in pI values 
with focus on the modifications deamidations and glycations.   
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Figure 1. 
 
LC-MS/MS of the digested samples identified multiple deamidations, glycations, carbamylations and 
oxidations on Met. The observed deamidation and glycation sites are listed in Table 1. The identified 
glycations also included the different AGEs 3-deoxyglucosone, carboxymethyl, carboxyethyl and MG-
HI. The modifications were mainly located on the surface of BLA though a few of the deamidations 
were located in the area around the active site. The focus of the project was on the deamidation and 
glycations and several of these were found in sites relevant for stability, activity and substrate binding.    
To determine the effect of some of the glycations and deamidations in specific sites suspected to be 
involved in BLAs activity and substrate binding nine BLA mutants was expressed with site specific 
mutations in single sites. The possible deamidation sites selected were changed to the corresponding 
acid to mimic the deamidation (Q→E, N→D), hereby mimicking the influence of the specific 
deamidation. For the selected glycation sites Lys was substituted with Met and Arg with Leu to 
evaluate the effect of removing the glucose reactive site.  
The mutants were expressed in Bacillus subtilis along with a wild type BLA. After purification the 
enzymes were analysed by SDS-PAGE revealing single bands of approximately 55 kDa. The mutants 
and BLA were also analysed by IEF gel to examine the influence of the mutations on the pI values. 
This revealed that most of the mutations resulted in the same pI decrease except the two mutations 
N172D and K306M which did not result in a change in pI value compared to BLA, Figure 2.  
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Figure 2 
 
The mutations influence on the stability of BLA was evaluated by DSC, Table 2. The Tmax value for 
BLA was determined to 103.2 °C and the mutations in general did not influence the stability as Tmax 
only decreased slightly for the three mutants Q9E, N172D and Q264E decreasing by 2.6, 4.3 and 4 °C, 
respectively. 
The kinetic parameters kcat, KM and the catalytic efficiency (kcat/KM) for BLA and the mutants are listed 
in Table 3. The parameters were determined both on a short maltoheptaose (G7) substrate and on 
amylose at 30°C pH 7.0.  
Alterations in the kinetic parameters on G7 substrates occur for the Q264E, Q360E and Q9E mutants. 
Q264E markedly decreased in KM which resulted in an increase in kcat/KM. Both kcat and KM increased 
for Q360 which meant that kcat/KM overall was unaffected by the mutation. The Q9E mutation had a 
negative effect on KM as this value almost doubled which decreased kcat/KM. The kcat value was slightly 
higher for both N265D and R437L though the variation was quite high for the determination on 
R437L so this was not significantly different from BLA.  
The kinetic parameters obtained on amylose revealed the same tendencies as the determinations on the 
G7 substrate. The changes were primarily observed for Q264E, Q360E and Q9E. For Q264E and 
Q360E the changes were the same as for the G7 substrate though the decrease in KM for Q264E was 
less pronounced. The changes in kinetic parameters were, however, different for Q9E. On amylose kcat 
decreased, whereas on the G7 substrate KM increased. The different changes observed on the different 
substrates for Q9E did, however result in a decrease in the catalytic efficiency for both substrates. 
Again R437L had a higher kcat value, with a high variation. 
The wash performance of the mutants was determined in a liquid and a powder detergent as the 
components of the two detergents differ considerably and so does the pH during the wash with a pH of 
5.9
6.5
pI
BLA Q264E N265D Q360E Q9E N172D K306M K383M R437L
 121 
 
approximately 8 in liquid detergent and 10 in powder. The washes were conducted at 40 °C as this is a 
standard wash temperature in Europe. The wash performance was determined on starch cotton 
swatches where the starch is coloured pink. The wash performance on the swatches was then 
determined spectrophotometrically by subjecting the cotton swatch to light and measuring the light 
reflecting from the swatch (the remission). The wash performance is determined in delta remission 
units which are the difference between the absorbance of the remission of a blank (a starch cotton 
swatch washed without enzyme) and the sample. The higher the delta remission the better the wash 
performance of the enzyme. 
 
Figure 3 
 
The wash performance for the BLA mutants in liquid detergent were all improved compared to BLA, 
Figure 3. Though, the wash performance for Q360E was approximately 1 delta remission higher than 
BLA, which is not enough to conclude an increased wash performance, the difference has to be at least 
1.5 delta remission units. The N265D mutant stood out from the rest with the best wash performance. 
The remaining variants had a better wash performance than BLA and Q360E but not as good a 
performance as N265D. The fact that more or less all the variants except Q360E increased in wash 
performance at these conditions was unexpected. 
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Figure 4 
 
The wash performances for the mutants and BLA in powder detergent are illustrated in Figure 4. 
Again N265D had the highest wash performance. The wash performance of K306M, Q360E, Q264E 
and K383M was better than of BLA, but not as good as N265D. The variants N172D and R437L had 
the same wash performance as BLA at these conditions, whereas Q9E had a lower wash performance.  
In general there was no strong correlation between the kinetic parameters obtained on G7 and amylose 
with the wash performance data, thus the structural factors influencing the kinetic parameters in the 
assay are not necessarily the same as the ones affecting the wash performance. 
  
Discussion 
 
Identification of deamidation and glycation sites 
 
Multiple deamidations of Asn and Gln residues as well as glycations of Lys and Arg residues were 
identified which all can be responsible for the creation of the multiple forms of varying pI values 
formed during the fermentation. The majority of modifications were observed on the surface of BLA, 
Figure 5, though a few deamidations were present inside the structure in the area around the active 
site. As mentioned previously several of the modification sites are suspected to be involved in the 
stability, activity and substrate binding. 
-1.50
0.50
2.50
4.50
6.50
8.50
10.50
0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00
D
el
ta
 r
em
is
si
on
 4
60
 n
m
mg enzyme/l
BLA
Q264E
N265D
Q360E
Q9E
N172D
K306M
K383M
R437L
 123 
 
In the fermentation of BLA sucrose was used as substrate but this carbohydrate is not a reducing sugar 
and therefore not able to form glycations directly. However, sucrose can be hydrolysed during 
sterilisation into fructose and glucose [28] and the glycations then stem from the sucrose hydrolysis 
products.  
 
Figure 5 
 
Both deamidations and modifications of Lys residues have in other studies shown to have a negative 
effect on the stability of BLA and modifications on Lys residues were also found to influence the 
activity and substrate specificity [29–33].  
Several residues related to the stability of BLA were also found to be modified especially the 
modification sites R127, N172, R173, K237 and N272 are likely to be important for the enzymes 
thermostability as they are located in the interface between domain A and B containing the Ca-Na-Ca 
triad proposed to play a vital role in the thermostability of BLA [1, 7, 9, 10, 34]. The sites N172 and 
R173 are also located in a part of Domain B which also is speculated to contain part of an extended 
substrate binding site from the active site, however, the sites involved are not fully elucidated [1]. 
The deamidations on the residues Q9, N326 and Q360 are all located in the active site and are 
proposed to be involved in the activity and the substrate binding. The residues Q264 and K234 are 
proposed to contribute to two of the subsites in the substrate binding site [1, 5, 7]. As N265 is located 
right next to Q264 it is also likely that this site can influence the substrate binding. The results 
obtained for the deamidation on N265 is not very good as the score is quite low and the modified site 
is not mapped by the MS/MS results. Though the results for the deamidation in Q264 were quite good 
Active site
N265
Q264
K234
R127
K136
R173
N172
Q298
K306
R437
N27
K381
K383
K86
R127
R437R442
Q443
N278
N246
K242
K306
N309
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and it is likely that N265 also become deamidated. The modifications in these sites located in the area 
of the active site and the substrate binding site will influence the activity and substrate binding affinity 
for BLA.  
The glycation site K306 is located in what could be the elongation of the substrate binding site 
involved in binding of longer substrates. The glycations in this site most likely affect substrate binding 
for longer substrates such as starch.  
Secondary carbohydrate binding sites have been found on Bacillus halmapalus α-amylase (BHA) [35]. 
The equivalence to these sites can be found on BLA. From the findings in BHA it can be deduced by 
sequence alignment and structural analysis that the residues W342, P432 and D430 in BLA may 
compose a maltose binding site and R437 and W467 a glucose binding sites.  
The residue R437 composing one part of the glucose binding site becomes glycated and deamidation 
occur in N463 which is located right next to this binding site. The glycation site K383 is located so 
close to W342 that a glycation in the site could interfere with the maltose binding site. These 
modifications especially the glycations could decrease the efficiency of the secondary binding sites or 
completely inactivate the sites. As the exact role of these sites are not fully understood the effect of the 
modifications in these sites are not known. Though, if the sites function as initial substrate recognition 
sites or substrate binding for longer substrates, glycations at the secondary binding sites could 
decrease the efficiency of the amylase.  
 
Characterisation of BLA mutants  
 
On the basis of the modifications and modification sites identified in the previous section BLA 
mutants were produced to determine the possible impact of some of the modifications on BLA. The 
modification sites chosen for mutagenesis were selected based on their possible impact on the active 
site, the substrate binding site or on secondary carbohydrate binding sites. 
All the mutations result in substitutions to an amino acid with a lower pI value, therefore a decrease in 
pI value should occur for all the variants. This is, however, not the case. It appears that the same 
amino acid substitutions at different parts of the molecule can result in different changes in pI value or 
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no change at all. Several microenvironmental factors can influence the pKa values of the amino acid 
residues in proteins such as electrostatic and hydrophobic effects, hydrogen bond formation and helix 
dipole interactions [36, 37]. This can explain why the same amino acid residue substitution or 
chemical modification at different positions of the amylase has different effects on the pI value. 
The Q264E mutation resulted in a great improvement on the catalytic efficiency compared to BLA and 
the other variants but in the wash performance the Q264E variant was quite average. The increased 
catalytic efficiency was caused by improved substrate binding. The crystal structure of a BLA variant 
(not from this project) with acarbose has been solved by Novozymes (structure is not published). In 
the crystal structure of the active site of BLA in complex with acarbose Q264 is oriented away from 
the substrate, Figure 6. In theory the carbonyl or amide groups on Gln should be able to make 
hydrogen bonds with hydroxyl groups on the substrate. The Gln side chain is very flexible in this 
structure so it is possible that hydrogen bonding does occur. The Q264E mutation increases the 
substrate binding. This strongly suggests that Glu is hydrogen bonding with hydroxyl groups on the 
substrate, whereas Gln does not. If Gln does hydrogen bond to the substrate, the bonds formed by Glu 
appear to be considerably stronger resulting in increased substrate binding. The improved substrate 
binding is accompanied by a positive effect on the wash performance at pH 8 and 10.      
 
Figure 6 
 
The kinetic parameters for the N265D variant did not show an effect of this mutation on the enzyme 
but it outperformed all the other variants in wash performance in both liquid and powder detergent. 
N265 is located right next to residue 264 in which Q264E has shown to interact with the substrate. The 
crystal structure of BLA in complex with acarbose, Figure 6, reveals that N265 is located close to the 
N265
Q264
S+3
S+2
S+1
S–1  
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substrate and it should be able to form hydrogen bonds with this. Since Q264E increased substrate 
binding it would be expected that the N265D mutation had a similar effect especially on a longer 
substrate as it looks like a longer substrate could bind with that side chain. This is, however, not 
confirmed by the KM values for the G7 substrate and amylose. The substantial increase in wash 
performance for N265D does show that the mutation has a positive effect on the performance. This 
indicates that it has improved substrate binding to the rice starch on the textile. Another possibility is 
that it is able to interact with the fabric hereby possibly improving the substrate amylase interaction.  
The kinetic parameters for Q9E revealed a lower catalytic efficiency on both substrates. Q9 is located 
right behind H327 which can interact with the substrate in subsite -1, Figure 7. This region is therefore 
very important for both substrate binding and catalytic activity. Q9 is most likely able to hydrogen 
bond with H327, though when the substrate binds in the active site H327 also hydrogen bond to one of 
the hydroxyl groups in the substrate. The Q9E mutation most likely results in salt bridge formation 
between the carboxy group on Q9E with the imidazole group in H327. This bond is stronger than the 
hydrogen bond so the interaction between H327 and the substrate will be weakened or even non-
existing. This can explain the decreased substrate binding for the G7 substrate resulting in lower 
catalytic efficiency. The mutation does not have a negative effect on the substrate affinity for the 
longer substrate probably because this binding is stabilised by more binding sites on BLA than the 
short substrate. The mutation does, however, result in a decreased substrate turnover. The possible loss 
of hydrogen bonding between His327 and amylose could result in a different conformation of the 
substrate in the active site, hereby lowering the catalytic efficiency. 
Despite the decrease in catalytic efficiency the wash performance of Q9E increased in liquid 
detergent. The wash performance in powder detergent was considerably lower than of BLA and all the 
other variants. This indicates that the site influence the pH profile of the amylase as the performance is 
good at pH 8 but decreases significantly at pH 10. This also correlates with other studies showing that 
pKa values of amino acid residues around the catalytic site can influence the pH activity profile of an 
enzyme [37]. The differences in wash performance could, however, also be due to some in-wash 
stability problems with the powder detergent possibly caused by one or several detergent components 
as for instance chelators can influence the stability of amylases [38]. Overall the different assays 
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reveal that the Q9 site has an influence on the substrate catalysis influencing substrate affinity and 
substrate turnover as well as possibly the pH activity profile.  
 
Figure 7 
 
Q360 is located very close to Q9 in the area around the active site, Figure 7. Q360 is surrounded by 
several hydrophilic amino acid residues. It is therefore possible that this site is involved in the overall 
packing of the surrounding area as it could be loosening up the packing of this area. The Q360E 
mutation which is more polar at neutral pH could further loosen up the packing, thus affecting the area 
around the active site. The position of Q360 is approximately 5.9 Å from the active site residue E261. 
The Q360E mutation is therefore likely to influence the pKa of E261. The kinetic parameters revealed 
that the Q360E mutation improved the substrate turnover but lowered kcat thus not influencing the 
overall catalytic efficiency. This indicates that the Q360E mutation gives rise to some slightly larger 
conformational changes in the area that changes the general substrate binding and catalytic turnover. 
The Q360E mutation does not influence the wash performance in liquid detergent but the performance 
is slightly improved in powder detergent. This could indicate that the site influences the pH activity 
profile of the amylase as no change in performance occurs at pH 8 but performance increases at pH 
10.  
The N172D mutation did not have any effect on the kinetic parameters. The crystal structure of the 
active site in complex with acarbose, Figure 8, reveals that N172 is relatively close to the substrate 
binding, but approximately 5 Å from the substrate which is too far to form hydrogen bonds. Therefore, 
it has no effect on the substrate binding. The wash performance in powder detergent was the same as 
for BLA though the performance improved in the liquid detergent. The Tmax determinations showed 
that the mutation resulted in a small decrease in the stability of BLA. As previously mentioned it has 
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been hypothesised that for thermostabile enzymes decreasing the stability might increase activity at 
lower temperatures. It is also possible that the mutation influences the interaction with the fabric at pH 
8 hereby improving wash performance. Though, it could also be other parameters responsible for the 
change such as the different components in the detergents. 
 
Figure 8 
 
The position of K306 in relation to the substrate binding site is illustrated in Figure 9A. It appears that 
this site could be located in an area in which longer substrates bind. Though, the K306M mutation did 
not have any effect on the kinetic parameters thus indicating that K306 is not important for interaction 
with amylose. The mutation does, however, increase wash performance. The K → M mutation on the 
enzyme surface would be expected to have a lower binding affinity toward the substrate on the textile 
as the positively charged Lys can be involved in these interactions. The amylose used in the kinetic 
assay was gelatinised; the starch on the textile in the wash experiments might have a different structure 
which could explain the different results. The improved wash performance could be caused by 
improved interaction with the substrate on the fabric or by lover unproductive binding of the enzyme 
to other surfaces such as the textile. 
K383 is located very close to the secondary binding site at W342, Figure 9B, so K383 could be 
involved in carbohydrate binding in this site. The mutation K383M did not result in any changes in the 
kinetic parameters for BLA. It did, however, result in improved wash performance. As described 
above the increased wash performance could be because the K383M mutation improves interaction of 
the enzyme with the substrate on the fabric. It is also possible that the mutation hinder the glycation in 
this site which could block the secondary binding site. 
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Figure 9 
 
R437 is a part of a secondary binding site in domain C along with W467, Figure 9C. The interaction 
with glucose shown in the figure is an estimated modelling of the position of R437 after the position of 
W439 in BHA which structure was solved with glucose in this binding site [35]. From this structure it 
could appear that R437 is able to form hydrogen bonds to the carbohydrate. The R437L mutation may 
have a small positive effect on the kcat and hereby a slight improvement of the catalytic efficiency, but 
the variation of this result is very high. These results indicate that the site may be involved in substrate 
binding possibly as an initial substrate recognition site. The R437L mutation also has a positive effect 
on the wash performance in liquid detergent. The fact that the improvement only occur in one of the 
detergents could indicate that the improvement is due to some interaction or lack of interaction with a 
detergent ingredient which is present in one of the detergents. 
The analysis of the variants shows that deamidations in the area close to the active site influence the 
kinetic parameters on different substrates and hereby the activity and substrate binding. Deamidations 
a bit further from the active site does not seem to have much effect on the kinetic parameters but they 
can influence factors such as stability. The Q→E and N→D variants also indicated that deamidations 
could affect wash performance generally positively though in the area close to the active site the 
modifications are also likely to influence the pH activity profile which can have a negative effect on 
wash performance. 
The removal of possible reducing sugar reactive sites on the surface of BLA (K→M and R→L) did 
not seem to have any effect on the kinetic parameters though all the substitutions seemed to have a 
positive effect on the wash performance in liquid detergent as well as in powder detergent for the 
A) B) C)
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K→M mutations. This may be the result of changes in the interaction of the amylase surface with the 
starch on the texile.  
 
Conclusion 
 
Deamidations and glycations were found to contribute to the formation of the multiple forms of BLA 
varying in pI values created during the fermentation. These modifications were found in sites which 
are important to the enzymes stability, activity and substrate binding. BLA mutants were produced 
with site specific mutations in identified modification sites related to the active site, substrate binding 
and secondary binding sites. The mutants mimicking deamidation in the area around the active site 
influenced the activity and the substrate binding in different ways though they generally resulted in an 
improved wash performance for the single mutations especially for the BLA mutant N265D. 
Removing the glycation sites (K→M and R→L) in sites related to binding of longer substrates and 
secondary binding sites did not influence catalytic efficiency for the mutants K306M, K383M and 
R437L though it resulted in improved wash performance especially in liquid detergent. 
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Figure Captions 
 
Figure 1: 
IEF of BLA where 12 bands over the entire pI span were selected for in-gel digest with trypsin and Asp-N 
followed by LC-MS/MS to identify the modifications responsible for the multiple forms.  
 
Figure 2:  
IEF gel of the 8 BLA variants and wt BLA expressed in Bacillus subtilis. 
 
Figure 3: 
The wash performance of the BLA variants on rice starch cotton patches in liquid detergent. Standard deviation 
for the determinations is shown. 
 
Figure 4: 
The wash performance of the BLA variants on rice starch cotton patches in powder detergent. Standard deviation 
for the determinations is shown. 
 
Figure 5:  
The surface of BLA showing the Asn and Gln found to become deamidated during the fermentation in grey and 
the glycated Lys and Arg residues are shown in black. PyMOL was used for molecular rendering (The PyMOL 
molecular Graphics System Vers. 1.3, Schrödinger, LCC)(PDB 1BLI). 
 
Figure 6:  
The active site of BLA in complex with acarbose showing the possible substrate binding residues of Q264 and 
N265 (Unpublished structure of BLA). The subsites +1, +2, +3 and -1 in the substrate binding site are shown as 
S+1, S+2, S+3 and S-1. (The PyMOL molecular Graphics System Vers. 1.3, Schrödinger, LCC). 
 
Figure 7:  
Close-up of acarbose in the active site showing the three active site residues D231, E261 and D328 along with 
the residues Q9, Q360 and His327 (Unpublished structure of BLA) (The PyMOL molecular Graphics System 
Vers. 1.3, Schrödinger, LCC). 
 
Figure 8:  
BLA in complex with acarbose in the active site showing the residue N172 (Unpublished structure of BLA). The 
subsites in the binding site are indicated by S and the site number. (The PyMOL molecular Graphics System 
Vers. 1.3, Schrödinger, LCC). 
 
Figure 9: 
Different views of the crystal structure of BLA (Unpublished structure of BLA). A) The structure of acarbose in 
the active site showing K306 in what could be an elongation of the substrate binding. The subsites in the binding 
site are indicated by S and the site number. B) K383 and the secondary binding site W342. C) R437 as part of a 
secondary binding site with W467 with glucose bound. The position of R437 is estimated by modelling after the 
position of W439 in BHA solved with glucose in the binding site.  
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Table 1: 
Modifications observed in the 12 digested BLA bands analysed by LC-MS/MS fragmenting with HCD and ETD. 
Hex: Glycation with hexose, 3DG: 3-Deoxyglucosone, Cbm: Carboxymethyl, Cbe: Carboxyethyl, MG-HI: 
methylglyoxal-derived hydroimidazolone, Dea: Deamidation, Covered is whether or not the modification site is 
directly mapped by the MS/MS results. 
 
Site  Modification Score Expect Covered 
Q9 Dea 61 7.8E-7 + 
R23 Cbm/Cbe 32 0.0031 + 
R24 MGHI 15 0.041 + 
N27 Dea 36 0.0016 + 
Q51 Dea 46 2.3E-5 - 
K88 Cbe 28 0.0091 + 
R127 MGHI 38 0.00015 + 
K136 Cbm 23 0.025 + 
K154 Cbe 43 0.0012 + 
N172 Dea 39 0.021 + 
R173 3DG 34 0.017 + 
K234 Cbm 53 0.00023 + 
K237 Cbm/Cbe 39 0.0011 + 
R242 Cbe/MGHI 71 2.5E-6 + 
N246 Dea 37 0.07 + 
Q264 Dea 52 5.8E-6 + 
N265 Dea 39 0.00038 - 
N272 Dea 26 0.0026 - 
N278 Dea 78 7.8E-5 + 
N280 Dea 43 0.028 + 
Q291 Dea 72 0.00034 + 
Q298 Dea 78 6.8E-7 + 
K306 Cbm 57 0.00033 + 
N309 Dea 42 6.5E-5 + 
K315 Hex/Cbm 50 0.0009 + 
N326 Dea 92 7.8E-8 + 
Q360 Dea 41 8.4E-5 + 
K381 Cbm 29 0.0011 + 
K383 Cbe 20 0.011 + 
K389 Cbm/Cbe 49 0.00057 + 
K392 Cbe 79 8.7E-5 + 
Q393 Dea 79 8.7E-5 + 
Q399 Dea 77 7.3E-5 + 
R413 Cbe 79 0.00012 + 
N421 Dea 67 0.0006 + 
R437 MGH1 30 0.001 + 
R442 MGH1/Cbe/Hex 54 0.00014 + 
Q443 Dea 39 0.00014 - 
N444  Dea 39 0.00014 + 
N463 Dea 49 1.2E-5 - 
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Table 2:  
Tmax values for the BLA variants determined by DSC. 
 BLA Q9E N172D Q264E N265D Q360E K306M K383M R437L 
Tmax (°C) 103.2 100.6 98.9 99.2 102.9 102.7 103.4 103.2 103.1 
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Table 3:  
The kinetic parameters kcat, KM and kcat/KM for the BLA mutants and BLA determined at 30°C pH 7.0 on 
maltoheptaose (G7)-pNP substrate and amylose. 
 G7-pNP Amylose 
Sample kcat (s
-1) KM (mM) kcat/KM (s
-1 mM-1) kcat (s
-1) KM (mg/ml) kcat/KM (s
-1 mg-1 ml) 
BLA 65 ± 12 0.011 ± 0.003 5922 200 ± 8 0.140 ± 0.03 1455 
Q9E 63 ± 14 0.027 ± 0.008 2394 117 ± 12 0.112 ± 0.04 1099 
N172D 70 ± 9 0.013 ± 0.005 5462 201 ± 6 0.129 ± 0.01 1555 
Q264E 60 ± 5 0.005 ± 0.001 13013 228 ± 15 0.089 ± 0.02 2632 
N265D 83 ± 5 0.011 ± 0.002 7277 232 ± 28 0.128 ± 0.03 1852 
Q360E 155 ± 24 0.026 ± 0.005 5996 416 ± 17 0.261 ± 0.06 1630 
K306M 70 ± 4 0.010 ± 0.001 7335 213 ± 38 0.125 ± 0.04 1740 
K383M 69 ± 10 0.010 ± 0.002 7133 241 ± 33 0.139 ± 0.02 1743 
R437L 81 ± 18 0.010 ± 0.003 8153 307 ± 67 0.137 ± 0.02 2249 
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Abstract 
Non-enzymatic glycation of proteins can occur during production and storage of recombinant proteins. 
The modification can result in stability and activity loss. The glycation can undergo a series of 
rearrangement reactions to form a group of more reactive carbonyl compounds termed advanced 
glycation end products (AGEs). Mass spectrometry (MS) based methods for identification and 
quantification of the glycations could be a useful tool in the characterisation of the relative level of 
glycation during the various production stages and the storage of proteins. Specific glycation sites on 
peptides can be determined by liquid chromatography (LC) - tandem mass spectrometry (MS/MS), 
however, fragmentation techniques such as collision induced dissociation (CID) results in extensive 
patterns of neutral loss and loss of labile modifications such as glycations. Electron transfer 
dissociation (ETD) leaves labile modifications intact allowing for direct mapping of peptide 
modifications such as glycations. This report asses the utility of isobaric stable isotope tagging and 
ETD for relative quantification of glycations and the following AGEs. ETD is compared to higher 
energy collision dissociation (HCD) for the identification and quantification of glycated peptides. The 
ETD fragmentation allowed for identification of a considerably higher number of glycated peptides 
compared to HCD. Quantification of glycated peptides was performed with ETD though the method is 
not as efficient as HCD in the formation of reporter ions suitable for quantification. It was also 
observed that in some cases the glycated peptides could influence the quantification results for both of 
the fragmentation techniques.  
 
Introduction 
The production of enzymes for technical application in a wide range of different industries has been 
growing for the last couple of decades [1]. However, during production and storage proteins can be 
modified by non-enzymatic glycation which can result in loss of stability and activity [2–4]. A mass 
spectrometry (MS) based method for identification and relative quantification of the glycations could 
be a useful tool in the characterisation of the glycation levels during the various production stages and 
storage of enzymes. 
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The labile modification glycation is a non-enzymatic reaction between primary amines on proteins and 
the carbonyl group of a reducing sugar. Since the reaction occurs at amino groups, the N-terminal ends 
of proteins along with lysine and argenine residues are prone to the reaction. The glycation forms a 
ketoamine also known as the Amadori compound which can undergo a series of rearrangement 
reactions to forms a group of more reactive carbonyl compounds termed advanced glycation end 
products (AGEs) [5, 6]. These AGEs include 3-deoxyglucosone, carboxymethyl, carboxyethyl and 
Methylglyoxal-derived hydroimidazolone (MG-HI) as some of the most described [7–9].  
Specific glycation sites on peptides can be determined by liquid chromatography (LC) - tandem mass 
spectrometry (MS/MS), however, some of the most common fragmentation techniques results in 
extensive patterns of neutral loss and loss of labile modifications such as glycations [10-13]. Electron 
transfer dissociation (ETD) is a soft fragmentation method which is very suitable for characterisation 
of peptides containing post-translational modifications (PTM) as it leaves labile modifications intact 
allowing for direct mapping of peptide modifications [10, 12, 14–16]. ETD does, however, also have 
some limitations as it is most effective on triply or above charged ions and on ions below 850 m/z [17, 
18]. 
Quantification has become an important tool in MS based proteomics which has resulted in numerous 
different methods for either absolute or relative quantification [19–21]. However, only a few methods 
exists for relative quantification of glycations by LC-MS and these are generally based on addition of 
internal standards of the corresponding isotopically labelled glycated peptides [22, 23].  
Isobaric stable isotope tagging allows for relative quantifications of proteins or peptides between two 
or more samples (up to 8) by use of MS/MS. The isobaric tags are made from light and heavy isotopes 
which mean that all the tags have the same total mass as well as the same physiochemical properties. 
The tags consist of a reporter group, a balance group and an amino reactive end which react with the 
amino groups of lysine and the N-terminus of peptides. Each sample is digested and labelled where 
after all samples are mixed and the differentially labelled peptides are selected for MS/MS as a single 
precursor ion. Upon fragmentation the specific reporter ions for each sample are released allowing for 
relative quantification from the reporter ion ratios. The MS/MS spectrum of the peptide is not altered 
by the tags and can therefore also be used to identify the peptide sequence. One of the advantages of 
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this method is the low level of noise generally obtained in MS/MS [24–27]. It has previously been 
shown that ETD can be used for relative quantification with isobaric tags. However, the reporter ions 
produced by ETD differ from those produced by CID due to the different fragmentation mechanism, 
producing c- and z-ions. This has resulted in some of the isobaric tags producing the same reporter 
ions so for instance the TMT 6-plex tags could previously only quantify up to four samples. However, 
very recently the position of some of the heavy isotopes have been changed for the TMT 6-plex tags 
so each tag now generates a unique reporter ions in ETD fragmentation (114, 115, 116, 117, 118 
and119 from the 126-131 TMT tags, respectively) [28–31].  
In this report we examine the possibility of identifying and performing relative quantification of the 
labile modifications glycation and AGE’s with TMT tags fragmenting with ETD. The results obtained 
by the identification and quantification of glycations and AGEs by ETD are compared to results 
obtained by higher energy collision dissociation (HCD). For these experiments Barley α-
amylase/subtilisin inhibitor (BASI) is used as model protein as it is a smaller protein (20 kDa) 
consisting of 7 Lys and 12 Arg residues [32, 33].   
 
Materials and methods 
Sample preparation 
Barley α-amylase/subtilisin inhibitor (BASI) was provided by Novozymes (Bagsvaerd, Denmark). The 
TMTsixplex isobaric mass tagging kit was purchased from Thermo Scientific (Rockford, IL). BASI (2 
mg/ml) incubated 4 days (BASIG4) and 8 days (BASIG8) in 5% glucose 25 mM NaHCO3 0.1 mM 
CaCl2 0.01% Triton-x 100 pH 9.5 at 40°C. Glycated BASI was digested, reduced, alkylated and 
labelled with TMT tags according to manufacturer protocol. Two TMT labelled samples were 
prepared mixing 1:1 of BASIG4 and BASIG8 so the tags used were 126:128 and 127:130 
(BASIG4:BASIG8). Labelled samples were purified on Solid phase extraction cartridge (C18 
octadecyl standard density) purchased from 3M (St. Paul, MN) according to manufactures protocol. 
The samples were dried and diluted in 5% formic acid. 
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Liquid chromatography and mass spectrometry 
All experiments were performed on a LTQ Orbitrap XL mass spectrometer (Thermo Scientific) with 
nano-ESI source (Nanospray Flexion Source, Thermo Scientific) couple to an EASY-nLC II (Thermo 
Scientific). For LC-MS/MS the peptides were separated on Thermo Scientific EASY-Column (C18) 2 
cm x 100 µm i.d. column. The elution was performed from 5–50% acetonitril in 0.1% formic acid over 
60 min at a flow rate of 250 nl/min. MS
1
 was performed in the orbitrap mass analyser with 60,000 
resolution, automatic gain control (AGC) target was 500,000 with a maximum ion injection time of 
300 ms. AGC target for MS/MS was 40,000 for the ion trap and 100,000 for the orbitrap. Normalized 
collision energy of 55% were used for HCD and fragment ions were detected in the orbitrap with 7500 
resolution with a maximum injection time of 300 ms using 2 microscans selecting precursor ions in the 
range 300–2000 m/z. ETD reactions were performed for 85 ms detecting fragment ions in the ion trap 
with a maximum injection time of 100 ms using 1 microscan selecting precursor ions in the range 
350–1200 m/z. For both HCD and ETD the four most abundant precursors rejecting charge state 1 for 
HCD and charge state 1 and 2 for ETD.   
 
Data analysis 
The data analysis was performed using Mascot Distiller (Matrix Science, UK), Mascot Daemon 
(Matrix Science, UK) and the Mascot search engine (Matrix Science, UK) for spectra processing, 
search automation, protein/peptide identification and quantification. The searches were conducted 
against a custom made database containing 14100 sequences (mainly enzyme sequences from different 
organisms) searching against tryptic peptides allowing 5 missed cleavages with 10 ppm precursor 
mass tolerance, 0.5 Da fragments mass tolerance for ETD and 0.02 Da mass tolerance for HCD with 
decoy database enabled. Static modification TMT6plex of N-terminus and carbamidomethyl (C) was 
set and the following variable modifications were chosen: Deamidation (NQ), Hex (KR), 3-
deoxyglucosone (KR), carboxymethyl (KR), carboxyethyl (KR), MG-HI (KR), Oxidation (M). For the 
TMT quantification normalization was not used, auto outlier removal was chosen and peptide 
threshold was set to above homology level. Each sample was determined by 3 runs. The quantification 
results were assessed by a 3-factor full factorial ANOVA model where outlier detection was used. 
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Results and discussion 
Identification of glycation sites 
BASI is a smaller protein (20 kDa) consisting of 181 amino acids with 7 Lys and 12 Arg residues. 
This makes it a good model protein for the study of glycations as it relatively small but there are still 
multiple possible glycation sites. Therefore digest of the glycated protein provides multiple glycated 
peptides.   
BASI was glycated by incubation with glucose for four (BASIG4) and eight days (BASIG8). The two 
samples were digested and labelled with TMT; 126 and 127 for BASIG4 and TMT 128 and 130 for 
BASIG8. The labelled samples were mixed 1:1 (126:128 and 127:130) and analysed by ETD and 
HCD. 
 
Table 1. Glycated peptides from BASI identified (ID) and quantified by ETD and HCD. Covered is 
the mapping of the glycated residue in the obtained peptide sequence coverage. The glycated residue is 
shown in bold. Hex: glucose, CBM: carboxymethyl, CBE: carboxyethyl, MG-H1:methylglyoxal-
derived hydroimidazolone. 
Amino acid Peptide Glycation ID Covered Quantified 
1-27 ADPPPVHDTDGHELRADANYYVLSANR CBE ETD ETD  
16-41 ADANYYVLSANRAHGGGLTMAPGHGR MG-H1 ETD/HCD ETD ETD/HCD 
16-41 ADANYYVLSANRAHGGGLTMAPGHGR CBM ETD/HCD ETD/HCD HCD 
16-41 ADANYYVLSANRAHGGGLTMAPGHGR CBE ETD/HCD ETD HCD 
28-61 AHGGGLTMAPGHGRHCPLFVSQDPNGQHDGFPVR MG-H1 ETD ETD  
42-72 HCPLFVSQDPNGQHDGFPVRITPYGVAPSDK MG-H1 ETD ETD  
62-75 ITPYGVAPSDKIIR Hex ETD/HCD ETD/HCD HCD 
62-75 ITPYGVAPSDKIIR CBM ETD/HCD ETD/HCD HCD 
76-85 LSTDVRISFR MG-H1 HCD HCD HCD 
76-85 LSTDVRISFR CBM ETD/HCD ETD HCD 
76-85 LSTDVRISFR CBE ETD/HCD ETD HCD 
86-107 AYTTCLQSTEWHIDSELAAGRR CBE ETD/HCD ETD HCD 
107-122 RHVITGPVKDPSPSGR CBM ETD ETD  
107-122 RHVITGPVKDPSPSGR MG-H1 ETD ETD  
108-122 HVITGPVKDPSPSGR Hex ETD/HCD ETD ETD/HCD 
108-122 HVITGPVKDPSPSGR CBM ETD/HCD ETD/HCD ETD/HCD 
123-130 ENAFRIEK MG-H1 ETD/HCD ETD/HCD HCD 
128-140 IEKYSGAEVHEYK Hex ETD/HCD ETD ETD/HCD 
128-140 IEKYSGAEVHEYK CBM ETD/HCD ETD/HCD HCD 
131-155 YSGAEVHEYKLMSCGDWCQDLGVFR Hex ETD/HCD ETD ETD/HCD 
141-158 LMSCGDWCQDLGVFRDLK MG-H1 ETD/HCD ETD/HCD HCD 
141-158 LMSCGDWCQDLGVFRDLK CBM ETD/HCD ETD HCD 
141-158 LMSCGDWCQDLGVFRDLK CBE ETD/HCD ETD HCD 
156-176 DLKGGAWFLGATEPYHVVVFK Hex ETD/HCD ETD ETD/HCD 
156-176 DLKGGAWFLGATEPYHVVVFK CBM ETD/HCD ETD/HCD ETD/HCD 
159-177 GGAWFLGATEPYHVVVFKK Hex ETD/HCD ETD ETD/HCD 
159-177 GGAWFLGATEPYHVVVFKK CBM ETD/HCD ETD/HCD ETD/HCD 
159-181 GGAWFLGATEPYHVVVFKKAPPA MG-H1 ETD/HCD  HCD 
 
The analysis of the samples resulted in identification of multiple glycated Lys and Arg residues, Table 
1, where several of the glycations were the advanced glycation end-products (AGEs): carboxymethyl, 
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carboxyethyl and methylglyoxal-derived hydroimidazolone (MG-HI). As expected ETD identified 
more glycation sites than HCD. ETD fragmentation also provided better sequence coverage of the 
glycated peptides. This is because ETD does not cleave of the modification during the fragmentation 
so the peptide fragments carrying the glycation can be identified by the Mascot search engine hereby 
giving higher peptide sequence coverage. Many of the glycated peptides were also identified with 
HCD though for most of these the glycated residues were not mapped. Though for some of the 
glycated peptides peaks corresponding to glycated peptide fragments were found in the HCD spectra.  
When the sequence coverage and the Lys and Arg residues are not covered the Mascot search engine 
assigns the glycation to the Arg or Lys residue in the C-terminal instead of the missed cleavage site. 
Trypsin does not cleave at a glycation site so the glycation should be at the missed cleavage site. This 
inability to assign the correct glycation site for glycated peptides with low sequence coverage were 
also observed in other experiments with SEQUEST as search engine (data not shown). The peptide 
G159 – A181was found to contain the MG-HI glycation but the sequence coverage was not very good 
with either of the fragmentation methods so it is not possible to determine which of the two Lys 
residues are modified (K176 or K177), though Mascot assigns the modification to K177. 
These data supports that ETD is an efficient fragmentation method for sequencing peptides with labile 
modifications such as glycations compared to methods such as HCD. Though HCD can be used for the 
identification of glycations however, the identification rate is lower as well as the sequence coverage 
of the glycated peptides and hereby identification of the specific glycation site.   
 
Relative quantification of glycation sites 
The two samples BASIG4 and BASIG8 was digested, labelled with TMT and mixed as described in 
the previous section. The intensities of the reporter ions are important for the quantification as reporter 
ions with low intensity exhibit poor quantifications providing high error rates. The reporter ions in 
ETD has to exceed 1,000 and for HCD 100,000 to achieve average errors below 10% [30]. Therefore, 
quantifications were only used for spectra with reporter ions above these intensities. 
The glycated peptides are quantified by ETD and HCD, Table 1. Quantification results are obtained by 
HCD for all the glycated peptides identified by this method whereas only around a third of the 
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glycated identified by ETD are quantified by this method. The lower number of peptide 
quantifications by ETD have also been observed and the reason for this is explained by others [30, 31].    
The ETD fragmentation produced lower reporter ion intensities and some of the ETD spectra for the 
identified glycated peptides did not contain any reporter ions. Viner and co-workers [31] speculate that 
the lower intensities for the reporter ions are due to ETD cleaving randomly along the peptide 
backbone unlike HCD and therefore produces lower yield of reporter ions.   
 
 
Figure 1. Relative quantification of glycated peptides between BASI incubated four days (BASIG4) and eight 
days (BASIG8) in glucose. The ratio is are for BASIG8/BASIG4 mixed 1:1 after labelling with the reporter ions 
128 and 130 for BASIG8, 126 and 127 for BASIG4. The relative quantification was determined with LC-
MS/MS fragmenting with ETD and HCD. 
 
The significance of the quantification results were evaluated by statistical analysis using a 3-factor full 
factorial ANOVA model on the peptides with the following glycations: K115, K158, K176 glycated 
with glucose as well as K158 and K176 glycated with carboxymethyl. These glycated peptides were 
chosen for the statistical analysis as they had more than one quantification determination for each of 
the  label combinations (130/127 and 128/126) with both fragmentation methods. Outlier removal was 
used to remove six determinations from the dataset. 
The quantification results for the five glycated peptides obtained for the different label combinations 
with the two fragmentation methods are shown in Figure 1 and the overall quantification results 
obtained by ETD and HCD for the five peptides are listed in Figure 2. The figures reveal that the 
quantification results obtained by HCD generally are higher than the ones obtained by ETD. 
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Figure 2. Comparison of relative quantification results for glycated peptides from BASI obtained by LC-MS/MS 
fragmenting with HCD and ETD. The ratios are for BASIG8/BASIG4. 
 
The statistical analysis revealed that the performance of the fragmentation methods depends on the 
glycated peptide analysed. HCD and ETD perform similarly on the peptides containing K115 and 
K176 glycated with glucose but the methods are giving significantly different results on the peptides 
containing K158 glycated with glucose, K158 and K176 glycated with carboxymethyl. The analysis 
also agreed with the observations from Figure 1 and 2 that the quantification ratios obtained by HCD 
are higher than the ones obtained by ETD. The performance of the fragmentation methods depends on 
the glycated peptides. This could at least partly be caused by the extensive pattern of neutral loss 
which HCD fragmentation of glycated peptides can result in. This neutral loss pattern could interfere 
with the reporter ions providing the variations in the ratio calculations between the two methods.   
The statistical analysis also revealed that the performance of the labels can depend on the glycated 
peptides. This was observed for the peptide with glycated K115 and the peptide containing K176 
glycated with carboxymethyl where the 128/126 and the 130/127 ratios differed significantly. The 
glycated peptides influence on the performance of the labels could be caused by the neutral losses 
occurring in HCD described previously. It is also possible that the fragmentation of some peptides 
form peptide ions close to or with the same mass as the reporter ions hereby interfering with the 
intensity of the reporter ions resulting in too high or too low quantification ratios. 
It is therefore necessary to used different label combinations for the quantification of glycated peptides 
to evaluate if the results are influenced by the glycated peptides. It has been proposed by others [31] to 
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used ETD for the identification of labile modifications and HCD for the quantification. Though as the 
glycated peptides can interfere with the quantification results it might be advisable to use both 
methods to determine if the results are reproducible by both. 
A larger investigation of the influence of the glycated peptides using more TMT labels and the 
different fragmentation methods might provide more insight into how the glycated peptides affect the 
performance of the fragmentation methods and the tags. This could also provide better insight into 
how to plan quantification experiment with TMT for the quantification of glycated peptides.   
 
Conclusion 
ETD outperforms HCD for the identification of glycation sites by LC-MS/MS as it identifies more 
glycated peptides and with higher sequence coverage. ETD is able to perform quantification of the 
glycated peptides with TMT labelling though the reporter ion intensities obtained by ETD are low so 
for many of the glycated peptides identified quantification cannot be performed. The reporter ion 
intensities produced by HCD are all high enough for quantification. Statistical analysis revealed that 
the glycated peptides can influence the quantification results. It is therefore important to perform the 
quantifications with different label combinations and also different fragmentation methods to 
determine if the results are correct.  
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